<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">41673</article-id><article-id pub-id-type="doi">10.7554/eLife.41673</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Genetic effects on promoter usage are highly context-specific and contribute to complex traits</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-113614"><name><surname>Alasoo</surname><given-names>Kaur</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1761-8881</contrib-id><email>kaur.alasoo@ut.ee</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121103"><name><surname>Rodrigues</surname><given-names>Julia</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121104"><name><surname>Danesh</surname><given-names>John</given-names></name><email>jd292@medschl.cam.ac.uk</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121105"><name><surname>Freitag</surname><given-names>Daniel F</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-121106"><name><surname>Paul</surname><given-names>Dirk S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8230-0116</contrib-id><email>dsp35@medschl.cam.ac.uk</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121107"><name><surname>Gaffney</surname><given-names>Daniel J</given-names></name><email>dg13@sanger.ac.uk</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Institute of Computer Science</institution><institution>University of Tartu</institution><addr-line><named-content content-type="city">Tartu</named-content></addr-line><country>Estonia</country></aff><aff id="aff2"><label>2</label><institution>Wellcome Sanger Institute, Wellcome Genome Campus</institution><addr-line><named-content content-type="city">Hinxton</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care</institution><institution>University of Cambridge</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">British Heart Foundation Centre of Excellence, Division of Cardiovascular Medicine</institution><institution>Addenbrooke’s Hospital</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">National Institute for Health Research Blood and Transplant Unit (NIHR BTRU) in Donor Health and Genomics, Department of Public Health and Primary Care</institution><institution>University of Cambridge</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Parker</surname><given-names>Stephen</given-names></name><role>Reviewing Editor</role><aff><institution>University of Michigan</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>McCarthy</surname><given-names>Mark I</given-names></name><role>Senior Editor</role><aff><institution>University of Oxford</institution><country>United Kingdom</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>08</day><month>01</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>8</volume><elocation-id>e41673</elocation-id><history><date date-type="received" iso-8601-date="2018-09-05"><day>05</day><month>09</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2019-01-08"><day>08</day><month>01</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Alasoo et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Alasoo et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-41673-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.41673.001</object-id><p>Genetic variants regulating RNA splicing and transcript usage have been implicated in both common and rare diseases. Although transcript usage quantitative trait loci (tuQTLs) have been mapped across multiple cell types and contexts, it is challenging to distinguish between the main molecular mechanisms controlling transcript usage: promoter choice, splicing and 3ʹ end choice. Here, we analysed RNA-seq data from human macrophages exposed to three inflammatory and one metabolic stimulus. In addition to conventional gene-level and transcript-level analyses, we also directly quantified promoter usage, splicing and 3ʹ end usage. We found that promoters, splicing and 3ʹ ends were predominantly controlled by independent genetic variants enriched in distinct genomic features. Promoter usage QTLs were also 50% more likely to be context-specific than other tuQTLs and constituted 25% of the transcript-level colocalisations with complex traits. Thus, promoter usage might be an underappreciated molecular mechanism mediating complex trait associations in a context-specific manner.</p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.41673.002</object-id><title>eLife digest</title><p>Genes contain all instructions needed to build an organism in form of DNA. Humans share around 99.5% of DNA, but it is the remaining 0.5% that contain the small genetic variations that make us unique. Subtle differences in genes can, for example, influence the color of our hair or eyes.</p><p>To build gene products, such as proteins, DNA first needs to be transcribed into RNA. Some genetic variants can affect how a gene is transcribed into an RNA molecule, for example by making it be transcribed too much or too little, which can lead to diseases. These variants can also influence where the transcription begins through a process called promoter usage. This can lead to shorter or longer RNAs, which can have different biological impacts.</p><p>With current research methods it is difficult to detect changes in the latter kind of alteration. As a result, it is harder to distinguish these from other types of changes. Now, Alasoo et al. wanted to find out what proportion of genetic variants that alter traits influence promoter usage, compared to other changes. To do so, a new computational method was developed to directly measure how genetic variants influence different parts of the RNA, such as promoters, middle sections and ends. The method was then applied to datasets of human immune cells. The experiments revealed that genetic variants often influence promoter usage. Many of the effects could only be found when cells are exposed to external stimuli, such as bacteria.</p><p>The results highlight that to discover genes responsible for human traits and disease we need to consider all the possible ways genetic differences between individuals could alter the gene products. Large published datasets could be reanalyzed using this method to identify new genes that could be implicated in human health and disease, potentially leading to new treatment options in future.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>splicing</kwd><kwd>RNA-seq</kwd><kwd>macrophages</kwd><kwd>genetics</kwd><kwd>transcription</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>WT09805</award-id><principal-award-recipient><name><surname>Alasoo</surname><given-names>Kaur</given-names></name><name><surname>Rodrigues</surname><given-names>Julia</given-names></name><name><surname>Gaffney</surname><given-names>Daniel J</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002301</institution-id><institution>Estonian Research Council</institution></institution-wrap></funding-source><award-id>MOBJD67</award-id><principal-award-recipient><name><surname>Alasoo</surname><given-names>Kaur</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>WT099754/Z/12/Z</award-id><principal-award-recipient><name><surname>Alasoo</surname><given-names>Kaur</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002301</institution-id><institution>Estonian Research Council</institution></institution-wrap></funding-source><award-id>IUT34-4</award-id><principal-award-recipient><name><surname>Alasoo</surname><given-names>Kaur</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000274</institution-id><institution>British Heart Foundation</institution></institution-wrap></funding-source><award-id>RG/13/13/30194</award-id><principal-award-recipient><name><surname>Danesh</surname><given-names>John</given-names></name><name><surname>Freitag</surname><given-names>Daniel F</given-names></name><name><surname>Paul</surname><given-names>Dirk S</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>British Heart Foundation Cambridge Centre of Excellence</institution></institution-wrap></funding-source><award-id>RE/13/6/30180</award-id><principal-award-recipient><name><surname>Danesh</surname><given-names>John</given-names></name><name><surname>Freitag</surname><given-names>Daniel F</given-names></name><name><surname>Paul</surname><given-names>Dirk S</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/L003120/1</award-id><principal-award-recipient><name><surname>Danesh</surname><given-names>John</given-names></name><name><surname>Freitag</surname><given-names>Daniel F</given-names></name><name><surname>Paul</surname><given-names>Dirk S</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000272</institution-id><institution>National Institute for Health Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Danesh</surname><given-names>John</given-names></name><name><surname>Freitag</surname><given-names>Daniel F</given-names></name><name><surname>Paul</surname><given-names>Dirk S</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>WT098503</award-id><principal-award-recipient><name><surname>Gaffney</surname><given-names>Daniel J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Re-analysis of large gene expression datasets with state-of-the-art quantification methods reveals additional candidate genes mediating complex trait associations.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Genome-wide association studies (GWAS) have discovered thousands of genetic loci associated with complex traits and diseases. However, identifying candidate causal genes and molecular mechanisms at these loci remains challenging. Complex trait-associated variants are enriched in regulatory elements and are therefore thought to act via regulation of gene expression levels, often in a cell type- and context-specific manner (<xref ref-type="bibr" rid="bib3">Alasoo et al., 2018</xref>; <xref ref-type="bibr" rid="bib23">Fairfax et al., 2014</xref>; <xref ref-type="bibr" rid="bib40">Kim-Hellmuth et al., 2017</xref>). However, such variants are equally enriched among splicing quantitative trait loci (QTLs) (<xref ref-type="bibr" rid="bib26">Fraser and Xie, 2009</xref>; <xref ref-type="bibr" rid="bib47">Li et al., 2016</xref>) and incorporating splicing QTLs in a transcriptome-wide association study increased the number of disease-associated genes by twofold (<xref ref-type="bibr" rid="bib48">Li et al., 2018</xref>). In addition to splicing, genetic variants can also alter transcript sequence by regulating promoter and 3ʹ end usage, which we refer to collectively hereafter as transcript usage QTLs (tuQTLs). Alternative transcript start and end sites underlie most transcript differences between tissues (<xref ref-type="bibr" rid="bib61">Pal et al., 2011</xref>; <xref ref-type="bibr" rid="bib66">Reyes and Huber, 2018</xref>), they are dynamically regulated in response to cellular stimuli (<xref ref-type="bibr" rid="bib1">Alasoo et al., 2015</xref>; <xref ref-type="bibr" rid="bib67">Richards et al., 2017</xref>) and they are also frequently dysregulated in cancer (<xref ref-type="bibr" rid="bib18">Demircioğlu et al., 2017</xref>; <xref ref-type="bibr" rid="bib46">Lee et al., 2018</xref>). Moreover, experimental procedures designed to capture either 5ʹ or 3ʹ ends of transcripts have identified disease-relevant genetic variants that regulate promoter or 3ʹ end usage (<xref ref-type="bibr" rid="bib28">Garieri et al., 2017</xref>; <xref ref-type="bibr" rid="bib84">Zhernakova et al., 2013</xref>). However, well-powered RNA-seq-based tuQTL studies performed across cell types (<xref ref-type="bibr" rid="bib9">Battle et al., 2014</xref>; <xref ref-type="bibr" rid="bib15">Chen et al., 2016</xref>; <xref ref-type="bibr" rid="bib44">Lappalainen et al., 2013</xref>; <xref ref-type="bibr" rid="bib47">Li et al., 2016</xref>; <xref ref-type="bibr" rid="bib60">Ongen and Dermitzakis, 2015</xref>) and conditions (<xref ref-type="bibr" rid="bib54">Nédélec et al., 2016</xref>; <xref ref-type="bibr" rid="bib80">Ye et al., 2018</xref>) have thus far not distinguished between promoter usage, splicing and 3ʹ end usage. Thus, how these distinct transcriptional mechanisms contribute to complex traits and how context-specific these genetic effects are is currently unclear.</p><p>In addition to splicing analysis, RNA-seq data can also be used to quantify promoter and 3ʹ end usage. The simplest approach would be to first quantify the expression of all annotated transcripts using one of the many quantification algorithms (benchmarked in <xref ref-type="bibr" rid="bib73">Teng et al., 2016</xref>). Linear regression can then be used to identify genetic variants that are associated with the usage of each transcript of a gene (<xref ref-type="bibr" rid="bib48">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib60">Ongen and Dermitzakis, 2015</xref>). Comparing the associated transcripts to each other can reveal which transcriptional changes take place (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). A key assumption here is that all expressed transcripts are also part of the annotation catalog. If some of the expressed transcripts are missing, then reads originating from the missing transcripts might be erroneously assigned to other transcripts that are not expressed at all (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) (<xref ref-type="bibr" rid="bib71">Soneson et al., 2018</xref>). This can lead to individual genetic variants being spuriously associated with multiple transcriptional changes. For example, a genetic variant regulating promoter usage might also appear to be associated with the inclusion of an internal exon (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), although there are no reads originating from that exon. Importantly, this is not just a theoretical concern, because 25–35% of the exon-exon junctions observed in RNA-seq data are not present in transcript databases (<xref ref-type="bibr" rid="bib60">Ongen and Dermitzakis, 2015</xref>), and up to 60% of the transcripts annotated by Ensembl (<xref ref-type="bibr" rid="bib81">Zerbino et al., 2018</xref>) are truncated at the 5ʹ or 3ʹ end (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>).</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.41673.003</object-id><label>Figure 1.</label><caption><title>Challenges of quantifying transcript usage from RNA-seq data.</title><p>Transcript quantification seeks to estimate the most likely configuration of <italic>known</italic> transcripts that best explains observed read counts supporting the inclusion of each exon. (<bold>A</bold>) In scenario A, each copy of the G allele increases the usage of transcript 2 by 10%. Since both expressed transcripts (transcript 1 and transcript 2) are annotated, we successfully detect the change and conclude that the G allele increases the expression of the proximal promoter of the gene. (<bold>B</bold>) In scenario B, each copy of the G allele still increases the usage of transcript 2 by 10%. However, since transcript 2 is missing from the annotations, reads originating from transcript 2 are now falsely assigned to transcript 3. Since transcript 3 also contains alternative second exon, we now falsely conclude that in addition to promoter usage, the G allele is also associated with increased inclusion of exon 2, even though there are no reads mapping to exon 2. Furthermore, the magnitude of the genetic effect is underestimated, because the reads assigned to transcript 3 are assumed to be evenly distributed across the promoter and the alternative exon. (<bold>C</bold>) Top panel: Two hypothetical transcripts that differ from each other at the promoter, at an internal exon and at the 3ʹ end. Middle panel: Leafcutter uses reads mapping to exon-exon junctions to identify alternatively excised introns. Bottom panel: txrevise uses the exons shared between transcripts (dark blue) as a scaffold to construct three independent transcriptional events from the two original transcripts.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Prevalence of truncated transcripts in the Ensembl database.</title><p>For protein coding transcripts, we extracted the cds_start_NF and cds_end_NF fields from the Ensembl v87 GTF file to identify transcripts that were truncated at either 5ʹ or 3ʹ ends. For non-protein coding transcripts, we considered all transcripts annotated as nonsense_mediated_decay, processed_transcript or retained_intron to be truncated at both 5ʹ or 3ʹ ends, because we observed that many of those started and ended abruptly in the middle of exons. We included only protein coding genes in the analysis.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.005</object-id><label>Figure 1—figure supplement 2.</label><caption><title>Extending truncated transcript annotations with txrevise.</title><p>(<bold>A</bold>) Original transcript annotations for <italic>IRF5</italic> in the Ensembl database. (<bold>B</bold>) Txrevise extends truncated <italic>IRF5</italic> transcripts by copying over exons from the longest transcript of the gene (ENST00000402030). The dark blue regions represent the annotated coding regions while the light blue regions represent either 5ʹ or 3ʹ UTRs or non-coding transcripts. This functionality is implemented in the extendTranscriptsPerGene function of the txrevise R package.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.006</object-id><label>Figure 1—figure supplement 3.</label><caption><title>Identifying groups of transcripts that share the most exons.</title><p>Before we can use txrevise to stratify transcripts into events, we need to identify a group of transcripts that all share at least one exon. <italic>IRF5</italic> has three exons that are shared between all of the transcripts and so we could use those as a scaffold for txrevise to construct independent transcriptional events (group 2). However, some genes do not have any exons that are shared across all transcripts. In that case, it might be preferential to choose the largest group of transcripts that share the most exons (group 1). Furthermore, even in the case of <italic>IRF5</italic>, one transcript (ENST00000613821) is much shorter than others and excluding it might lead to better stratification of transcripts into alternative promoter, internal exon and 3ʹ end events (group 1). However, it is challenging to automatically decide whether to prefer more shared exons between transcripts (as illustrated by group 1) or larger number of transcripts (eg. group 2). Thus, txrevise uses an heuristic approach that first ranks groups of transcripts according to the number of exons that they share and then picks the first two groups that share the largest number of exons between each other. In case of IRF5, these two groups are denoted as group 1 and group 2 on this figure. This functionality is implemented by the identifyTranscriptGroups function of the txrevise R package.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig1-figsupp3-v2.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.007</object-id><label>Figure 1—figure supplement 4.</label><caption><title>Filling in alternative internal exons for promoter and 3ʹ end events.</title><p>(<bold>A</bold>) Original transcript start events constructed by txrevise contain an alternative second exon. (<bold>B</bold>) To construct promoter events, the alternative second exon is added into all transcripts and redundant transcripts are removed.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig1-figsupp4-v2.tif"/></fig></fig-group><p>To overcome the issue of missing transcript annotations, recent tuQTL studies have focussed on quantifying transcription at the level of individual exons (<xref ref-type="bibr" rid="bib22">Fadista et al., 2014</xref>; <xref ref-type="bibr" rid="bib44">Lappalainen et al., 2013</xref>; <xref ref-type="bibr" rid="bib57">Odhams et al., 2017</xref>), introns (<xref ref-type="bibr" rid="bib57">Odhams et al., 2017</xref>) or exon-exon junctions (<xref ref-type="fig" rid="fig1">Figure 1C</xref>) (<xref ref-type="bibr" rid="bib48">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib57">Odhams et al., 2017</xref>; <xref ref-type="bibr" rid="bib60">Ongen and Dermitzakis, 2015</xref>). While these approaches often discover complementary genetic associations (<xref ref-type="bibr" rid="bib57">Odhams et al., 2017</xref>; <xref ref-type="bibr" rid="bib60">Ongen and Dermitzakis, 2015</xref>), they do not explicitly reveal the transcriptional mechanism (promoter usage, alternative splicing or 3ʹ end usage) underlying the genetic associations. The most successful approach to differentiate between distinct transcriptional mechanisms has been ‘event-level’ analysis where reference transcripts are split into independent events (e.g. promoters, splicing events and 3ʹ ends) whose expressions is then quantified using standard transcript quantification methods (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). This approach was pioneered by MISO (<xref ref-type="bibr" rid="bib37">Katz et al., 2010</xref>) and was recently used to identify promoter usage QTLs in the GEUVADIS dataset (<xref ref-type="bibr" rid="bib67">Richards et al., 2017</xref>). Despite its success, MISO covers only a subset of promoter events (alternative first exons) and its event annotations have not been updated since it was first published. Thus, there is a need for a method that is able to detect a comprehensive set of promoter, splicing and 3ʹ end usage QTLs in an uniform manner.</p><p>In this study, we re-analysed RNA-seq data from human induced pluripotent stem cell-derived macrophages (IPSDMs) exposed to three inflammatory stimuli (18 hr IFNɣ stimulation, 5 hr <italic>Salmonella</italic> infection and IFNɣ stimulation followed by <italic>Salmonella</italic> infection) (<xref ref-type="bibr" rid="bib3">Alasoo et al., 2018</xref>). We also collected a new dataset of IPSDMs from 70 individuals stimulated with acetylated LDL (acLDL) for 24 hr. We mapped genetic associations at the level of total gene expression, full-length transcript usage and exon-exon junction usage in each experimental condition. In addition to existing quantification methods, we also developed a complementary approach (txrevise) that stratifies reference transcript annotations into independent promoter, splicing and 3ʹ end events. Using txrevise, we found that promoter and 3ʹ end usage QTLs constituted 55% of detected tuQTLs, exhibited distinct genetic architectures from canonical expression or splicing QTLs, and often colocalised with complex trait associations. Promoter usage QTLs were also 50% more likely to be context-specific than canonical splicing QTLs. Thus, context-specific regulation of promoter usage might be a previously underappreciated molecular mechanism underlying complex trait associations.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Quantifying transcript usage in stimulated macrophages</title><p>We analysed RNA-seq data from human induced pluripotent stem cell (iPSC)-derived macrophages exposed to three inflammatory stimuli (18 hr IFNɣ stimulation, 5 hr <italic>Salmonella</italic> infection, and IFNɣ stimulation followed by <italic>Salmonella</italic> infection) and one metabolic stimulus (24 hr acLDL stimulation). While the gene expression analysis of the IFNɣ+<italic>Salmonella</italic> dataset from 84 individuals has previously been described (<xref ref-type="bibr" rid="bib3">Alasoo et al., 2018</xref>), the acLDL data from 70 individuals was newly generated for the current study. The acLDL dataset allowed us to assess how our results generalise to weaker, non-inflammatory stimuli. Both datasets included independent unstimulated control samples (denoted as ‘naive’ and ‘Ctrl’). In each condition, we quantified gene expression and transcript usage using the following established quantification approaches: (i) gene-level read count quantified with featureCounts (<xref ref-type="bibr" rid="bib49">Liao et al., 2014</xref>), (ii) full-length transcript usage quantified with Salmon (<xref ref-type="bibr" rid="bib62">Patro et al., 2017</xref>) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), and (iii) exon-exon junction usage quantified with Leafcutter (<xref ref-type="bibr" rid="bib48">Li et al., 2018</xref>) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>).</p><p>Inspired by event level analysis proposed by MISO (<xref ref-type="bibr" rid="bib37">Katz et al., 2010</xref>; <xref ref-type="bibr" rid="bib67">Richards et al., 2017</xref>), we also developed a complementary approach (txrevise) to stratify reference transcript annotations into independent promoter, splicing and 3ʹ end events. To achieve this, txrevise identifies constitutive exons shared between all transcripts of a gene and uses those to assign non-constitutive exons to promoter, internal exon or 3ʹ end events (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Since up to 60% of the transcripts annotated by Ensembl (<xref ref-type="bibr" rid="bib81">Zerbino et al., 2018</xref>) are truncated at the 5ʹ or 3ʹ end (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), txrevise extends truncated transcripts by copying over exons from the longest transcript of the gene (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). This step eliminates a large number of implausible alternative promoter and 3ʹ end events that lack experimental evidence. To make the approach suitable for genes with non-overlapping transcripts, we also select a subset of transcripts that share the largest number of exons between them (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). Finally, to ensure that the new alternative promoter and 3ʹ end events do not capture splicing changes, txrevise masks alternative exons in promoter and 3ʹ end events that are not the first or last exons (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>). Although this means that some splicing events near the promoters and 3ʹ ends of the genes may remain undetected by txrevise, it is a trade-off that improves the overall interpretability of txrevise tuQTLs. The R package as well as custom transcriptional events constructed by txrevise are available from GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/kauralasoo/txrevise">https://github.com/kauralasoo/txrevise</ext-link>; <xref ref-type="bibr" rid="bib4">Alasoo, 2018a</xref>).</p></sec><sec id="s2-2"><title>Genetic effects on transcript usage</title><p>Depending on the experimental condition and quantification method, we detected between 1500 and 3500 QTLs at a 10% false discovery rate (FDR) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Leafcutter consistently detected the lowest number of QTLs per condition, while txrevise detected approximately 30% more associations than other methods (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), 55% of which affected promoter or 3ʹ end usage instead of internal exons (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). However, this increase in QTLs can be partially explained by the fact that txrevise detected multiple associations for ~24% of the genes while the full-length tuQTL analysis was limited to single lead association per gene (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). Some of these additional QTLs are likely to represent independent causal variants, such as the three independent tuQTLs detected for the <italic>IRF5</italic> gene (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>) while others could be explained by technical biases such as large gene expression QTL (eQTL) effects (<xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5</xref>) or positional biases in the RNA-seq data (<xref ref-type="fig" rid="fig2s6">Figure 2—figure supplement 6</xref>). Alternatively, additional associations could also be caused by transcriptional coupling where promoter or 3ʹ end choice directly influences the splicing of an internal exon or <italic>vice versa</italic> (<xref ref-type="bibr" rid="bib6">Anvar et al., 2018</xref>; <xref ref-type="bibr" rid="bib13">Bentley, 2014</xref>).</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.41673.008</object-id><label>Figure 2.</label><caption><title>Diversity of QTLs detected by different quantification methods.</title><p>In panels A-C, all txrevise QTLs from promoters, internal exons and 3ʹ ends have been pooled to facilitate comparison with eQTLs as well as Leafcutter and full-length transcript usage QTLs. (<bold>A</bold>) Number of QTLs detected by read count, full-length transcript usage, Leafcutter and txrevise methods in each condition (N, naive; I, IFNɣ; S, <italic>Salmonella</italic>; I + S, IFNɣ+<italic>Salmonella</italic>; Ctrl; AcLDL) at 10% FDR. The number of QTLs detected by Leafcutter and txrevise are reported at the level of independent events (intron clusters or promoters/internal exons/3ʹ ends) and can include multiple QTLs per gene (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). The quantile-quantile plots are presented in <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>. (<bold>B</bold>) Sharing of QTLs detected by four quantification methods. The numbers on the heatmap show the fraction of QTLs detect by one method that were replicated by each of the three other methods (r<sup>2</sup> &gt;0.8 between lead variants). Only QTLs with FDR &lt; 0.01 were included in the analysis. (<bold>C</bold>) Enrichment of genomic annotations at QTLs detected by the four quantification methods. (<bold>D</bold>) Comparison of Leafcutter tuQTLs to promoter, internal exon and 3ʹ end usage QTLs detected by txevise. Genomic annotations used for enrichment analysis: <italic>promoter</italic> - promoter flanking regions (−2000 bp to +200 bp); <italic>5ʹ UTR, coding, intron, 3ʹ UTR</italic> - corresponding regions extracted from Ensembl transcripts; <italic>poly(A)</italic> - experimentally determined polyadenylation sites (±25 bp) (<xref ref-type="bibr" rid="bib30">Gruber et al., 2016</xref>); <italic>open chromatin</italic> - open chromatin regions from macrophages (<xref ref-type="bibr" rid="bib3">Alasoo et al., 2018</xref>); <italic>splicing factor</italic> - experimentally determined binding sites of splicing factors detected by eCLIP (<xref ref-type="bibr" rid="bib76">Van Nostrand et al., 2017</xref>). The points on panels C and D show the natural logarithm of enrichment for each annotation and the lines represent the 95% confidence intervals from fgwas (<xref ref-type="bibr" rid="bib64">Pickrell, 2014</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.009</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Diversity of transcript usage QTLs.</title><p>(<bold>A</bold>) Number of detected transcript usage QTLs affecting exon-exon junction usage (Leafcutter) or different parts of the transcript (promoters, internal exons, 3ʹ ends) in each experimental condition. N, naive; I, IFNɣ; S, <italic>Salmonella</italic>; I + S, IFNɣ+<italic>Salmonella</italic>. (<bold>B</bold>) Fraction of txrevise promoter, internal exon and 3ʹ end usage QTLs that were replicated by Leafcutter (lead variant within r<sup>2</sup> &gt;0.8 for the same gene; see Materials and methods).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.010</object-id><label>Figure 2—figure supplement 2.</label><caption><title>Fraction of genes with multiple independent tuQTLs detected by Leafcutter and txrevise.</title><p>We first identified all tuQTLs for the same gene at the same 10% FDR threshold and then ascertained their independence by thresholding on LD at two levels of stringency (r<sup>2</sup> &lt;0.2 or r<sup>2</sup> &lt;0.8).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.011</object-id><label>Figure 2—figure supplement 3.</label><caption><title>Quantile-quantile plots of the QTLs detected by the four quantification methods.</title><p>The number of independent features tested by each quantification method are marked on the plot. In case of transcript usage QTLs (full-length transcripts, Leafcutter and txrevise), the ‘--grp-best’ option of QTLtools ensured that permutation p-values were corrected for the number of alternative transcripts, exon-exon junction or transcriptional events tested. Only the quantile-quantile plots from the naive condition are shown, but the other conditions looked very similar.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig2-figsupp3-v2.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.012</object-id><label>Figure 2—figure supplement 4.</label><caption><title>Genetics of transcript usage of the <italic>IRF5</italic> gene.</title><p>(<bold>A</bold>) Three independent tuQTLs for <italic>IRF5</italic> regulating splicing in the first exon, intron retention in coding exon 5, and 3ʹ UTR length. PP4 represents the posterior probability from coloc (<xref ref-type="bibr" rid="bib29">Giambartolomei et al., 2014</xref>) that the GWAS and QTL signals share a single causal variant. Only the promoter splicing QTL colocalises with a GWAS hit for rheumatoid arthritis (RA) (<xref ref-type="bibr" rid="bib58">Okada et al., 2014</xref>) (PP4 = 0.92). The red dot represents the RA GWAS variant while the other dots are shaded according to the r<sup>2</sup> from the lead GWAS variant. (<bold>B</bold>) RNA-seq read coverage plots of the three tuQTLs stratified by the genotypes of the lead variants. Only txrevise detected all three tuQTLs. Leafcutter only detected the first splicing event, because the other two did not manifest at level of junction reads. Similarly, full-length transcript usage analysis only detected the polyadenylation event, because it had the largest effect size. FPM, fragments per million.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig2-figsupp4-v2.tif"/></fig><fig id="fig2s5" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.013</object-id><label>Figure 2—figure supplement 5.</label><caption><title>Example of an apparent tuQTL caused by a strong eQTL.</title><p>(<bold>A</bold>) RNA-seq read coverage plot of the <italic>HAUS8</italic> gene stratified by the genotype of the lead eQTL variant. FPM, fragments per million. (<bold>B</bold>) The rs146734736 variant is an IFNɣ+<italic>Salmonella</italic> specific eQTL for the <italic>HAUS8</italic> gene, regulating its total gene expression level. (<bold>C</bold>) The y-axis shows the absolute expression of the secondary promoter (ENST00000597917) in transcripts per million (TPM) units as estimated by Salmon. The lead eQTL variant is not associated with the absolute expression level of the secondary promoter in either condition. Furthermore, the average expression of the ENST00000597917 promoter is below 1 TPM, suggesting that it is either not expressed or expressed at a very low level. This is mirrored by very low read coverage at the alternative promoter (panel A). (<bold>D</bold>) Since the rs146734736 variant is associated with total expression level of the <italic>HAUS8</italic> gene (panel B), but not with the absolute expression level of the ENST00000597917 promoter (panel C), it appears to be associated with the <italic>usage</italic> of the ENST00000597917 promoter. This is because promoter usage is calculated by dividing the expression level of one promoter by the total expression of all promoters of the gene. N, naive; I + S, IFNɣ+<italic>Salmonella</italic>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig2-figsupp5-v2.tif"/></fig><fig id="fig2s6" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.014</object-id><label>Figure 2—figure supplement 6.</label><caption><title>Simulated promoter usage QTL for the <italic>RNF220</italic> gene leads to a false positive association at the 3ʹ end.</title><p>Simulations were performed using polyester (<xref ref-type="bibr" rid="bib27">Frazee et al., 2015</xref>). (<bold>A</bold>) Simulated read coverage of the <italic>RNF220</italic> gene. Each additional copy of the alternative allele was simulated to decrease the usage of the long 5ʹ end over the short 5ʹ end (<italic>Expressed transcripts</italic>). Note that due to positional bias (<xref ref-type="bibr" rid="bib51">Love et al., 2016</xref>; <xref ref-type="bibr" rid="bib68">Roberts et al., 2011</xref>) in the RNA-seq data, the read coverage gradually decreases at the 5ʹ and 3ʹ ends of the transcript. The extent of this bias is likely to depend on the fragment length distribution of the dataset. While the simulated data had fragment length distribution with mean = 250 and sd = 25, this can vary substantially for real-world datasets. Importantly, increased usage of the short 5ʹ end leads to lower read coverage at exons 3–5 due to this bias (highlighted by the dashed orange box). FPM, fragments per million. (<bold>B</bold>) Estimated usage of the long 5ʹ end event stratified by the genotype of the simulated causal variant. In this case, txrevise is able to correctly detect the decrease in long 5ʹ end usage. (<bold>C</bold>) Estimated usage of the transcript with the long 3ʹ end stratified by the causal promoter usage QTL variant. Although we simulated no change at the 3ʹ end of the gene, txrevise still detects a false positive association. This is due to the fact that individuals with higher expression of the transcript with a short 5ʹ end have relatively fewer reads mapping to exons 3–5 (dashed orange box) compared to the exons that are specific to the long 3ʹ end. Consequently, it seems that the genetic variant decreasing short 5ʹ end usage is also associated with increased expression of the long 3ʹ end even though there are no additional reads mapping to the long 3ʹ end.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig2-figsupp6-v2.tif"/></fig><fig id="fig2s7" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.015</object-id><label>Figure 2—figure supplement 7.</label><caption><title>Shared genetic effect on promoter usage and chromatin accessibility at the promoter of <italic>HDLBP</italic>.</title><p>(<bold>A</bold>) The RNA-seq read coverage plot from the <italic>HDLBP</italic> locus stratified by the genotype of the promoter usage QTL (puQTL) lead variant (rs62187434). The blue gene models depict the alternative promoter events quantified by txrevise. The affected promoter region is highlighted by the red rectangle and zoomed-in view is shown on panel C. (<bold>B</bold>) Manhattan plot of the puQTL p-values from the region. The affected first exon regulated by the puQTL is marked on panel A. The puQTL lead variant is in high LD with a chromatin accessibility QTL (caQTL) lead variant in the same promoter region (r<sup>2</sup> = 0.96). The lead variants of both QTLs are marked by the red circles. (<bold>C</bold>) Closer view of the genomic region covering the two alternative promoters. The caQTL lead variant (rs12624196, top panel) is in the middle of the broader accessible region spanning the two promoters P1 and P2 and is associated with increased chromatin accessibility at the second promoter (P2), but not the first promoter (P1) (middle panel). The caQTL variant is also associated with increased transcription from the alternative first exons downstream of the P2 promoter (bottom panel). FPM - fragments per million.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig2-figsupp7-v2.tif"/></fig></fig-group><p>Different quantification methods may be biased towards discovering events with specific genomic properties, which is not captured by the number of QTLs detected. To address this, we quantified how often the lead QTL variants (FDR &lt; 0.01) from different methods were in high linkage disequilibrium (LD) (r<sup>2</sup> &gt;0.8) with each other (see Materials and methods). Consistent with previous reports that tuQTLs are largely independent from eQTLs (<xref ref-type="bibr" rid="bib47">Li et al., 2016</xref>), we found that only 11–25% of the lead variants detected at the read count level replicated at the transcript level (r<sup>2</sup> &gt;0.8, irrespective of the replication p-value), independent of which quantification method was used (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). In contrast, ~50% of the Leafcutter QTLs were also detected by txrevise or full-length transcript usage approaches. Similarly, the tuQTLs detected by txrevise and full-length transcript usage quantification were in high LD more than 60% of the time (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Finally, we found that while 44% of the txrevise internal exon QTLs were in high LD with Leafcutter QTLs, this decreased to ~20% for promoter and 3ʹ end QTLs (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), suggesting that Leafcutter is less suited to capture those events. Thus, different quantification approaches appear to capture complementary sets of genetic associations.</p></sec><sec id="s2-3"><title>Genomic properties of transcript usage QTLs</title><p>To characterise the genetic associations detected by different quantification methods, we compared the relative enrichments of the identified QTLs across multiple genomic annotations. We constructed genomic tracks for eight annotations: open chromatin measured by ATAC-seq (<xref ref-type="bibr" rid="bib3">Alasoo et al., 2018</xref>), promoter flanking regions (−2000 bp to +200 bp), 5ʹ UTRs, coding sequence (CDS), introns, 3ʹ UTRs, polyadenylation sites (<xref ref-type="bibr" rid="bib30">Gruber et al., 2016</xref>), and eCLIP-binding sites for RNA-binding proteins involved in splicing regulation (splicing factors) (<xref ref-type="bibr" rid="bib76">Van Nostrand et al., 2017</xref>). We then used the hierarchical model implemented in fgwas (<xref ref-type="bibr" rid="bib64">Pickrell, 2014</xref>) to estimate the enrichment of each genomic annotation among the QTLs detected by each quantification method. Consistent with the limited overlap between eQTLs and tuQTLs (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), we found that eQTLs were strongly enriched in sites of open chromatin (<xref ref-type="fig" rid="fig2">Figure 2C</xref>; log enrichment of 3.31, 95% CI [3.15, 3.47]), whereas all transcript-level QTLs were enriched at the binding sites of splicing factors detected by eCLIP (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, mean log enrichment of 2.29). Importantly, when all txrevise tuQTLs were pooled, the enrichment patterns were broadly similar to tuQTLs detected by full-length Ensembl transcripts (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). This suggests that txrevise events and full-length transcripts capture similar genetic associations but txrevise facilitates more accurate identification of the underlying transcriptional event (i.e. promoter, internal exon or 3ʹ end usage) (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Finally, compared to Leafcutter, full-length transcript usage and txrevise QTLs were both more strongly enriched at 3ʹ UTRs (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, mean log enrichment of 1.85), suggesting that they capture changes in 3ʹ UTR length that do not manifest at the level of junction reads and are thus missed by Leafcutter.</p><p>To compare different types of transcriptional events, we repeated the fgwas analysis on the promoter, internal exon and 3ʹ end QTLs detected by txrevise as well as Leafcutter splicing QTLs. We found that Leafcutter and internal exon QTLs showed broadly similar enrichment patterns, with a strong enrichment at the binding sites of splicing factors (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, mean log enrichment of 2.53). In contrast, promoter and 3ʹ end usage QTLs were specifically enriched at promoters (<xref ref-type="fig" rid="fig2">Figure 2D</xref>; log enrichment of 2.76, 95% CI [2.59, 2.95]) and 3ʹ UTRs (<xref ref-type="fig" rid="fig2">Figure 2D</xref>; log enrichment of 3.60, 95% CI [3.43, 3.76]), respectively (<xref ref-type="fig" rid="fig2">Figure 2D</xref>), and showed only a modest enrichment at the binding sites of splicing factors (<xref ref-type="fig" rid="fig2">Figure 2D</xref>; mean log enrichment of 1.17). Compared to other events, promoter usage QTLs were relatively more enriched in open chromatin regions (log enrichment of 1.58, 95% CI [1.42, 1.74]). Thus, promoter usage, splicing and 3ʹ end usage appear to be regulated by largely independent sets of genetic variants enriched in distinct genomic regions.</p><p>Motivated by the enrichment of promoter usage QTLs in open chromatin regions (<xref ref-type="fig" rid="fig2">Figure 2D</xref>), we analysed chromatin accessibility QTLs that we previously identified in a subset of 41 individuals of the same study (<xref ref-type="bibr" rid="bib3">Alasoo et al., 2018</xref>). We wanted to determine how often changes in promoter usage also manifest at the level of promoter accessibility. We found that 124/786 (15.8%) of the promoter usage QTLs were in high LD with at least one chromatin accessibility QTL (r<sup>2</sup> &gt;0.9) compared to 10.2% of the internal exon and 3ʹ end usage QTLs (Fisher’s exact test p-value=3.87×10<sup>−5</sup>). These overlaps could correspond to both distal regulatory elements affecting promoter usage or direct changes in local promoter accessibility. To focus on local promoter accessibility, we further required the center of the accessible region to be no farther than 1000 bp from the closest promoter of the gene, leaving 46/786 (5.8%) promoter usage QTLs with a putative coordinated effect on promoter accessibility. One such example affecting promoter usage and promoter accessibility of the <italic>HDLBP</italic> gene is highlighted in <xref ref-type="fig" rid="fig2s7">Figure 2—figure supplement 7</xref>. However, larger studies with increased statistical power are needed to characterise the true extent of coordination between promoter accessibility and promoter usage.</p></sec><sec id="s2-4"><title>Colocalisation with complex trait associations</title><p>To assess the relevance of different QTLs for interpreting complex trait associations, we performed statistical colocalisation analysis with GWAS summary statistics for 33 immune-mediated and metabolic traits and diseases (see Materials and methods). We found that 47 of 138 colocalised QTLs influenced total gene expression level (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) (PP3+PP4 &gt;0.8, PP4/PP3 &gt;9; PP3, posterior probability of a model with two distinct causal variants; PP4, posterior probability of a model with one common causal variant). In contrast, the remaining 91 colocalised QTLs were associated with at least one of the transcript-level phenotypes (full-length transcript usage, txrevise or Leafcutter) but not with total gene expression (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Similarly, 44 of 91 transcript-level colocalisations were detected only by a single transcript quantification approach (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). An important caveat of this analysis is that it does not directly test if the colocalisations are specific to one quantification method or simply missed by others because of limited power. Thus, our estimates of method-specificity are likely to be inflated.</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.41673.016</object-id><label>Figure 3.</label><caption><title>Overlap of colocalised gene-trait pairs detected by the four quantification methods across 33 complex traits.</title><p>The UpSetR plot is an alternative to Venn diagrams for visualising intersection of multiple sets (<xref ref-type="bibr" rid="bib16">Conway et al., 2017</xref>). The horizontal bars show the total number of colocalised trait-gene pairs detected by each quantification method. The dark circles indicate different patterns of sharing between the quantification methods and the vertical bars show how many gene-trait pairs followed a given sharing pattern. For example, in panel A, the first column shows that 34 colocalised gene-trait pairs were detected only at the total read count level but not at the transcript level. Similarly, the second column shows that 21 colocalised gene-trait pairs were detected by all transcript-level methods but not by total read count. (<bold>A</bold>) Sharing of colocalised gene-trait pairs between the four quantification methods. (<bold>B</bold>) Sharing of colocalised gene-trait pairs between Leafcutter and three independent txrevise event types (promoters, internal exons, 3ʹ ends).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.017</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Colocalisation between <italic>CD33</italic> splicing QTL and GWAS hit for Alzheimer’s disease.</title><p>(<bold>A</bold>) Manhattan plots of the Alzheimer’s disease (AD) GWAS hit (<xref ref-type="bibr" rid="bib43">Lambert et al., 2013</xref>) and a splicing QTL (sQTL) for <italic>CD33</italic>. PP4 represents the posterior probability from coloc (<xref ref-type="bibr" rid="bib29">Giambartolomei et al., 2014</xref>) that the GWAS and sQTL signals share a single causal variant. The dots are shaded according to r<sup>2</sup> from the lead GWAS variant. (<bold>B</bold>) Read coverage plot of the<italic> CD33</italic> gene stratified by the genotype of the lead sQTL variant (rs3865444). The alternatively spliced exon 2 is highlighted by the red rectangle. Ensembl transcript annotations falsely link skipped exon 2 to alternative 5ʹ and 3ʹ UTRs, although these do not appear to be regulated by the sQTL variant. FPM, fragments per million. (<bold>C</bold>) Usage of the <italic>CD33</italic> transcript with skipped exon 2 stratified by the lead sQTL variant. (<bold>D</bold>) Usage of the <italic>CD33</italic> transcript containing exon 2 stratified by the lead sQTL variant. N, naive.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.018</object-id><label>Figure 3—figure supplement 2.</label><caption><title>Colocalisation between <italic>HMGCR</italic> splicing QTL and GWAS hit for LDL.</title><p>(<bold>A</bold>) Manhattan plots of the LDL GWAS hit (<xref ref-type="bibr" rid="bib34">Iotchkova et al., 2016</xref>) and an splicing QTL (sQTL) for <italic>HMGCR</italic>. PP4 represents the posterior probability from coloc (<xref ref-type="bibr" rid="bib29">Giambartolomei et al., 2014</xref>) that the GWAS and sQTL signals share a single causal variant. The dots are shaded according to r<sup>2</sup> from the lead LDL GWAS variant. (<bold>B</bold>) Read coverage plot of the <italic>HMGCR</italic> gene stratified by the genotype of the lead sQTL variant (rs3846662). The alternatively spliced exon 13 is highlighted by the red rectangle. Ensembl transcript annotations falsely link skipped exon 13 to alternative 5ʹ and 3ʹ UTRs although these do not appear to be differentially regulated by the sQTL variant. FPM, fragments per million. (<bold>C</bold>) Usage of the <italic>HMGCR</italic> transcript with skipped exon 13 stratified by the lead sQTL variant. (<bold>D</bold>) Usage of the <italic>HMGCR</italic> transcript containing exon 13 stratified by the lead sQTL variant. N, naive.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig3-figsupp2-v2.tif"/></fig></fig-group><p>Finally, to quantify the relative contribution of promoter usage, splicing and 3ʹ end usage to complex traits, we stratified the txrevise colocalisations by transcriptional event type. We found that 44 of 77 colocalised QTLs influenced internal exons and the rest regulated promoters and 3ʹ ends (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). We were able to replicate known associations between splicing of exon two in <italic>CD33</italic> and Alzheimer’s disease (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) (<xref ref-type="bibr" rid="bib52">Malik et al., 2013</xref>) and splicing of exon 13 in <italic>HMGCR</italic> and LDL cholesterol (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>) (<xref ref-type="bibr" rid="bib14">Burkhardt et al., 2008</xref>). Importantly, while half of the promoter and internal exon colocalisations were also detected by Leafcutter, only 1/10 3ʹ end events were captured by Leafcutter, probably because these are less likely to manifest at the level of junction reads (<xref ref-type="fig" rid="fig3">Figure 3B</xref>).</p></sec><sec id="s2-5"><title>Condition-specificity of expression and transcript usage QTLs</title><p>Next, we explored how the genetic effects of eQTLs and tuQTLs varied in response to stimuli. To define response QTLs, we started with QTLs detected (FDR &lt; 10%) in each of the four simulated conditions (I, S, I + S and acLDL) and used an interaction test to identify cases where the QTL effect size was significantly different between the simulated and corresponding naive condition (FDR &lt; 10%). To exclude small but significant differences in effect size, we used a linear mixed model to identify QTLs where the interaction term explained more than 50% of the total genetic variance in the data (see Materials and methods). Although the fraction of QTLs that were response QTLs varied greatly between conditions (<xref ref-type="fig" rid="fig4">Figure 4A</xref>) and correlated with the number of differentially expressed genes (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>) as previously reported (<xref ref-type="bibr" rid="bib40">Kim-Hellmuth et al., 2017</xref>), we found that the fraction of response tuQTLs was relatively consistent between the four quantification methods (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). While previous reports have highlighted that eQTLs are more condition-specific than tuQTLs (<xref ref-type="bibr" rid="bib54">Nédélec et al., 2016</xref>), we found no clear pattern in our data with stronger stimuli (S and I + S) showing larger fraction of condition-specific eQTLs, and weaker stimuli (I, acLDL) showing smaller fraction of response eQTLs (<xref ref-type="fig" rid="fig4">Figure 4A</xref>) compared to tuQTLs. However, when we focussed on the transcriptional events detected by txrevise, we found that promoter usage QTLs were 50% more likely to be response QTLs than tuQTLs regulating either internal exons or 3ʹ ends (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) (Fisher’s exact test combined p-value=2.79×10<sup>−6</sup>).</p><fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.41673.019</object-id><label>Figure 4.</label><caption><title>Condition-specificity of eQTLs and tuQTLs.</title><p>(<bold>A</bold>) Fraction of all QTLs detected in each simulated condition that are response QTLs (FDR &lt; 10% and more than 50% of the genetic variance explained by the interaction term). (<bold>B</bold>) Fraction of txrevise tuQTLs classified as response QTLs, stratified by the part of the gene that they influence (promoters, internal exons or 3ʹ ends). (<bold>C</bold>) Fraction of GWAS colocalisations that are response QTLs. (<bold>D</bold>) Colocalisation between a GWAS hit for rheumatoid arthritis (RA) and IFNɣ-specific tuQTL at the <italic>CD40</italic> locus. PP4 represents the posterior probability from coloc (<xref ref-type="bibr" rid="bib29">Giambartolomei et al., 2014</xref>) that the GWAS and QTL signals share a single causal variant. The dots are shaded according to r<sup>2</sup> from the lead RA GWAS variant. (<bold>E</bold>) Top panel: The lead GWAS variant (rs4239702) is associated with increased expression of the short 5ʹ UTR of the <italic>CD40</italic> gene. Bottom panel: Ensembl annotations couple the short 5ʹ UTR to skipped exon 6, but this is not supported by RNA-seq data (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). FPM, fragments per million. (<bold>F</bold>) Relative expression of the short 5ʹ UTR stratified by the genotype of the lead GWAS variant. N, naive; I, IFNɣ; S, <italic>Salmonella</italic>; I + S, IFNɣ+<italic>Salmonella</italic>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.020</object-id><label>Figure 4—figure supplement 1.</label><caption><title>Relationship between differential expression and response eQTL count.</title><p>The x-axis shows the number of differentially expressed (DE) genes between the naive and one of the stimulated conditions and the y-axis shows the number of response eQTLs detected in that condition relative to the unstimulated condition N, naive; I, IFNɣ; S, <italic>Salmonella</italic>; I + S, IFNɣ+<italic>Salmonella</italic>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.021</object-id><label>Figure 4—figure supplement 2.</label><caption><title>Genetics of <italic>CD40</italic> expression.</title><p>(<bold>A</bold>) Absolute expression of the ENST00000372285 promoter in TPM units stratified by the genotype of the rs4239702 variant. (<bold>B</bold>) Absolute expression of the ENST00000372276 promoter in TPM units stratified by the genotype of the rs4239702 variant. (<bold>C</bold>) Normalized <italic>CD40</italic> read count stratified by the genotype of the rs4239702 variant. (<bold>D</bold>) Rate of <italic>CD40</italic> exon 6 skipping stratified by the genotype of the rs4239702 variant. N, naive; I, IFNɣ.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig4-figsupp2-v2.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41673.022</object-id><label>Figure 4—figure supplement 3.</label><caption><title>Regulation of <italic>CD40</italic> promoter usage in response to 2 hr lipopolysaccharide (LPS) stimulation in primary macrophages.</title><p>The genome browser screenshot shows the read coverage of the Cap Analysis of Gene Expression (CAGE) data from two replicates of monocyte-derived macrophages before and after stimulation with LPS. The data was generated by the FANTOM5 consortium (<xref ref-type="bibr" rid="bib7">Baillie et al., 2017</xref>). The <italic>CD40</italic> promoter containing the short 5ʹ UTR is strongly upregulated after 2 hr LPS stimulation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41673-fig4-figsupp3-v2.tif"/></fig></fig-group><p>Finally, we assessed the condition-specificity of QTLs that colocalised with complex trait loci. We found that, on average, 12% of the GWAS colocalisations corresponded to response QTLs (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). One example is an IFNɣ-specific promoter usage QTL for the <italic>CD40</italic> gene that colocalises with a GWAS signal for rheumatoid arthritis (<xref ref-type="bibr" rid="bib58">Okada et al., 2014</xref>). The alternative C allele of the rs4239702 variant is associated with increased usage of the transcript with the short 5ʹ UTR (<xref ref-type="fig" rid="fig4">Figure 4E,F</xref>). This tuQTL was also visible at the absolute expression level of the two alternative promoters (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>), but was missed by Leafcutter, because there is no change in junction reads. Although the variant was not significantly associated with total gene expression level (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>), the two promoters contain the same start codon. As a result, the likely functional consequence of the <italic>CD40</italic> tuQTL is modulation of protein abundance. Although the same tuQTL was also detected at the full-length transcript usage level, the affected transcripts also differ from each other by alternatively spliced exon 6, making it challenging to interpret the result (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). The preferential upregulation of the transcript with the short 5ʹ UTR after exposure to an inflammatory stimulus is also supported by FANTOM5 capped analysis of gene expression (CAGE) data from primary macrophages (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>) (<xref ref-type="bibr" rid="bib7">Baillie et al., 2017</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We have performed a comprehensive analysis of the genetic determinants of transcript usage in human iPSC-derived macrophages exposed to four different stimuli. Our approach to stratify transcripts into individual events greatly improved the interpretability of molecular mechanisms underlying tuQTLs. Consequently, we were able to discover that 55% of the transcript-level associations affected promoter or 3ʹ end usage and these variants were enriched in markedly different genomic features relative to canonical splicing QTLs. We also found that promoter usage QTLs were 50% more likely to be condition-specific than other transcriptional events and often colocalised with GWAS hits for complex traits. Thus, event-level analysis might be preferable over transcript-level analysis when the aim is to identify specific transcriptional changes underlying genetic associations.</p><p>We were able to link 6% of the promoter usage QTLs to coordinated changes in promoter accessibility. A likely reason for such a small overlap is limited statistical power in our chromatin accessibility dataset that contained only 41 individuals, leading us to miss many true effects on promoter accessibility. Alternatively, as other studies have suggested, promoter accessibility might not be an accurate proxy of activity and may merely be a prerequisite for transcription to take place (<xref ref-type="bibr" rid="bib65">Pliner et al., 2018</xref>), but demonstrating this would require better powered datasets to confidently demonstrate lack of effect on promoter accessibility. There is a great potential to study this further in larger datasets that have profiled gene expression, chromatin accessibility or histone modifications in hundreds of individuals (<xref ref-type="bibr" rid="bib15">Chen et al., 2016</xref>; <xref ref-type="bibr" rid="bib42">Kumasaka et al., 2019</xref>).</p><p>Choosing the optimal quantification method for RNA-seq data is a challenging problem. The field of detecting and quantifying individual transcriptional changes from RNA-seq data has been developing rapidly. One of the most successful approaches has been the use of reads spanning exon-exon junctions to detect differential usage of individual exons within genes. In our study, we used Leafcutter to perform junction-level analysis, but other options are available such as JUM (<xref ref-type="bibr" rid="bib79">Wang and Rio, 2018</xref>) or MAJIQ (<xref ref-type="bibr" rid="bib77">Vaquero-Garcia et al., 2016</xref>). A key advantage of junction-level analysis is that it can discover novel exon-exon junctions and is thus well-suited for characterising rare or unannotated splicing events. On the other hand, changes in 5ʹ and 3ʹ UTR length are not captured by junction-level methods, because these events do not overlap exon-exon junctions. Changes in UTR length can only be detected by methods that consider all reads originating from alternative transcript ends such as MISO (<xref ref-type="bibr" rid="bib37">Katz et al., 2010</xref>) or txrevise proposed here. MISO provides more fine-grained events that can differentiate between various types of splicing events. Txrevise, on the other hand, provides a more comprehensive catalog of promoter and 3ʹ end events that can be continuously updated as reference annotations improve. A promising alternative to both of these methods is Whippet, which quantifies transcriptional events by aligning reads directly to the splice graph of the gene (<xref ref-type="bibr" rid="bib72">Sterne-Weiler et al., 2017</xref>). Thus, no single approach is consistently superior to others and characterizing the full spectrum of transcriptional consequences of genetic variation requires a combination of analytical strategies (<xref ref-type="bibr" rid="bib57">Odhams et al., 2017</xref>; <xref ref-type="bibr" rid="bib60">Ongen and Dermitzakis, 2015</xref>).</p><p>An important limitation of txrevise is that it is only able to quantify splicing events present in reference transcript databases. However, our approach can easily be extended by incorporating additional annotations such experimentally determined promoters from the FANTOM5 (<xref ref-type="bibr" rid="bib25">Forrest et al., 2014</xref>) projects or alternative polyadenylation sites from the PolyAsite database (<xref ref-type="bibr" rid="bib30">Gruber et al., 2016</xref>), as is done by QAPA (<xref ref-type="bibr" rid="bib32">Ha et al., 2018</xref>). Another option might be to incorporate novel transcripts identified by transcript assembly methods such as StringTie (<xref ref-type="bibr" rid="bib63">Pertea et al., 2015</xref>) into existing annotation databases. Nevertheless, since txrevise relies on Salmon for event-level quantification, it is still susceptible to some of the same limitations as full-length transcript quantification. Even though event-level analysis reduces the problem slightly, a positive transcript expression estimate does not guarantee that any specific exon is actually present in the transcript, especially if the transcript annotations are incomplete (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) (<xref ref-type="bibr" rid="bib71">Soneson et al., 2018</xref>). Secondly, large eQTL effects and positional biases in the RNA-seq data can occasionally lead to spurious changes in transcript usage (<xref ref-type="fig" rid="fig2s5">Figure 2—figure supplements 5</xref> and <xref ref-type="fig" rid="fig2s6">6</xref>). Therefore, it is important to visually confirm candidate transcriptional events using either base-level read coverage plots (<xref ref-type="bibr" rid="bib2">Alasoo, 2017</xref>) or Sashimi plots (<xref ref-type="bibr" rid="bib38">Katz et al., 2015</xref>) before embarking on follow-up experiments.</p><p>A key aim of QTL mapping studies is to elucidate the molecular mechanisms underlying complex trait associations. In our analysis, we found that over 50% of the genetic effects that colocalise with complex traits regulated transcript usage and did not manifest at the total gene expression level. Moreover, 42% of the transcript-level colocalisations affected promoter or 3ʹ end usage instead of splicing of internal exons. Importantly, no single quantification method was able to capture the full range of genetic effects, confirming that different quantification approaches often identify complementary sets of QTLs (<xref ref-type="bibr" rid="bib57">Odhams et al., 2017</xref>; <xref ref-type="bibr" rid="bib60">Ongen and Dermitzakis, 2015</xref>). Thus, there is great potential to discover additional disease associations by re-analysing large published RNA-seq datasets such as GTEx (<xref ref-type="bibr" rid="bib10">Battle et al., 2017</xref>) with state-of-the-art quantification methods.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Cell culture and reagents</title><sec id="s4-1-1"><title>Donors and cell lines</title><p>Human induced pluripotent stem cells (iPSCs) lines from 123 healthy donors (72 female and 51 male) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) were obtained from the HipSci project (<xref ref-type="bibr" rid="bib39">Kilpinen et al., 2017</xref>). Of these lines, 57 were initially grown in feeder-dependent medium and 66 were grown in feeder-free E8 medium. The cell lines were screened for mycoplasma by the HipSci project (<xref ref-type="bibr" rid="bib39">Kilpinen et al., 2017</xref>). All samples for the HipSci project (<xref ref-type="bibr" rid="bib39">Kilpinen et al., 2017</xref>) were collected from consented research volunteers recruited from the NIHR Cambridge BioResource (<ext-link ext-link-type="uri" xlink:href="http://www.cambridgebioresource.org.uk">http://www.cambridgebioresource.org.uk</ext-link>). Samples were initially collected under ethics for iPSC derivation (REC Ref: 09/H0304/77, V2 04/01/2013), which require managed data access for all genetically identifying data. Later samples were collected under a revised consent (REC Ref: 09/H0304/77, V3 15/03/2013) under which all data, except from the Y chromosome from males, can be made openly available. The ethics approval was obtained from East of England - Cambridge East Research Ethics Committee. The iPSC lines used in this study are commercially available via the European Collection of Authenticated Cell Cultures. No new primary human samples were collected for this study.</p><p>The details of the iPSC culture, macrophage differentiation and stimulation for the IFNɣ+<italic>Salmonella</italic> study have been described previously (<xref ref-type="bibr" rid="bib3">Alasoo et al., 2018</xref>) (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Macrophages for the acLDL study were obtained from the same differentiation experiments.</p></sec><sec id="s4-1-2"><title>AcLDL stimulation</title><p>Macrophages differentiated from a total of 71 iPSC lines were used for the acLDL stimulation. The final sample size was decided on the basis of similar gene expression and splicing QTL mapping studies performed previously (<xref ref-type="bibr" rid="bib3">Alasoo et al., 2018</xref>; <xref ref-type="bibr" rid="bib47">Li et al., 2016</xref>; <xref ref-type="bibr" rid="bib54">Nédélec et al., 2016</xref>). Macrophages were grown in RPMI 1640 (Gibco) supplemented with 10% FBS (labtech), 2 mM L-glutamine (Sigma) and 100 ng/ml hM-CSF (R and D) at a cell density of 150,000 cells per well on a six-well plate. On day 6 of the macrophage differentiation, two wells of the six-well plate were exposed to 100 µg/ml human acLDL (Life Technologies) for 24 hr, whereas the other two wells were incubated in fresh RPMI 1640 medium without stimulation throughout this period.</p><p>For RNA extraction, cells were washed once with PBS and lysed in 300 µl of RLT buffer (Qiagen) per well of a six-well plate. Lysates from two wells were immediately pooled and stored at −80°C. RNA was extracted using a RNA Mini Kit (Qiagen) following the manufacturer’s instructions and eluted in 35 µl nuclease-free water. RNA concentration was measured using NanoDrop, and RNA integrity was measured on Agilent 2100 Bioanalyzer using a RNA 6000 Nano Total RNA Kit.</p></sec></sec><sec id="s4-2"><title>RNA sequencing and quality control</title><p>All RNA-seq libraries from the acLDL study were constructed manually using poly-A selection and the Illumina TruSeq stranded library preparation kit. The TruSeq libraries were quantified using Bioanalyzer and manually pooled for sequencing. The samples were sequenced on Illumina HiSeq 2000 using V4 chemistry and multiplexed at six samples/lane. The control and acLDL stimulated RNA samples from a single donor were always sequenced in the same experimental batch. Sample metadata is presented in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. RNA-seq reads from both studies were aligned to the GRCh38 reference genome and Ensembl 87 transcript annotations using STAR v2.4.0j (<xref ref-type="bibr" rid="bib19">Dobin et al., 2013</xref>). Subsequently, VerifyBamID v1.1.2 (<xref ref-type="bibr" rid="bib36">Jun et al., 2012</xref>) was used to detect and correct any sample swaps between donors. Two samples from one donor (HPSI0513i-xegx_2) were excluded from downstream analysis, because they appeared to be outliers on the principal component analysis (PCA) plot of the samples.</p></sec><sec id="s4-3"><title>Quantifying gene and transcript expression</title><p>We used four alternative strategies to quantify transcription from RNA-seq data: (i) gene-level read count quantified with featureCounts (<xref ref-type="bibr" rid="bib49">Liao et al., 2014</xref>), (ii) full-length transcript usage quantified with Salmon (<xref ref-type="bibr" rid="bib62">Patro et al., 2017</xref>) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), (iii) promoter, internal exon and 3ʹ end usage quantified with txrevise, and (iv) exon-exon junction usage quantified with Leafcutter (<xref ref-type="bibr" rid="bib48">Li et al., 2018</xref>).</p><sec id="s4-3-1"><title>Gene-level read counts</title><p>We used featureCounts v1.5.0 (<xref ref-type="bibr" rid="bib49">Liao et al., 2014</xref>) to count the number of uniquely mapping fragments overlapping transcript annotations from Ensembl 87. We excluded short RNAs and pseudogenes from the analysis leaving 35,033 unique genes of which 19,796 were protein coding. Furthermore, in both IFNɣ+<italic>Salmonella</italic> and acLDL dataset, we used only genes with mean expression in at least one of the conditions greater than one transcripts per million (TPM) (<xref ref-type="bibr" rid="bib78">Wagner et al., 2012</xref>) in all downstream analyses. This resulted in 12,660 and 12,103 genes included for analysis in the IFNɣ+<italic>Salmonella</italic> and acLDL datasets, respectively. We quantile-normalised the data and corrected for sample-specific GC content bias using the conditional quantile normalisation (cqn) (<xref ref-type="bibr" rid="bib33">Hansen et al., 2012</xref>) R package as recommended previously (<xref ref-type="bibr" rid="bib21">Ellis et al., 2013</xref>).</p></sec><sec id="s4-3-2"><title>Full-length transcript usage</title><p>We downloaded the FASTA files with messenger RNA (mRNA) and non-coding RNA sequences from the Ensembl website (version 87). We concatenated the two files and used salmon v0.8.2 (<xref ref-type="bibr" rid="bib62">Patro et al., 2017</xref>) with ‘--seqBias --gcBias --libType ISR’ options to quantify the expression level of each transcript. We used tximport (<xref ref-type="bibr" rid="bib70">Soneson et al., 2015</xref>) package to import the expression estimates into R and calculated the relative expression of each transcript by dividing the TPM expression estimate of each transcript with the sum of the expression estimates of all transcripts of the gene.</p></sec><sec id="s4-3-3"><title>Quantifying transcriptional events with txrevise</title><p>We downloaded exon coordinates for all Ensembl 87 transcripts using the makeTxDbFromBiomart function from the GenomicFeatures (<xref ref-type="bibr" rid="bib45">Lawrence et al., 2013</xref>) R package. We also downloaded metadata for these transcripts using the biomart (<xref ref-type="bibr" rid="bib20">Durinck et al., 2005</xref>) R package. Finally, we extracted transcript tags from the GTF file downloaded from the Ensembl website using the extractTranscriptTags.py script available from the txrevise repository (<ext-link ext-link-type="uri" xlink:href="https://github.com/kauralasoo/txrevise">https://github.com/kauralasoo/txrevise</ext-link>). This step was necessary, because Ensembl contains a large number of truncated transcripts (marked with cds_start_NF or cds_end_NF tags) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), but this information is not present in biomart.</p><p>We developed the txrevise R package to pre-process transcript annotations prior to quantification. First, we extended all truncated protein coding transcripts using exons from the longest annotated transcript of the gene that was part of the GENCODE Basic gene set (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). We also performed the same step on transcripts annotated in Ensembl as retained_intron, processed_transcript or nonsense_mediated_decay, because they often ended abruptly in the middle of the exons and were unlikely to correspond to true transcription start and end sites.</p><p>Next, we focused on splitting full-length transcripts into alternative promoters, internal exons and 3ʹ ends. However, some genes contained either non-overlapping transcripts or very short transcripts that complicated this process. Thus, for each gene we first identified a group of transcripts that shared the largest number of exons with each other. We then used the shared exons as a scaffold to construct three types of independent transcriptional events: alternative promoters, internal exons and 3ʹ ends (group 1) (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). We also repeated this process on a second group of transcripts that shared the second-most exons with each other (group 2) (see <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref> for illustration). Thus, the original transcripts from each gene were split into up to six sets of transcriptional events (two sets of alternative promoters, internal exons and 3ʹ ends). Next, to ensure that the new alternative promoter and 3ʹ end events did not capture splicing changes, we masked all alternative exons that were not the first or last exons (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>). We applied this step only to alternative promoter and 3ʹ end events and not to internal exon events. This final step can optionally be skipped to discover more association at the expense of losing some interpretability, because a subset of the promoter and 3ʹ end events might be tagging splicing changes. We used Salmon (<xref ref-type="bibr" rid="bib62">Patro et al., 2017</xref>) with ‘--seqBias --gcBias --libType ISR’ options to independently quantify the expression of each set of transcriptional events. Finally, we used tximport (<xref ref-type="bibr" rid="bib70">Soneson et al., 2015</xref>) to import the event expression estimates into R and calculated the relative expression of each transcriptional event by dividing the TPM expression estimate of each event with the sum of the expression estimates of all events within the same group of transcripts. This normalisation was performed separately for each type of transcriptional event (promoters, internal exons and 3ʹ ends) and also separately for the two groups of transcripts used for constructing the alternative events, ensuring that the normalized value always represented the relative usage of one transcriptional event compared to other events of the same type that shared the same scaffold.</p></sec><sec id="s4-3-4"><title>Quantifying intron excision ratios with Leafcutter</title><p>Finally, we used Leafcutter (<xref ref-type="bibr" rid="bib48">Li et al., 2018</xref>) to quantify the relative excision frequencies of alternative introns. We used the spliced alignments from STAR as input to Leafcutter. We did not correct for reference mapping bias, because we wanted to be able to directly compare Leafcutter results with those from Salmon and there is no obvious way to correct for reference mapping bias in Salmon quantification. We used the default parameters of requiring at least 50 reads supporting each intron cluster and allowing introns of up to 500 kb in length.</p></sec></sec><sec id="s4-4"><title>Mapping expression and transcript usage QTLs</title><sec id="s4-4-1"><title>Preparing genotype data</title><p>We obtained imputed genotypes for all of the samples from the HipSci (<xref ref-type="bibr" rid="bib39">Kilpinen et al., 2017</xref>) project. We used CrossMap v0.1.8 (<xref ref-type="bibr" rid="bib82">Zhao et al., 2014</xref>) to convert variant coordinates from GRCh37 reference genome to GRCh38. Subsequently, we filtered the VCF file with bcftools v.1.2 to retain only bi-allelic variants (both SNPs and indels) with IMP2 score &gt;0.4 and minor allele frequency (MAF) &gt;0.05. We created a separate VCF files for the IFNɣ+<italic>Salmonella</italic> study (84 individuals) and the acLDL study (70 individuals). The same VCF files were used for all downstream analyses and were imported into R using the SNPRelate R package (<xref ref-type="bibr" rid="bib83">Zheng et al., 2012</xref>).</p></sec><sec id="s4-4-2"><title>Association testing</title><p>We used QTLTools (<xref ref-type="bibr" rid="bib17">Delaneau et al., 2017</xref>) to map QTLs in two stages. First, we used the permutation pass with ‘--permute 10000 --grp-best’ options to calculate the minimal lead variant p-value for each feature (gene, transcript or splicing event) in a ± 100 kb window around each feature. We included the first six principal components of the phenotype matrix as covariates in the QTL analysis. The ‘--grp-best’ option ensured that in case of transcript usage QTLs, the permutation p-values were corrected for the number of alternative transcripts, exon-exon junction or transcriptional events tested. For txrevise, we performed the permutations across the two groups of transcripts what were used for event construction. Quantile-quantile plots confirmed that the permutation p-values were well calibrated (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). Finally, we performed Benjamini-Hochberg FDR correction on the permutation p-values to identify QTLs that were significant at the 10% FDR level. For gene expression and full-length transcript usage QTLs this approach identified at most one lead variant per gene. For txrevise analysis we report up to three lead variants per gene: one for each independent transcriptional event type (promoters, internal exons, 3ʹ ends) (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). If the two groups of events identified different genetic associations, we report only the one lead variant that had the smallest permutation p-value across groups. Leafcutter analysis sometimes also identified multiple associations per gene if there were multiple independent intron clusters within those genes (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplements 2</xref> and <xref ref-type="fig" rid="fig2s3">3</xref>). Finally, we note that additional secondary associations could be discovered by performing conditional analysis on the QTLs that have already been detected, but we did not do that analysis.</p><p>Secondly, we used the nominal pass to calculate nominal association p-values in a ± 500 kb <italic>cis</italic> window around each feature. We used a larger <italic>cis</italic> window for the nominal pass to ensure that we did not have missing data in the colocalisation analysis (see below), where we used the ±200 kb <italic>cis</italic> window around each lead QTL variant. However, the colocalisation analysis was still based on the lead QTL variants identified in the ±100 kb window. Thus, even if a stronger QTL lead variant was detected in the ±500 kb window, this was not used for any downstream analysis.</p></sec></sec><sec id="s4-5"><title>QTL replication between quantification methods</title><p>To compare the QTLs detected by different quantification methods, we estimated the fraction of QTL lead variants detected by each method that were replicated by the other methods. Since read count and full-length transcript usage analysis were performed at the gene level, we decided to perform the replication analysis at the gene level as well. Because txrevise and Leafcutter quantified multiple events per gene and sometimes detected multiple independent QTLs (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>), we picked the lead variant with the smallest p-value across all of the events quantified for a given gene as the gene-level lead variant. For each pairwise comparison of quantification methods, we first identified all lead variant-gene pairs with FDR &lt; 0.01 detected by the query method. Subsequently, we extracted the lead variants for the same genes detected by the replication method and estimated the fraction of those that were in high LD (r<sup>2</sup> &gt;0.8) with each other. We then repeated this analysis for all pairs of quantification methods. Note that this measure is not necessarily symmetric between the quantification methods and also depends on the statistical power of each method. Since Leafcutter had lower statistical power than other methods on our dataset, it also replicated smaller fraction of QTLs detected by the other methods. In contrast, ~50% of the Leafcutter QTLs were replicated by txrevise and full-length transcript usage (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><p>We acknowledge that our definition of replication ignores the direction of the effect of the genetic variant on gene expression or transcript usage. For example, if Leafcutter detects a genetic variant that is associated with increased inclusion of an exon in a gene and txrevise detects that the same variant is associated with decreased inclusion of the same exon in the same gene, we would still consider it to be a ‘successful’ replication. However, in practice it is difficult to map Leafcutter events to specific Ensembl transcripts or txrevise events, especially if Leafcutter includes novel exon-exon junctions not present in the Ensembl database. Furthermore, comparing the effect size direction between eQTLs and tuQTLs is not possible, because any variant that is associated with increased usage of one transcript is by definition also associated with decreased usage of some other transcripts of the same gene.</p></sec><sec id="s4-6"><title>QTL enrichment in genomics annotations</title><sec id="s4-6-1"><title>Constructing genomic annotations</title><sec id="s4-6-1-1"><title>Gene features</title><p>We downloaded transcript annotations from Ensembl version 87 (<xref ref-type="bibr" rid="bib81">Zerbino et al., 2018</xref>) using the GenomicFeatures (<xref ref-type="bibr" rid="bib45">Lawrence et al., 2013</xref>) R package. We retained only protein coding transcripts and used fiveUTRsByTranscript, threeUTRsByTranscript, cdsBy, intronsByTranscript and promoters functions to extract 5ʹ UTRs, 3ʹ UTRs, coding sequences, introns and promoters, respectively. We defined promoters as sequences 2000 bp upstream and 200 bp downstream of the annotated transcription start sites.</p></sec><sec id="s4-6-1-2"><title>Polyadenylation sites</title><p>We downloaded the coordinates of experimentally determined human polyadenylation sites from the PolyASite database (version r1.0) (<xref ref-type="bibr" rid="bib30">Gruber et al., 2016</xref>). After converting the coordinates to the GRCh38 reference genome with CrossMap (<xref ref-type="bibr" rid="bib82">Zhao et al., 2014</xref>), we extended each polyadenylation site to ±25 bp from the center of the site.</p></sec><sec id="s4-6-1-3"><title>Chromatin accessibility</title><p>We downloaded the coordinates of accessible chromatin regions in macrophages across four conditions (N, I, S, I + S) from our previous study (<xref ref-type="bibr" rid="bib3">Alasoo et al., 2018</xref>). Specifically, we downloaded the ATAC_peak_metadata.txt.gz file from Zenodo (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.1170560">https://doi.org/10.5281/zenodo.1170560</ext-link>).</p></sec><sec id="s4-6-1-4"><title>RNA-binding proteins</title><p>We downloaded processed eCLIP (<xref ref-type="bibr" rid="bib75">Van Nostrand et al., 2016</xref>) peak calls for 93 RNA binding proteins (RBPs) (<xref ref-type="bibr" rid="bib76">Van Nostrand et al., 2017</xref>) from the ENCODE web site (<ext-link ext-link-type="uri" xlink:href="https://www.encodeproject.org">https://www.encodeproject.org</ext-link>). Each protein was measured in two biological replicates, resulting in 186 sets of peaks. We only used data from the K562 myelogenous leukemia cell line. We further used Supplementary Table 1 from (<xref ref-type="bibr" rid="bib76">Van Nostrand et al., 2017</xref>) to identify a subset of 29 RBPs that have previously been implicated in splicing regulation, five factors that have been implicated in 3ʹ end processing and two factors (SRSF7 and HNRNPK) that have been implicated in both. Within each group (splicing, 3ʹ end processing and both), we first removed all peaks that were detected only once and then merged all peaks into a single genomic annotation.</p></sec></sec><sec id="s4-6-2"><title>Enrichment analysis</title><p>We used fgwas v0.3.6 (<xref ref-type="bibr" rid="bib64">Pickrell, 2014</xref>) with the ‘-fine’ option to identify the genomic annotations in which different types of QTLs were enriched. We converted QTLtools p-values to z-scores using the stats.norm.ppf(p/2, loc = 0, scale = 1) function from SciPy (<xref ref-type="bibr" rid="bib35">Jones et al., 2001</xref>), where p is the nominal p-value from QTLtools. The sign of the z-score was determined based on the sign of the QTL effect size. We included all genomic annotations into a joint fgwas model using the ‘-w’ option. For the enrichment analysis, we used QTLs from the naive condition only, but we found that the enrichments patterns were very similar in all stimulated conditions.</p></sec></sec><sec id="s4-7"><title>Context-specificity of expression and transcript usage QTLs</title><p>To identify response QTLs, we started with QTLs detected (FDR &lt; 10%) in each of the four stimulated conditions (I, S, I + S and acLDL) and used an interaction test to identify cases where the QTL effect size was significantly different between one of the stimulated and corresponding naive condition (FDR &lt; 10%). We performed this test separately for each of the four stimulated condition (I, S, I + S and AcLDL). Furthermore, to take advantage of our profiling of gene expression in overlapping set of donors in the stimulated and naive conditions, we also included the cell line as a random effect and fitted a linear mixed model using the lme4 (<xref ref-type="bibr" rid="bib8">Bates et al., 2015</xref>) package. Specifically, for each phenotype and lead variant pair, we used the anova function to compare the following two models:</p><p>H0: phenotype ~genotype + condition + (1|donor)</p><p>H1: phenotype ~genotype + condition+condition:genotype + (1|donor)</p><p>where (1|donor) denotes the donor-specific random effect. We obtained the p-value of rejecting the null hypothesis and used the p.adjust function to identify phenotype and lead variant pairs that were significant at 10% Benjamini-Hochberg FDR.</p><p>For some QTLs, we noticed that although the interaction test p-value was significant, the difference in the effect size between the two conditions was very small. To identify response QTLs with large effect size differences between naive and stimulated conditions, we turned to variance component analysis. Specifically, for the same phenotype and lead variant pairs tested above, we also fitted the following linear mixed model:</p><p>phenotype ~ (1|genotype) + (1|condition) + (1|condition:genotype)</p><p>where genotype, condition and the interaction between the two were all fitted as random effects. We then quantified the variance explained by each of the three components using the VarCorr function form the lme4 package. Finally, we calculated the variance explained by the interactions term relative to the total genetic variance:</p><p>σ<sup>2</sup><sub>relative</sub> = σ<sup>2</sup><sub>interaction</sub> /(σ<sup>2</sup><sub>interaction</sub>+σ<sup>2</sup><sub>genotype</sub>)</p><p>We defined response QTLs as those with FDR &lt; 10% from the interaction test and σ<sup>2</sup><sub>relative</sub> &gt; 0.5 from the variance component analysis. Although fitting genotype as a random effect in this way is suboptimal because it ignores the expected linear relationship between the alternative allele dosage and phenotype, we empirically found that filtering both on the p-value of the interaction test as well as σ<sup>2</sup><sub>relative</sub> was effective at identifying QTLs with large effect size differences between conditions.</p></sec><sec id="s4-8"><title>Overlap with genome-wide association studies</title><sec id="s4-8-1"><title>Summary statistics</title><p>We obtained full summary statistics for ten immune-mediated disorders: inflammatory bowel disease (IBD) including ulcerative colitis (UC) and Crohn’s disease (CD) (<xref ref-type="bibr" rid="bib50">Liu et al., 2015</xref>), Alzheimer’s disease (AD) (<xref ref-type="bibr" rid="bib43">Lambert et al., 2013</xref>), rheumatoid arthritis (RA) (<xref ref-type="bibr" rid="bib58">Okada et al., 2014</xref>), systemic lupus erythematosus (SLE) (<xref ref-type="bibr" rid="bib12">Bentham et al., 2015</xref>), type one diabetes (T1D) (<xref ref-type="bibr" rid="bib59">Onengut-Gumuscu et al., 2015</xref>), schizophrenia (SCZ) (Schizophrenia Working Group of the <xref ref-type="bibr" rid="bib69">Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014</xref>), multiple sclerosis (MS) (<xref ref-type="bibr" rid="bib11">Beecham et al., 2013</xref>), celiac disease (CEL) (<xref ref-type="bibr" rid="bib74">Trynka et al., 2011</xref>) and narcolepsy (NAR) (<xref ref-type="bibr" rid="bib24">Faraco et al., 2013</xref>). We also obtained summary statistics for type two diabetes (T2D) (<xref ref-type="bibr" rid="bib53">Morris et al., 2012</xref>), cardiovascular disease (CAD) (<xref ref-type="bibr" rid="bib55">Nelson et al., 2017</xref>; <xref ref-type="bibr" rid="bib56">Nikpay et al., 2015</xref>) and myocardial infarction (MI) (<xref ref-type="bibr" rid="bib56">Nikpay et al., 2015</xref>). Finally, we obtained summary statistics for 20 cardiometabolic traits from a recent meta-analysis (<xref ref-type="bibr" rid="bib34">Iotchkova et al., 2016</xref>). Summary statistics for T1D, CEL, IBD, RA, AD, MS and SLE were downloaded in 2015. SCZ, T2D and NAR were downloaded in 2016. T2D summary statistics were converted from GRCh36 to GRCh37 coordinates using the LiftOver tool, all the other summary statistics already used GRCh37 coordinates.</p></sec><sec id="s4-8-2"><title>Colocalisation analysis</title><p>We used coloc v2.3–1 (<xref ref-type="bibr" rid="bib29">Giambartolomei et al., 2014</xref>) to test for colocalisation between gene expression and transcript usage QTLs and GWAS hits. We ran coloc on a 400 kb region centered on each lead eQTL and tuQTL variant that was less than 100 kb away from at least one GWAS variant with a nominal p-value&lt;10<sup>−5</sup>. We used the following prior probabilities: p1 = 10<sup>−4</sup>, p2 = 10<sup>−4</sup> and p12 = 10<sup>−5</sup>. We then applied a set of filtering steps to identify a stringent set of eQTLs and tuQTLs that colocalised with GWAS hits. Similarly to a previous study (<xref ref-type="bibr" rid="bib31">Guo et al., 2015</xref>), we first removed all cases where PP3+PP4 &lt;0.8, to exclude loci where we were underpowered to detect colocalisation. We then required PP4/(PP3+PP4) &gt;0.9 to only keep loci where coloc strongly preferred the model of a single shared causal variant driving both association signals over a model of two distinct causal variants. We excluded all colocalisation results from the MHC region (GRCh38: 6:28,510,120–33,480,577) because they were likely to be false positives due to complicated LD patterns in this region. We only kept results where the minimal GWAS p-value was &lt;10<sup>−6</sup>. Plots illustrating the sharing of colocalised GWAS signals by different quantification methods were made using UpSetR (<xref ref-type="bibr" rid="bib16">Conway et al., 2017</xref>).</p></sec></sec><sec id="s4-9"><title>Code availability</title><p>The Snakemake (<xref ref-type="bibr" rid="bib41">Köster and Rahmann, 2012</xref>) files used for gene and transcript expression quantification, QTL mapping and colocalisaton are available from the project’s GitHub repository (<ext-link ext-link-type="uri" xlink:href="https://github.com/kauralasoo/macrophage-tuQTLs">https://github.com/kauralasoo/macrophage-tuQTLs</ext-link>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://github.com/elifesciences-publications/macrophage-tuQTLs">https://github.com/elifesciences-publications/macrophage-tuQTLs</ext-link>; <xref ref-type="bibr" rid="bib5">Alasoo, 2018b</xref>). The same repository also contains R scripts that were used for all data analysis and figures. The txrevise R package is available from GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/kauralasoo/txrevise">https://github.com/kauralasoo/txrevise</ext-link>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://github.com/elifesciences-publications/txrevise">https://github.com/elifesciences-publications/txrevise</ext-link>; <xref ref-type="bibr" rid="bib4">Alasoo, 2018a</xref>) and wiggleplotr R package that was used to make transcript read coverage plots is available from Bioconductor (<ext-link ext-link-type="uri" xlink:href="http://bioconductor.org/packages/wiggleplotr/">http://bioconductor.org/packages/wiggleplotr/</ext-link>).</p></sec><sec id="s4-10"><title>Data availability</title><p>RNA-seq data from the acLDL stimulation study is available from ENA (PRJEB20734) and EGA (EGAS00001000876). RNA-seq data from the IFNɣ+<italic>Salmonella</italic> study is available from ENA (PRJEB18997) and EGA (EGAS00001002236). The imputed genotype data for HipSci cell lines is available from ENA (PRJEB11749) and EGA (EGAD00010000773). Processed data and QTL summary statistics are available from Zenodo: <ext-link ext-link-type="uri" xlink:href="https://zenodo.org/communities/macrophage-tuqtls/.">https://zenodo.org/communities/macrophage-tuqtls/.</ext-link></p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Jeremy Schwartzentruber and Leopold Parts for their helpful comments on the manuscript. We thank WTSI DNA Pipelines and Cytometry Core Facility for their sequencing and flow cytometry services. We thank Elena Vigorito and Joanna MM Howson (Cardiovascular Epidemiology Unit) for their help with statistical analyses during the early phases of this project. This work was supported by the Wellcome Trust (WT098051) and the British Heart Foundation Cambridge Centre of Excellence (RE/13/6/30180). KA was supported by a PhD fellowship from the Wellcome Trust (WT099754/Z/12/Z), a postdoctoral fellowship from the Estonian Research Council (MOBJD67) and a grant from the Estonian Research Council (IUT34-4). The Cardiovascular Epidemiology Unit is supported by the UK Medical Research Council (MR/L003120/1), British Heart Foundation (RG/13/13/30194) and National Institute for Health Research [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust]. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The iPSC lines were generated at the Wellcome Sanger Institute, under the Human Induced Pluripotent Stem Cell Initiative funded by a strategic award (WT098503) from the Wellcome Trust and Medical Research Council. We also acknowledge Life Science Technologies Corporation as the provider of cytotune. This work was carried out in part at the High-Performance Computing Center of University of Tartu.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Since October 2015, Daniel F Freitag has been a full-time employee of Bayer AG, Germany</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Funding acquisition, Investigation, Methodology, Writing—original draft, Writing—review and editing, Performed the macrophage differentiation experiments</p></fn><fn fn-type="con" id="con2"><p>Data curation, Investigation, Methodology, Performed the macrophage differentiation experiments, Optimised and performed the acLDL stimulation experiments</p></fn><fn fn-type="con" id="con3"><p>Supervision, Funding acquisition, Project administration</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Funding acquisition, Methodology, Project administration</p></fn><fn fn-type="con" id="con5"><p>Resources, Supervision, Writing—original draft, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Resources, Supervision, Funding acquisition, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Human subjects: Human induced pluripotent stem cells (iPSCs) lines from 123 healthy donors (72 female and 51 male) (Supplementary file 1) were obtained from the HipSci project (Kilpinen et al., 2017). All samples for the HipSci project (Kilpinen et al., 2017) were collected from consented research volunteers recruited from the NIHR Cambridge BioResource (http://www.cambridgebioresource.org.uk). Samples were initially collected under ethics for iPSC derivation (REC Ref: 09/H0304/77, V2 04/01/2013), which require managed data access for all genetically identifying data. Later samples were collected under a revised consent (REC Ref: 09/H0304/77, V3 15/03/2013) under which all data, except from the Y chromosome from males, can be made openly available. The ethics approval was obtained from East of England - Cambridge East Research Ethics Committee. The iPSC lines used in this study are commercially available via the European Collection of Authenticated Cell Cultures. No new primary human samples were collected for this study.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.41673.023</object-id><label>Supplementary file 1.</label><caption><title>Metadata for the macrophage differentiation experiments performed in this study.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-41673-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><object-id pub-id-type="doi">10.7554/eLife.41673.024</object-id><label>Supplementary file 2.</label><caption><title>Metadata for the RNA-seq samples generated in this study.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-41673-supp2-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.41673.025</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-41673-transrepform-v2.docx"/></supplementary-material><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>RNA-seq data from the acLDL stimulation study is available from ENA (PRJEB20734) and EGA (EGAS00001000876). RNA-seq data from the IFNɣ + Salmonella study is available from ENA (PRJEB18997) and EGA (EGAS00001002236). The imputed genotype data for HipSci cell lines is available from ENA (PRJEB11749) and EGA (EGAD00010000773). Processed data and QTL summary statistics are available from Zenodo: <ext-link ext-link-type="uri" xlink:href="https://zenodo.org/communities/macrophage-tuqtls/">https://zenodo.org/communities/macrophage-tuqtls/</ext-link>.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Alasoo</surname><given-names>K</given-names></name><name><surname>Rodrigues</surname><given-names>J</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Freitag</surname><given-names>DF</given-names></name><name><surname>Paul</surname><given-names>DS</given-names></name><name><surname>Gaffney</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>Genetic effects on promoter usage are highly context-specific and contribute to complex traits</data-title><source>European Nucleotide Archive</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/ena/data/view/PRJEB20734">PRJEB20734</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Alasoo</surname><given-names>K</given-names></name><name><surname>Rodrigues</surname><given-names>J</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Freitag</surname><given-names>DF</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>Genetic effects on promoter usage are highly context-specific and contribute to complex traits</data-title><source>European Genome-phenome Archive</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/ega/studies/EGAS00001000876">EGAS00001000876</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Alasoo</surname><given-names>K</given-names></name><name><surname>Rodrigues</surname><given-names>J</given-names></name><name><surname>Mukhopadhyay</surname><given-names>S</given-names></name><name><surname>Knights</surname><given-names>AJ</given-names></name><name><surname>Mann</surname><given-names>AL</given-names></name><name><surname>Kundu</surname><given-names>K</given-names></name><name><surname>Hale</surname><given-names>C</given-names></name><name><surname>Dougan</surname><given-names>G</given-names></name><name><surname>Gaffney</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>Shared genetic effects on chromatin and gene expression indicate a role for enhancer priming in immune response</data-title><source>European Nucleotide Archive</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/ena/data/view/PRJEB18997">PRJEB18997</pub-id></element-citation></p><p><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Alasoo</surname><given-names>K</given-names></name><name><surname>Rodrigues</surname><given-names>J</given-names></name><name><surname>Mukhopadhyay</surname><given-names>S</given-names></name><name><surname>Knights</surname><given-names>AJ</given-names></name><name><surname>Mann</surname><given-names>AL</given-names></name><name><surname>Kundu</surname><given-names>K</given-names></name><name><surname>Hale</surname><given-names>C</given-names></name><name><surname>Dougan</surname><given-names>G</given-names></name><name><surname>Gaffney</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>Shared genetic effects on chromatin and gene expression indicate a role for enhancer priming in immune response</data-title><source>European Genome-phenome Archive</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/ega/studies/EGAS00001002236">EGAS00001002236</pub-id></element-citation></p><p><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Kilpinen</surname><given-names>H</given-names></name><name><surname>Goncalves</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>Common genetic variation drives molecular heterogeneity in human iPSCs</data-title><source>European Nucleotide Archive</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/ena/data/view/PRJEB11749">PRJEB11749</pub-id></element-citation></p><p><element-citation id="dataset6" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Kilpinen</surname><given-names>H</given-names></name><name><surname>Goncalves</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>Common genetic variation drives molecular heterogeneity in human iPSCs</data-title><source>European Genome-phenome Archive</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/ega/datasets/EGAD00010000773">EGAD00010000773</pub-id></element-citation></p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alasoo</surname> <given-names>K</given-names></name><name><surname>Martinez</surname> <given-names>FO</given-names></name><name><surname>Hale</surname> <given-names>C</given-names></name><name><surname>Gordon</surname> <given-names>S</given-names></name><name><surname>Powrie</surname> <given-names>F</given-names></name><name><surname>Dougan</surname> <given-names>G</given-names></name><name><surname>Mukhopadhyay</surname> <given-names>S</given-names></name><name><surname>Gaffney</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Transcriptional profiling of macrophages derived from monocytes and iPS cells identifies a conserved response to LPS and novel alternative transcription</article-title><source>Scientific Reports</source><volume>5</volume><elocation-id>12524</elocation-id><pub-id pub-id-type="doi">10.1038/srep12524</pub-id><pub-id pub-id-type="pmid">26224331</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Alasoo</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>wiggleplotr: Make read coverage plots from BigWig files</data-title><source>Bioconductor</source></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alasoo</surname> <given-names>K</given-names></name><name><surname>Rodrigues</surname> <given-names>J</given-names></name><name><surname>Mukhopadhyay</surname> <given-names>S</given-names></name><name><surname>Knights</surname> <given-names>AJ</given-names></name><name><surname>Mann</surname> <given-names>AL</given-names></name><name><surname>Kundu</surname> <given-names>K</given-names></name><name><surname>Hale</surname> <given-names>C</given-names></name><name><surname>Dougan</surname> <given-names>G</given-names></name><name><surname>Gaffney</surname> <given-names>DJ</given-names></name><collab>HIPSCI Consortium</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Shared genetic effects on chromatin and gene expression indicate a role for enhancer priming in immune response</article-title><source>Nature Genetics</source><volume>50</volume><fpage>424</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0046-7</pub-id><pub-id pub-id-type="pmid">29379200</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Alasoo</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018a</year><data-title>txrevise</data-title><source>Github</source><version designator="5532b3d">5532b3d</version><ext-link ext-link-type="uri" xlink:href="https://github.com/kauralasoo/txrevise">https://github.com/kauralasoo/txrevise</ext-link></element-citation></ref><ref id="bib5"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Alasoo</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018b</year><data-title>macrophage-tuQTLs</data-title><source>Github</source><version designator="5fafd68">5fafd68</version><ext-link ext-link-type="uri" xlink:href="https://github.com/kauralasoo/macrophage-tuQTLs">https://github.com/kauralasoo/macrophage-tuQTLs</ext-link></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anvar</surname> <given-names>SY</given-names></name><name><surname>Allard</surname> <given-names>G</given-names></name><name><surname>Tseng</surname> <given-names>E</given-names></name><name><surname>Sheynkman</surname> <given-names>GM</given-names></name><name><surname>de Klerk</surname> <given-names>E</given-names></name><name><surname>Vermaat</surname> <given-names>M</given-names></name><name><surname>Yin</surname> <given-names>RH</given-names></name><name><surname>Johansson</surname> <given-names>HE</given-names></name><name><surname>Ariyurek</surname> <given-names>Y</given-names></name><name><surname>den Dunnen</surname> <given-names>JT</given-names></name><name><surname>Turner</surname> <given-names>SW</given-names></name><name><surname>'t Hoen</surname> <given-names>PAC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Full-length mRNA sequencing uncovers a widespread coupling between transcription initiation and mRNA processing</article-title><source>Genome Biology</source><volume>19</volume><elocation-id>46</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-018-1418-0</pub-id><pub-id pub-id-type="pmid">29598823</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baillie</surname> <given-names>JK</given-names></name><name><surname>Arner</surname> <given-names>E</given-names></name><name><surname>Daub</surname> <given-names>C</given-names></name><name><surname>De Hoon</surname> <given-names>M</given-names></name><name><surname>Itoh</surname> <given-names>M</given-names></name><name><surname>Kawaji</surname> <given-names>H</given-names></name><name><surname>Lassmann</surname> <given-names>T</given-names></name><name><surname>Carninci</surname> <given-names>P</given-names></name><name><surname>Forrest</surname> <given-names>AR</given-names></name><name><surname>Hayashizaki</surname> <given-names>Y</given-names></name><name><surname>Faulkner</surname> <given-names>GJ</given-names></name><name><surname>Wells</surname> <given-names>CA</given-names></name><name><surname>Rehli</surname> <given-names>M</given-names></name><name><surname>Pavli</surname> <given-names>P</given-names></name><name><surname>Summers</surname> <given-names>KM</given-names></name><name><surname>Hume</surname> <given-names>DA</given-names></name><collab>FANTOM Consortium</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease</article-title><source>PLOS Genetics</source><volume>13</volume><elocation-id>e1006641</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006641</pub-id><pub-id pub-id-type="pmid">28263993</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname> <given-names>D</given-names></name><name><surname>Mächler</surname> <given-names>M</given-names></name><name><surname>Bolker</surname> <given-names>B</given-names></name><name><surname>Walker</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fitting linear mixed-effects models using lme4</article-title><source>Journal of Statistical Software</source><volume>67</volume><fpage>1</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.18637/jss.v067.i01</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battle</surname> <given-names>A</given-names></name><name><surname>Mostafavi</surname> <given-names>S</given-names></name><name><surname>Zhu</surname> <given-names>X</given-names></name><name><surname>Potash</surname> <given-names>JB</given-names></name><name><surname>Weissman</surname> <given-names>MM</given-names></name><name><surname>McCormick</surname> <given-names>C</given-names></name><name><surname>Haudenschild</surname> <given-names>CD</given-names></name><name><surname>Beckman</surname> <given-names>KB</given-names></name><name><surname>Shi</surname> <given-names>J</given-names></name><name><surname>Mei</surname> <given-names>R</given-names></name><name><surname>Urban</surname> <given-names>AE</given-names></name><name><surname>Montgomery</surname> <given-names>SB</given-names></name><name><surname>Levinson</surname> <given-names>DF</given-names></name><name><surname>Koller</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals</article-title><source>Genome Research</source><volume>24</volume><fpage>14</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1101/gr.155192.113</pub-id><pub-id pub-id-type="pmid">24092820</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battle</surname> <given-names>A</given-names></name><name><surname>Brown</surname> <given-names>CD</given-names></name><name><surname>Engelhardt</surname> <given-names>BE</given-names></name><name><surname>Montgomery</surname> <given-names>SB</given-names></name><collab>GTEx Consortium</collab><collab>Laboratory, Data Analysis &amp;Coordinating Center (LDACC)—Analysis Working Group</collab><collab>Statistical Methods groups—Analysis Working Group</collab><collab>Enhancing GTEx (eGTEx) groups</collab><collab>NIH Common Fund</collab><collab>NIH/NCI</collab><collab>NIH/NHGRI</collab><collab>NIH/NIMH</collab><collab>NIH/NIDA</collab><collab>Biospecimen Collection Source Site—NDRI</collab><collab>Biospecimen Collection Source Site—RPCI</collab><collab>Biospecimen Core Resource—VARI</collab><collab>Brain Bank Repository—University of Miami Brain Endowment Bank</collab><collab>Leidos Biomedical—Project Management</collab><collab>ELSI Study</collab><collab>Genome Browser Data Integration &amp;Visualization—EBI</collab><collab>Genome Browser Data Integration &amp;Visualization—UCSC Genomics Institute, University of California Santa Cruz</collab><collab>Lead analysts:</collab><collab>Laboratory, Data Analysis &amp;Coordinating Center (LDACC):</collab><collab>NIH program management:</collab><collab>Biospecimen collection:</collab><collab>Pathology:</collab><collab>eQTL manuscript working group:</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Genetic effects on gene expression across human tissues</article-title><source>Nature</source><volume>550</volume><fpage>204</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1038/nature24277</pub-id><pub-id pub-id-type="pmid">29022597</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beecham</surname> <given-names>AH</given-names></name><name><surname>Patsopoulos</surname> <given-names>NA</given-names></name><name><surname>Xifara</surname> <given-names>DK</given-names></name><name><surname>Davis</surname> <given-names>MF</given-names></name><name><surname>Kemppinen</surname> <given-names>A</given-names></name><name><surname>Cotsapas</surname> <given-names>C</given-names></name><name><surname>Shah</surname> <given-names>TS</given-names></name><name><surname>Spencer</surname> <given-names>C</given-names></name><name><surname>Booth</surname> <given-names>D</given-names></name><name><surname>Goris</surname> <given-names>A</given-names></name><name><surname>Oturai</surname> <given-names>A</given-names></name><name><surname>Saarela</surname> <given-names>J</given-names></name><name><surname>Fontaine</surname> <given-names>B</given-names></name><name><surname>Hemmer</surname> <given-names>B</given-names></name><name><surname>Martin</surname> <given-names>C</given-names></name><name><surname>Zipp</surname> <given-names>F</given-names></name><name><surname>D'Alfonso</surname> <given-names>S</given-names></name><name><surname>Martinelli-Boneschi</surname> <given-names>F</given-names></name><name><surname>Taylor</surname> <given-names>B</given-names></name><name><surname>Harbo</surname> <given-names>HF</given-names></name><name><surname>Kockum</surname> <given-names>I</given-names></name><name><surname>Hillert</surname> <given-names>J</given-names></name><name><surname>Olsson</surname> <given-names>T</given-names></name><name><surname>Ban</surname> <given-names>M</given-names></name><name><surname>Oksenberg</surname> <given-names>JR</given-names></name><name><surname>Hintzen</surname> <given-names>R</given-names></name><name><surname>Barcellos</surname> <given-names>LF</given-names></name><name><surname>Agliardi</surname> <given-names>C</given-names></name><name><surname>Alfredsson</surname> <given-names>L</given-names></name><name><surname>Alizadeh</surname> <given-names>M</given-names></name><name><surname>Anderson</surname> <given-names>C</given-names></name><name><surname>Andrews</surname> <given-names>R</given-names></name><name><surname>Søndergaard</surname> <given-names>HB</given-names></name><name><surname>Baker</surname> <given-names>A</given-names></name><name><surname>Band</surname> <given-names>G</given-names></name><name><surname>Baranzini</surname> <given-names>SE</given-names></name><name><surname>Barizzone</surname> <given-names>N</given-names></name><name><surname>Barrett</surname> <given-names>J</given-names></name><name><surname>Bellenguez</surname> <given-names>C</given-names></name><name><surname>Bergamaschi</surname> <given-names>L</given-names></name><name><surname>Bernardinelli</surname> <given-names>L</given-names></name><name><surname>Berthele</surname> <given-names>A</given-names></name><name><surname>Biberacher</surname> <given-names>V</given-names></name><name><surname>Binder</surname> <given-names>TM</given-names></name><name><surname>Blackburn</surname> <given-names>H</given-names></name><name><surname>Bomfim</surname> <given-names>IL</given-names></name><name><surname>Brambilla</surname> <given-names>P</given-names></name><name><surname>Broadley</surname> <given-names>S</given-names></name><name><surname>Brochet</surname> <given-names>B</given-names></name><name><surname>Brundin</surname> <given-names>L</given-names></name><name><surname>Buck</surname> <given-names>D</given-names></name><name><surname>Butzkueven</surname> <given-names>H</given-names></name><name><surname>Caillier</surname> <given-names>SJ</given-names></name><name><surname>Camu</surname> <given-names>W</given-names></name><name><surname>Carpentier</surname> <given-names>W</given-names></name><name><surname>Cavalla</surname> <given-names>P</given-names></name><name><surname>Celius</surname> <given-names>EG</given-names></name><name><surname>Coman</surname> <given-names>I</given-names></name><name><surname>Comi</surname> <given-names>G</given-names></name><name><surname>Corrado</surname> <given-names>L</given-names></name><name><surname>Cosemans</surname> <given-names>L</given-names></name><name><surname>Cournu-Rebeix</surname> <given-names>I</given-names></name><name><surname>Cree</surname> <given-names>BA</given-names></name><name><surname>Cusi</surname> <given-names>D</given-names></name><name><surname>Damotte</surname> <given-names>V</given-names></name><name><surname>Defer</surname> <given-names>G</given-names></name><name><surname>Delgado</surname> <given-names>SR</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><name><surname>di Sapio</surname> <given-names>A</given-names></name><name><surname>Dilthey</surname> <given-names>AT</given-names></name><name><surname>Donnelly</surname> <given-names>P</given-names></name><name><surname>Dubois</surname> <given-names>B</given-names></name><name><surname>Duddy</surname> <given-names>M</given-names></name><name><surname>Edkins</surname> <given-names>S</given-names></name><name><surname>Elovaara</surname> <given-names>I</given-names></name><name><surname>Esposito</surname> <given-names>F</given-names></name><name><surname>Evangelou</surname> <given-names>N</given-names></name><name><surname>Fiddes</surname> <given-names>B</given-names></name><name><surname>Field</surname> <given-names>J</given-names></name><name><surname>Franke</surname> <given-names>A</given-names></name><name><surname>Freeman</surname> <given-names>C</given-names></name><name><surname>Frohlich</surname> <given-names>IY</given-names></name><name><surname>Galimberti</surname> <given-names>D</given-names></name><name><surname>Gieger</surname> <given-names>C</given-names></name><name><surname>Gourraud</surname> <given-names>PA</given-names></name><name><surname>Graetz</surname> <given-names>C</given-names></name><name><surname>Graham</surname> <given-names>A</given-names></name><name><surname>Grummel</surname> <given-names>V</given-names></name><name><surname>Guaschino</surname> <given-names>C</given-names></name><name><surname>Hadjixenofontos</surname> <given-names>A</given-names></name><name><surname>Hakonarson</surname> <given-names>H</given-names></name><name><surname>Halfpenny</surname> <given-names>C</given-names></name><name><surname>Hall</surname> <given-names>G</given-names></name><name><surname>Hall</surname> <given-names>P</given-names></name><name><surname>Hamsten</surname> <given-names>A</given-names></name><name><surname>Harley</surname> <given-names>J</given-names></name><name><surname>Harrower</surname> <given-names>T</given-names></name><name><surname>Hawkins</surname> <given-names>C</given-names></name><name><surname>Hellenthal</surname> <given-names>G</given-names></name><name><surname>Hillier</surname> <given-names>C</given-names></name><name><surname>Hobart</surname> <given-names>J</given-names></name><name><surname>Hoshi</surname> <given-names>M</given-names></name><name><surname>Hunt</surname> <given-names>SE</given-names></name><name><surname>Jagodic</surname> <given-names>M</given-names></name><name><surname>Jelčić</surname> <given-names>I</given-names></name><name><surname>Jochim</surname> <given-names>A</given-names></name><name><surname>Kendall</surname> <given-names>B</given-names></name><name><surname>Kermode</surname> <given-names>A</given-names></name><name><surname>Kilpatrick</surname> <given-names>T</given-names></name><name><surname>Koivisto</surname> <given-names>K</given-names></name><name><surname>Konidari</surname> <given-names>I</given-names></name><name><surname>Korn</surname> <given-names>T</given-names></name><name><surname>Kronsbein</surname> <given-names>H</given-names></name><name><surname>Langford</surname> <given-names>C</given-names></name><name><surname>Larsson</surname> <given-names>M</given-names></name><name><surname>Lathrop</surname> <given-names>M</given-names></name><name><surname>Lebrun-Frenay</surname> <given-names>C</given-names></name><name><surname>Lechner-Scott</surname> <given-names>J</given-names></name><name><surname>Lee</surname> <given-names>MH</given-names></name><name><surname>Leone</surname> <given-names>MA</given-names></name><name><surname>Leppä</surname> <given-names>V</given-names></name><name><surname>Liberatore</surname> <given-names>G</given-names></name><name><surname>Lie</surname> <given-names>BA</given-names></name><name><surname>Lill</surname> <given-names>CM</given-names></name><name><surname>Lindén</surname> <given-names>M</given-names></name><name><surname>Link</surname> <given-names>J</given-names></name><name><surname>Luessi</surname> <given-names>F</given-names></name><name><surname>Lycke</surname> <given-names>J</given-names></name><name><surname>Macciardi</surname> <given-names>F</given-names></name><name><surname>Männistö</surname> <given-names>S</given-names></name><name><surname>Manrique</surname> <given-names>CP</given-names></name><name><surname>Martin</surname> <given-names>R</given-names></name><name><surname>Martinelli</surname> <given-names>V</given-names></name><name><surname>Mason</surname> <given-names>D</given-names></name><name><surname>Mazibrada</surname> <given-names>G</given-names></name><name><surname>McCabe</surname> <given-names>C</given-names></name><name><surname>Mero</surname> <given-names>IL</given-names></name><name><surname>Mescheriakova</surname> <given-names>J</given-names></name><name><surname>Moutsianas</surname> <given-names>L</given-names></name><name><surname>Myhr</surname> <given-names>KM</given-names></name><name><surname>Nagels</surname> <given-names>G</given-names></name><name><surname>Nicholas</surname> <given-names>R</given-names></name><name><surname>Nilsson</surname> <given-names>P</given-names></name><name><surname>Piehl</surname> <given-names>F</given-names></name><name><surname>Pirinen</surname> <given-names>M</given-names></name><name><surname>Price</surname> <given-names>SE</given-names></name><name><surname>Quach</surname> <given-names>H</given-names></name><name><surname>Reunanen</surname> <given-names>M</given-names></name><name><surname>Robberecht</surname> <given-names>W</given-names></name><name><surname>Robertson</surname> <given-names>NP</given-names></name><name><surname>Rodegher</surname> <given-names>M</given-names></name><name><surname>Rog</surname> <given-names>D</given-names></name><name><surname>Salvetti</surname> <given-names>M</given-names></name><name><surname>Schnetz-Boutaud</surname> <given-names>NC</given-names></name><name><surname>Sellebjerg</surname> <given-names>F</given-names></name><name><surname>Selter</surname> <given-names>RC</given-names></name><name><surname>Schaefer</surname> <given-names>C</given-names></name><name><surname>Shaunak</surname> <given-names>S</given-names></name><name><surname>Shen</surname> <given-names>L</given-names></name><name><surname>Shields</surname> <given-names>S</given-names></name><name><surname>Siffrin</surname> <given-names>V</given-names></name><name><surname>Slee</surname> <given-names>M</given-names></name><name><surname>Sorensen</surname> <given-names>PS</given-names></name><name><surname>Sorosina</surname> <given-names>M</given-names></name><name><surname>Sospedra</surname> <given-names>M</given-names></name><name><surname>Spurkland</surname> <given-names>A</given-names></name><name><surname>Strange</surname> <given-names>A</given-names></name><name><surname>Sundqvist</surname> <given-names>E</given-names></name><name><surname>Thijs</surname> <given-names>V</given-names></name><name><surname>Thorpe</surname> <given-names>J</given-names></name><name><surname>Ticca</surname> <given-names>A</given-names></name><name><surname>Tienari</surname> <given-names>P</given-names></name><name><surname>van Duijn</surname> <given-names>C</given-names></name><name><surname>Visser</surname> <given-names>EM</given-names></name><name><surname>Vucic</surname> <given-names>S</given-names></name><name><surname>Westerlind</surname> <given-names>H</given-names></name><name><surname>Wiley</surname> <given-names>JS</given-names></name><name><surname>Wilkins</surname> <given-names>A</given-names></name><name><surname>Wilson</surname> <given-names>JF</given-names></name><name><surname>Winkelmann</surname> <given-names>J</given-names></name><name><surname>Zajicek</surname> <given-names>J</given-names></name><name><surname>Zindler</surname> <given-names>E</given-names></name><name><surname>Haines</surname> <given-names>JL</given-names></name><name><surname>Pericak-Vance</surname> <given-names>MA</given-names></name><name><surname>Ivinson</surname> <given-names>AJ</given-names></name><name><surname>Stewart</surname> <given-names>G</given-names></name><name><surname>Hafler</surname> <given-names>D</given-names></name><name><surname>Hauser</surname> <given-names>SL</given-names></name><name><surname>Compston</surname> <given-names>A</given-names></name><name><surname>McVean</surname> <given-names>G</given-names></name><name><surname>De Jager</surname> <given-names>P</given-names></name><name><surname>Sawcer</surname> <given-names>SJ</given-names></name><name><surname>McCauley</surname> <given-names>JL</given-names></name><collab>International Multiple Sclerosis Genetics Consortium (IMSGC)</collab><collab>Wellcome Trust Case Control Consortium 2 (WTCCC2)</collab><collab>International IBD Genetics Consortium (IIBDGC)</collab></person-group><year iso-8601-date="2013">2013</year><article-title>Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis</article-title><source>Nature Genetics</source><volume>45</volume><fpage>1353</fpage><lpage>1360</lpage><pub-id pub-id-type="doi">10.1038/ng.2770</pub-id><pub-id pub-id-type="pmid">24076602</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bentham</surname> <given-names>J</given-names></name><name><surname>Morris</surname> <given-names>DL</given-names></name><name><surname>Cunninghame Graham</surname> <given-names>DS</given-names></name><name><surname>Pinder</surname> <given-names>CL</given-names></name><name><surname>Tombleson</surname> <given-names>P</given-names></name><name><surname>Behrens</surname> <given-names>TW</given-names></name><name><surname>Martín</surname> <given-names>J</given-names></name><name><surname>Fairfax</surname> <given-names>BP</given-names></name><name><surname>Knight</surname> <given-names>JC</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Replogle</surname> <given-names>J</given-names></name><name><surname>Syvänen</surname> <given-names>A-C</given-names></name><name><surname>Rönnblom</surname> <given-names>L</given-names></name><name><surname>Graham</surname> <given-names>RR</given-names></name><name><surname>Wither</surname> <given-names>JE</given-names></name><name><surname>Rioux</surname> <given-names>JD</given-names></name><name><surname>Alarcón-Riquelme</surname> <given-names>ME</given-names></name><name><surname>Vyse</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus</article-title><source>Nature Genetics</source><volume>47</volume><fpage>1457</fpage><lpage>1464</lpage><pub-id pub-id-type="doi">10.1038/ng.3434</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bentley</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Coupling mRNA processing with transcription in time and space</article-title><source>Nature Reviews Genetics</source><volume>15</volume><fpage>163</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1038/nrg3662</pub-id><pub-id pub-id-type="pmid">24514444</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkhardt</surname> <given-names>R</given-names></name><name><surname>Kenny</surname> <given-names>EE</given-names></name><name><surname>Lowe</surname> <given-names>JK</given-names></name><name><surname>Birkeland</surname> <given-names>A</given-names></name><name><surname>Josowitz</surname> <given-names>R</given-names></name><name><surname>Noel</surname> <given-names>M</given-names></name><name><surname>Salit</surname> <given-names>J</given-names></name><name><surname>Maller</surname> <given-names>JB</given-names></name><name><surname>Pe'er</surname> <given-names>I</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>Altshuler</surname> <given-names>D</given-names></name><name><surname>Stoffel</surname> <given-names>M</given-names></name><name><surname>Friedman</surname> <given-names>JM</given-names></name><name><surname>Breslow</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>28</volume><fpage>2078</fpage><lpage>2084</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.108.172288</pub-id><pub-id pub-id-type="pmid">18802019</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Ge</surname> <given-names>B</given-names></name><name><surname>Casale</surname> <given-names>FP</given-names></name><name><surname>Vasquez</surname> <given-names>L</given-names></name><name><surname>Kwan</surname> <given-names>T</given-names></name><name><surname>Garrido-Martín</surname> <given-names>D</given-names></name><name><surname>Watt</surname> <given-names>S</given-names></name><name><surname>Yan</surname> <given-names>Y</given-names></name><name><surname>Kundu</surname> <given-names>K</given-names></name><name><surname>Ecker</surname> <given-names>S</given-names></name><name><surname>Datta</surname> <given-names>A</given-names></name><name><surname>Richardson</surname> <given-names>D</given-names></name><name><surname>Burden</surname> <given-names>F</given-names></name><name><surname>Mead</surname> <given-names>D</given-names></name><name><surname>Mann</surname> <given-names>AL</given-names></name><name><surname>Fernandez</surname> <given-names>JM</given-names></name><name><surname>Rowlston</surname> <given-names>S</given-names></name><name><surname>Wilder</surname> <given-names>SP</given-names></name><name><surname>Farrow</surname> <given-names>S</given-names></name><name><surname>Shao</surname> <given-names>X</given-names></name><name><surname>Lambourne</surname> <given-names>JJ</given-names></name><name><surname>Redensek</surname> <given-names>A</given-names></name><name><surname>Albers</surname> <given-names>CA</given-names></name><name><surname>Amstislavskiy</surname> <given-names>V</given-names></name><name><surname>Ashford</surname> <given-names>S</given-names></name><name><surname>Berentsen</surname> <given-names>K</given-names></name><name><surname>Bomba</surname> <given-names>L</given-names></name><name><surname>Bourque</surname> <given-names>G</given-names></name><name><surname>Bujold</surname> <given-names>D</given-names></name><name><surname>Busche</surname> <given-names>S</given-names></name><name><surname>Caron</surname> <given-names>M</given-names></name><name><surname>Chen</surname> <given-names>SH</given-names></name><name><surname>Cheung</surname> <given-names>W</given-names></name><name><surname>Delaneau</surname> <given-names>O</given-names></name><name><surname>Dermitzakis</surname> <given-names>ET</given-names></name><name><surname>Elding</surname> <given-names>H</given-names></name><name><surname>Colgiu</surname> <given-names>I</given-names></name><name><surname>Bagger</surname> <given-names>FO</given-names></name><name><surname>Flicek</surname> <given-names>P</given-names></name><name><surname>Habibi</surname> <given-names>E</given-names></name><name><surname>Iotchkova</surname> <given-names>V</given-names></name><name><surname>Janssen-Megens</surname> <given-names>E</given-names></name><name><surname>Kim</surname> <given-names>B</given-names></name><name><surname>Lehrach</surname> <given-names>H</given-names></name><name><surname>Lowy</surname> <given-names>E</given-names></name><name><surname>Mandoli</surname> <given-names>A</given-names></name><name><surname>Matarese</surname> <given-names>F</given-names></name><name><surname>Maurano</surname> <given-names>MT</given-names></name><name><surname>Morris</surname> <given-names>JA</given-names></name><name><surname>Pancaldi</surname> <given-names>V</given-names></name><name><surname>Pourfarzad</surname> <given-names>F</given-names></name><name><surname>Rehnstrom</surname> <given-names>K</given-names></name><name><surname>Rendon</surname> <given-names>A</given-names></name><name><surname>Risch</surname> <given-names>T</given-names></name><name><surname>Sharifi</surname> <given-names>N</given-names></name><name><surname>Simon</surname> <given-names>MM</given-names></name><name><surname>Sultan</surname> <given-names>M</given-names></name><name><surname>Valencia</surname> <given-names>A</given-names></name><name><surname>Walter</surname> <given-names>K</given-names></name><name><surname>Wang</surname> <given-names>SY</given-names></name><name><surname>Frontini</surname> <given-names>M</given-names></name><name><surname>Antonarakis</surname> <given-names>SE</given-names></name><name><surname>Clarke</surname> <given-names>L</given-names></name><name><surname>Yaspo</surname> <given-names>ML</given-names></name><name><surname>Beck</surname> <given-names>S</given-names></name><name><surname>Guigo</surname> <given-names>R</given-names></name><name><surname>Rico</surname> <given-names>D</given-names></name><name><surname>Martens</surname> <given-names>JHA</given-names></name><name><surname>Ouwehand</surname> <given-names>WH</given-names></name><name><surname>Kuijpers</surname> <given-names>TW</given-names></name><name><surname>Paul</surname> <given-names>DS</given-names></name><name><surname>Stunnenberg</surname> <given-names>HG</given-names></name><name><surname>Stegle</surname> <given-names>O</given-names></name><name><surname>Downes</surname> <given-names>K</given-names></name><name><surname>Pastinen</surname> <given-names>T</given-names></name><name><surname>Soranzo</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genetic drivers of epigenetic and transcriptional variation in human immune cells</article-title><source>Cell</source><volume>167</volume><fpage>1398</fpage><lpage>1414</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.026</pub-id><pub-id pub-id-type="pmid">27863251</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conway</surname> <given-names>JR</given-names></name><name><surname>Lex</surname> <given-names>A</given-names></name><name><surname>Gehlenborg</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>UpSetR: an R package for the visualization of intersecting sets and their properties</article-title><source>Bioinformatics</source><volume>33</volume><fpage>2938</fpage><lpage>2940</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btx364</pub-id><pub-id pub-id-type="pmid">28645171</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delaneau</surname> <given-names>O</given-names></name><name><surname>Ongen</surname> <given-names>H</given-names></name><name><surname>Brown</surname> <given-names>AA</given-names></name><name><surname>Fort</surname> <given-names>A</given-names></name><name><surname>Panousis</surname> <given-names>NI</given-names></name><name><surname>Dermitzakis</surname> <given-names>ET</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A complete tool set for molecular QTL discovery and analysis</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>15452</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms15452</pub-id><pub-id pub-id-type="pmid">28516912</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Demircioğlu</surname> <given-names>D</given-names></name><name><surname>Kindermans</surname> <given-names>M</given-names></name><name><surname>Nandi</surname> <given-names>T</given-names></name><name><surname>Cukuroglu</surname> <given-names>E</given-names></name><name><surname>Calabrese</surname> <given-names>C</given-names></name><name><surname>Fonseca</surname> <given-names>NA</given-names></name><name><surname>Kahles</surname> <given-names>A</given-names></name><name><surname>Lehmann</surname> <given-names>K</given-names></name><name><surname>Stegle</surname> <given-names>O</given-names></name><name><surname>Pcawg-</surname> <given-names>P-N</given-names></name><name><surname>Brazma</surname> <given-names>A</given-names></name><name><surname>Brooks</surname> <given-names>A</given-names></name><name><surname>Rätsch</surname> <given-names>G</given-names></name><name><surname>Tan</surname> <given-names>P</given-names></name><name><surname>Göke</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A pan cancer analysis of promoter activity highlights the regulatory role of alternative transcription start sites and their association with noncoding mutations</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/176487</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname> <given-names>A</given-names></name><name><surname>Davis</surname> <given-names>CA</given-names></name><name><surname>Schlesinger</surname> <given-names>F</given-names></name><name><surname>Drenkow</surname> <given-names>J</given-names></name><name><surname>Zaleski</surname> <given-names>C</given-names></name><name><surname>Jha</surname> <given-names>S</given-names></name><name><surname>Batut</surname> <given-names>P</given-names></name><name><surname>Chaisson</surname> <given-names>M</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durinck</surname> <given-names>S</given-names></name><name><surname>Moreau</surname> <given-names>Y</given-names></name><name><surname>Kasprzyk</surname> <given-names>A</given-names></name><name><surname>Davis</surname> <given-names>S</given-names></name><name><surname>De Moor</surname> <given-names>B</given-names></name><name><surname>Brazma</surname> <given-names>A</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>BioMart and bioconductor: a powerful link between biological databases and microarray data analysis</article-title><source>Bioinformatics</source><volume>21</volume><fpage>3439</fpage><lpage>3440</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bti525</pub-id><pub-id pub-id-type="pmid">16082012</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname> <given-names>SE</given-names></name><name><surname>Gupta</surname> <given-names>S</given-names></name><name><surname>Ashar</surname> <given-names>FN</given-names></name><name><surname>Bader</surname> <given-names>JS</given-names></name><name><surname>West</surname> <given-names>AB</given-names></name><name><surname>Arking</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>RNA-Seq optimization with eQTL gold standards</article-title><source>BMC Genomics</source><volume>14</volume><elocation-id>892</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-14-892</pub-id><pub-id pub-id-type="pmid">24341889</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fadista</surname> <given-names>J</given-names></name><name><surname>Vikman</surname> <given-names>P</given-names></name><name><surname>Laakso</surname> <given-names>EO</given-names></name><name><surname>Mollet</surname> <given-names>IG</given-names></name><name><surname>Esguerra</surname> <given-names>JL</given-names></name><name><surname>Taneera</surname> <given-names>J</given-names></name><name><surname>Storm</surname> <given-names>P</given-names></name><name><surname>Osmark</surname> <given-names>P</given-names></name><name><surname>Ladenvall</surname> <given-names>C</given-names></name><name><surname>Prasad</surname> <given-names>RB</given-names></name><name><surname>Hansson</surname> <given-names>KB</given-names></name><name><surname>Finotello</surname> <given-names>F</given-names></name><name><surname>Uvebrant</surname> <given-names>K</given-names></name><name><surname>Ofori</surname> <given-names>JK</given-names></name><name><surname>Di Camillo</surname> <given-names>B</given-names></name><name><surname>Krus</surname> <given-names>U</given-names></name><name><surname>Cilio</surname> <given-names>CM</given-names></name><name><surname>Hansson</surname> <given-names>O</given-names></name><name><surname>Eliasson</surname> <given-names>L</given-names></name><name><surname>Rosengren</surname> <given-names>AH</given-names></name><name><surname>Renström</surname> <given-names>E</given-names></name><name><surname>Wollheim</surname> <given-names>CB</given-names></name><name><surname>Groop</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism</article-title><source>PNAS</source><volume>111</volume><fpage>13924</fpage><lpage>13929</lpage><pub-id pub-id-type="doi">10.1073/pnas.1402665111</pub-id><pub-id pub-id-type="pmid">25201977</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fairfax</surname> <given-names>BP</given-names></name><name><surname>Humburg</surname> <given-names>P</given-names></name><name><surname>Makino</surname> <given-names>S</given-names></name><name><surname>Naranbhai</surname> <given-names>V</given-names></name><name><surname>Wong</surname> <given-names>D</given-names></name><name><surname>Lau</surname> <given-names>E</given-names></name><name><surname>Jostins</surname> <given-names>L</given-names></name><name><surname>Plant</surname> <given-names>K</given-names></name><name><surname>Andrews</surname> <given-names>R</given-names></name><name><surname>McGee</surname> <given-names>C</given-names></name><name><surname>Knight</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression</article-title><source>Science</source><volume>343</volume><elocation-id>1246949</elocation-id><pub-id pub-id-type="doi">10.1126/science.1246949</pub-id><pub-id pub-id-type="pmid">24604202</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faraco</surname> <given-names>J</given-names></name><name><surname>Lin</surname> <given-names>L</given-names></name><name><surname>Kornum</surname> <given-names>BR</given-names></name><name><surname>Kenny</surname> <given-names>EE</given-names></name><name><surname>Trynka</surname> <given-names>G</given-names></name><name><surname>Einen</surname> <given-names>M</given-names></name><name><surname>Rico</surname> <given-names>TJ</given-names></name><name><surname>Lichtner</surname> <given-names>P</given-names></name><name><surname>Dauvilliers</surname> <given-names>Y</given-names></name><name><surname>Arnulf</surname> <given-names>I</given-names></name><name><surname>Lecendreux</surname> <given-names>M</given-names></name><name><surname>Javidi</surname> <given-names>S</given-names></name><name><surname>Geisler</surname> <given-names>P</given-names></name><name><surname>Mayer</surname> <given-names>G</given-names></name><name><surname>Pizza</surname> <given-names>F</given-names></name><name><surname>Poli</surname> <given-names>F</given-names></name><name><surname>Plazzi</surname> <given-names>G</given-names></name><name><surname>Overeem</surname> <given-names>S</given-names></name><name><surname>Lammers</surname> <given-names>GJ</given-names></name><name><surname>Kemlink</surname> <given-names>D</given-names></name><name><surname>Sonka</surname> <given-names>K</given-names></name><name><surname>Nevsimalova</surname> <given-names>S</given-names></name><name><surname>Rouleau</surname> <given-names>G</given-names></name><name><surname>Desautels</surname> <given-names>A</given-names></name><name><surname>Montplaisir</surname> <given-names>J</given-names></name><name><surname>Frauscher</surname> <given-names>B</given-names></name><name><surname>Ehrmann</surname> <given-names>L</given-names></name><name><surname>Högl</surname> <given-names>B</given-names></name><name><surname>Jennum</surname> <given-names>P</given-names></name><name><surname>Bourgin</surname> <given-names>P</given-names></name><name><surname>Peraita-Adrados</surname> <given-names>R</given-names></name><name><surname>Iranzo</surname> <given-names>A</given-names></name><name><surname>Bassetti</surname> <given-names>C</given-names></name><name><surname>Chen</surname> <given-names>WM</given-names></name><name><surname>Concannon</surname> <given-names>P</given-names></name><name><surname>Thompson</surname> <given-names>SD</given-names></name><name><surname>Damotte</surname> <given-names>V</given-names></name><name><surname>Fontaine</surname> <given-names>B</given-names></name><name><surname>Breban</surname> <given-names>M</given-names></name><name><surname>Gieger</surname> <given-names>C</given-names></name><name><surname>Klopp</surname> <given-names>N</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><name><surname>Wijmenga</surname> <given-names>C</given-names></name><name><surname>Hallmayer</surname> <given-names>J</given-names></name><name><surname>Onengut-Gumuscu</surname> <given-names>S</given-names></name><name><surname>Rich</surname> <given-names>SS</given-names></name><name><surname>Winkelmann</surname> <given-names>J</given-names></name><name><surname>Mignot</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>ImmunoChip study implicates antigen presentation to T cells in narcolepsy</article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1003270</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003270</pub-id><pub-id pub-id-type="pmid">23459209</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forrest</surname> <given-names>AR</given-names></name><name><surname>Kawaji</surname> <given-names>H</given-names></name><name><surname>Rehli</surname> <given-names>M</given-names></name><name><surname>Baillie</surname> <given-names>JK</given-names></name><name><surname>de Hoon</surname> <given-names>MJ</given-names></name><name><surname>Haberle</surname> <given-names>V</given-names></name><name><surname>Lassmann</surname> <given-names>T</given-names></name><name><surname>Kulakovskiy</surname> <given-names>IV</given-names></name><name><surname>Lizio</surname> <given-names>M</given-names></name><name><surname>Itoh</surname> <given-names>M</given-names></name><name><surname>Andersson</surname> <given-names>R</given-names></name><name><surname>Mungall</surname> <given-names>CJ</given-names></name><name><surname>Meehan</surname> <given-names>TF</given-names></name><name><surname>Schmeier</surname> <given-names>S</given-names></name><name><surname>Bertin</surname> <given-names>N</given-names></name><name><surname>Jørgensen</surname> <given-names>M</given-names></name><name><surname>Dimont</surname> <given-names>E</given-names></name><name><surname>Arner</surname> <given-names>E</given-names></name><name><surname>Schmidl</surname> <given-names>C</given-names></name><name><surname>Schaefer</surname> <given-names>U</given-names></name><name><surname>Medvedeva</surname> <given-names>YA</given-names></name><name><surname>Plessy</surname> <given-names>C</given-names></name><name><surname>Vitezic</surname> <given-names>M</given-names></name><name><surname>Severin</surname> <given-names>J</given-names></name><name><surname>Semple</surname> <given-names>C</given-names></name><name><surname>Ishizu</surname> <given-names>Y</given-names></name><name><surname>Young</surname> <given-names>RS</given-names></name><name><surname>Francescatto</surname> <given-names>M</given-names></name><name><surname>Alam</surname> <given-names>I</given-names></name><name><surname>Albanese</surname> <given-names>D</given-names></name><name><surname>Altschuler</surname> <given-names>GM</given-names></name><name><surname>Arakawa</surname> <given-names>T</given-names></name><name><surname>Archer</surname> <given-names>JA</given-names></name><name><surname>Arner</surname> <given-names>P</given-names></name><name><surname>Babina</surname> <given-names>M</given-names></name><name><surname>Rennie</surname> <given-names>S</given-names></name><name><surname>Balwierz</surname> <given-names>PJ</given-names></name><name><surname>Beckhouse</surname> <given-names>AG</given-names></name><name><surname>Pradhan-Bhatt</surname> <given-names>S</given-names></name><name><surname>Blake</surname> <given-names>JA</given-names></name><name><surname>Blumenthal</surname> <given-names>A</given-names></name><name><surname>Bodega</surname> <given-names>B</given-names></name><name><surname>Bonetti</surname> <given-names>A</given-names></name><name><surname>Briggs</surname> <given-names>J</given-names></name><name><surname>Brombacher</surname> <given-names>F</given-names></name><name><surname>Burroughs</surname> <given-names>AM</given-names></name><name><surname>Califano</surname> <given-names>A</given-names></name><name><surname>Cannistraci</surname> <given-names>CV</given-names></name><name><surname>Carbajo</surname> <given-names>D</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Chierici</surname> <given-names>M</given-names></name><name><surname>Ciani</surname> <given-names>Y</given-names></name><name><surname>Clevers</surname> <given-names>HC</given-names></name><name><surname>Dalla</surname> <given-names>E</given-names></name><name><surname>Davis</surname> <given-names>CA</given-names></name><name><surname>Detmar</surname> <given-names>M</given-names></name><name><surname>Diehl</surname> <given-names>AD</given-names></name><name><surname>Dohi</surname> <given-names>T</given-names></name><name><surname>Drabløs</surname> <given-names>F</given-names></name><name><surname>Edge</surname> <given-names>AS</given-names></name><name><surname>Edinger</surname> <given-names>M</given-names></name><name><surname>Ekwall</surname> <given-names>K</given-names></name><name><surname>Endoh</surname> <given-names>M</given-names></name><name><surname>Enomoto</surname> <given-names>H</given-names></name><name><surname>Fagiolini</surname> <given-names>M</given-names></name><name><surname>Fairbairn</surname> <given-names>L</given-names></name><name><surname>Fang</surname> <given-names>H</given-names></name><name><surname>Farach-Carson</surname> <given-names>MC</given-names></name><name><surname>Faulkner</surname> <given-names>GJ</given-names></name><name><surname>Favorov</surname> <given-names>AV</given-names></name><name><surname>Fisher</surname> <given-names>ME</given-names></name><name><surname>Frith</surname> <given-names>MC</given-names></name><name><surname>Fujita</surname> <given-names>R</given-names></name><name><surname>Fukuda</surname> <given-names>S</given-names></name><name><surname>Furlanello</surname> <given-names>C</given-names></name><name><surname>Furino</surname> <given-names>M</given-names></name><name><surname>Furusawa</surname> <given-names>J</given-names></name><name><surname>Geijtenbeek</surname> <given-names>TB</given-names></name><name><surname>Gibson</surname> <given-names>AP</given-names></name><name><surname>Gingeras</surname> <given-names>T</given-names></name><name><surname>Goldowitz</surname> <given-names>D</given-names></name><name><surname>Gough</surname> <given-names>J</given-names></name><name><surname>Guhl</surname> <given-names>S</given-names></name><name><surname>Guler</surname> <given-names>R</given-names></name><name><surname>Gustincich</surname> <given-names>S</given-names></name><name><surname>Ha</surname> <given-names>TJ</given-names></name><name><surname>Hamaguchi</surname> <given-names>M</given-names></name><name><surname>Hara</surname> <given-names>M</given-names></name><name><surname>Harbers</surname> <given-names>M</given-names></name><name><surname>Harshbarger</surname> <given-names>J</given-names></name><name><surname>Hasegawa</surname> <given-names>A</given-names></name><name><surname>Hasegawa</surname> <given-names>Y</given-names></name><name><surname>Hashimoto</surname> <given-names>T</given-names></name><name><surname>Herlyn</surname> <given-names>M</given-names></name><name><surname>Hitchens</surname> <given-names>KJ</given-names></name><name><surname>Ho Sui</surname> <given-names>SJ</given-names></name><name><surname>Hofmann</surname> <given-names>OM</given-names></name><name><surname>Hoof</surname> <given-names>I</given-names></name><name><surname>Hori</surname> <given-names>F</given-names></name><name><surname>Huminiecki</surname> <given-names>L</given-names></name><name><surname>Iida</surname> <given-names>K</given-names></name><name><surname>Ikawa</surname> <given-names>T</given-names></name><name><surname>Jankovic</surname> <given-names>BR</given-names></name><name><surname>Jia</surname> <given-names>H</given-names></name><name><surname>Joshi</surname> <given-names>A</given-names></name><name><surname>Jurman</surname> <given-names>G</given-names></name><name><surname>Kaczkowski</surname> <given-names>B</given-names></name><name><surname>Kai</surname> <given-names>C</given-names></name><name><surname>Kaida</surname> <given-names>K</given-names></name><name><surname>Kaiho</surname> <given-names>A</given-names></name><name><surname>Kajiyama</surname> <given-names>K</given-names></name><name><surname>Kanamori-Katayama</surname> <given-names>M</given-names></name><name><surname>Kasianov</surname> <given-names>AS</given-names></name><name><surname>Kasukawa</surname> <given-names>T</given-names></name><name><surname>Katayama</surname> <given-names>S</given-names></name><name><surname>Kato</surname> <given-names>S</given-names></name><name><surname>Kawaguchi</surname> <given-names>S</given-names></name><name><surname>Kawamoto</surname> <given-names>H</given-names></name><name><surname>Kawamura</surname> <given-names>YI</given-names></name><name><surname>Kawashima</surname> <given-names>T</given-names></name><name><surname>Kempfle</surname> <given-names>JS</given-names></name><name><surname>Kenna</surname> <given-names>TJ</given-names></name><name><surname>Kere</surname> <given-names>J</given-names></name><name><surname>Khachigian</surname> <given-names>LM</given-names></name><name><surname>Kitamura</surname> <given-names>T</given-names></name><name><surname>Klinken</surname> <given-names>SP</given-names></name><name><surname>Knox</surname> <given-names>AJ</given-names></name><name><surname>Kojima</surname> <given-names>M</given-names></name><name><surname>Kojima</surname> <given-names>S</given-names></name><name><surname>Kondo</surname> <given-names>N</given-names></name><name><surname>Koseki</surname> <given-names>H</given-names></name><name><surname>Koyasu</surname> <given-names>S</given-names></name><name><surname>Krampitz</surname> <given-names>S</given-names></name><name><surname>Kubosaki</surname> <given-names>A</given-names></name><name><surname>Kwon</surname> <given-names>AT</given-names></name><name><surname>Laros</surname> <given-names>JF</given-names></name><name><surname>Lee</surname> <given-names>W</given-names></name><name><surname>Lennartsson</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>K</given-names></name><name><surname>Lilje</surname> <given-names>B</given-names></name><name><surname>Lipovich</surname> <given-names>L</given-names></name><name><surname>Mackay-Sim</surname> <given-names>A</given-names></name><name><surname>Manabe</surname> <given-names>R</given-names></name><name><surname>Mar</surname> <given-names>JC</given-names></name><name><surname>Marchand</surname> <given-names>B</given-names></name><name><surname>Mathelier</surname> <given-names>A</given-names></name><name><surname>Mejhert</surname> <given-names>N</given-names></name><name><surname>Meynert</surname> <given-names>A</given-names></name><name><surname>Mizuno</surname> <given-names>Y</given-names></name><name><surname>de Lima Morais</surname> <given-names>DA</given-names></name><name><surname>Morikawa</surname> <given-names>H</given-names></name><name><surname>Morimoto</surname> <given-names>M</given-names></name><name><surname>Moro</surname> <given-names>K</given-names></name><name><surname>Motakis</surname> <given-names>E</given-names></name><name><surname>Motohashi</surname> <given-names>H</given-names></name><name><surname>Mummery</surname> <given-names>CL</given-names></name><name><surname>Murata</surname> <given-names>M</given-names></name><name><surname>Nagao-Sato</surname> <given-names>S</given-names></name><name><surname>Nakachi</surname> <given-names>Y</given-names></name><name><surname>Nakahara</surname> <given-names>F</given-names></name><name><surname>Nakamura</surname> <given-names>T</given-names></name><name><surname>Nakamura</surname> <given-names>Y</given-names></name><name><surname>Nakazato</surname> <given-names>K</given-names></name><name><surname>van Nimwegen</surname> <given-names>E</given-names></name><name><surname>Ninomiya</surname> <given-names>N</given-names></name><name><surname>Nishiyori</surname> <given-names>H</given-names></name><name><surname>Noma</surname> <given-names>S</given-names></name><name><surname>Noma</surname> <given-names>S</given-names></name><name><surname>Noazaki</surname> <given-names>T</given-names></name><name><surname>Ogishima</surname> <given-names>S</given-names></name><name><surname>Ohkura</surname> <given-names>N</given-names></name><name><surname>Ohimiya</surname> <given-names>H</given-names></name><name><surname>Ohno</surname> <given-names>H</given-names></name><name><surname>Ohshima</surname> <given-names>M</given-names></name><name><surname>Okada-Hatakeyama</surname> <given-names>M</given-names></name><name><surname>Okazaki</surname> <given-names>Y</given-names></name><name><surname>Orlando</surname> <given-names>V</given-names></name><name><surname>Ovchinnikov</surname> <given-names>DA</given-names></name><name><surname>Pain</surname> <given-names>A</given-names></name><name><surname>Passier</surname> <given-names>R</given-names></name><name><surname>Patrikakis</surname> <given-names>M</given-names></name><name><surname>Persson</surname> <given-names>H</given-names></name><name><surname>Piazza</surname> <given-names>S</given-names></name><name><surname>Prendergast</surname> <given-names>JG</given-names></name><name><surname>Rackham</surname> <given-names>OJ</given-names></name><name><surname>Ramilowski</surname> <given-names>JA</given-names></name><name><surname>Rashid</surname> <given-names>M</given-names></name><name><surname>Ravasi</surname> <given-names>T</given-names></name><name><surname>Rizzu</surname> <given-names>P</given-names></name><name><surname>Roncador</surname> <given-names>M</given-names></name><name><surname>Roy</surname> <given-names>S</given-names></name><name><surname>Rye</surname> <given-names>MB</given-names></name><name><surname>Saijyo</surname> <given-names>E</given-names></name><name><surname>Sajantila</surname> <given-names>A</given-names></name><name><surname>Saka</surname> <given-names>A</given-names></name><name><surname>Sakaguchi</surname> <given-names>S</given-names></name><name><surname>Sakai</surname> <given-names>M</given-names></name><name><surname>Sato</surname> <given-names>H</given-names></name><name><surname>Savvi</surname> <given-names>S</given-names></name><name><surname>Saxena</surname> <given-names>A</given-names></name><name><surname>Schneider</surname> <given-names>C</given-names></name><name><surname>Schultes</surname> <given-names>EA</given-names></name><name><surname>Schulze-Tanzil</surname> <given-names>GG</given-names></name><name><surname>Schwegmann</surname> <given-names>A</given-names></name><name><surname>Sengstag</surname> <given-names>T</given-names></name><name><surname>Sheng</surname> <given-names>G</given-names></name><name><surname>Shimoji</surname> <given-names>H</given-names></name><name><surname>Shimoni</surname> <given-names>Y</given-names></name><name><surname>Shin</surname> <given-names>JW</given-names></name><name><surname>Simon</surname> <given-names>C</given-names></name><name><surname>Sugiyama</surname> <given-names>D</given-names></name><name><surname>Sugiyama</surname> <given-names>T</given-names></name><name><surname>Suzuki</surname> <given-names>M</given-names></name><name><surname>Suzuki</surname> <given-names>N</given-names></name><name><surname>Swoboda</surname> <given-names>RK</given-names></name><name><surname>'t Hoen</surname> <given-names>PA</given-names></name><name><surname>Tagami</surname> <given-names>M</given-names></name><name><surname>Takahashi</surname> <given-names>N</given-names></name><name><surname>Takai</surname> <given-names>J</given-names></name><name><surname>Tanaka</surname> <given-names>H</given-names></name><name><surname>Tatsukawa</surname> <given-names>H</given-names></name><name><surname>Tatum</surname> <given-names>Z</given-names></name><name><surname>Thompson</surname> <given-names>M</given-names></name><name><surname>Toyodo</surname> <given-names>H</given-names></name><name><surname>Toyoda</surname> <given-names>T</given-names></name><name><surname>Valen</surname> <given-names>E</given-names></name><name><surname>van de Wetering</surname> <given-names>M</given-names></name><name><surname>van den Berg</surname> <given-names>LM</given-names></name><name><surname>Verado</surname> <given-names>R</given-names></name><name><surname>Vijayan</surname> <given-names>D</given-names></name><name><surname>Vorontsov</surname> <given-names>IE</given-names></name><name><surname>Wasserman</surname> <given-names>WW</given-names></name><name><surname>Watanabe</surname> <given-names>S</given-names></name><name><surname>Wells</surname> <given-names>CA</given-names></name><name><surname>Winteringham</surname> <given-names>LN</given-names></name><name><surname>Wolvetang</surname> <given-names>E</given-names></name><name><surname>Wood</surname> <given-names>EJ</given-names></name><name><surname>Yamaguchi</surname> <given-names>Y</given-names></name><name><surname>Yamamoto</surname> <given-names>M</given-names></name><name><surname>Yoneda</surname> <given-names>M</given-names></name><name><surname>Yonekura</surname> <given-names>Y</given-names></name><name><surname>Yoshida</surname> <given-names>S</given-names></name><name><surname>Zabierowski</surname> <given-names>SE</given-names></name><name><surname>Zhang</surname> <given-names>PG</given-names></name><name><surname>Zhao</surname> <given-names>X</given-names></name><name><surname>Zucchelli</surname> <given-names>S</given-names></name><name><surname>Summers</surname> <given-names>KM</given-names></name><name><surname>Suzuki</surname> <given-names>H</given-names></name><name><surname>Daub</surname> <given-names>CO</given-names></name><name><surname>Kawai</surname> <given-names>J</given-names></name><name><surname>Heutink</surname> <given-names>P</given-names></name><name><surname>Hide</surname> <given-names>W</given-names></name><name><surname>Freeman</surname> <given-names>TC</given-names></name><name><surname>Lenhard</surname> <given-names>B</given-names></name><name><surname>Bajic</surname> <given-names>VB</given-names></name><name><surname>Taylor</surname> <given-names>MS</given-names></name><name><surname>Makeev</surname> <given-names>VJ</given-names></name><name><surname>Sandelin</surname> <given-names>A</given-names></name><name><surname>Hume</surname> <given-names>DA</given-names></name><name><surname>Carninci</surname> <given-names>P</given-names></name><name><surname>Hayashizaki</surname> <given-names>Y</given-names></name><collab>FANTOM Consortium and the RIKEN PMI and CLST (DGT)</collab></person-group><year iso-8601-date="2014">2014</year><article-title>A promoter-level mammalian expression atlas</article-title><source>Nature</source><volume>507</volume><fpage>462</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1038/nature13182</pub-id><pub-id pub-id-type="pmid">24670764</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraser</surname> <given-names>HB</given-names></name><name><surname>Xie</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Common polymorphic transcript variation in human disease</article-title><source>Genome Research</source><volume>19</volume><fpage>567</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1101/gr.083477.108</pub-id><pub-id pub-id-type="pmid">19189928</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frazee</surname> <given-names>AC</given-names></name><name><surname>Jaffe</surname> <given-names>AE</given-names></name><name><surname>Langmead</surname> <given-names>B</given-names></name><name><surname>Leek</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Polyester: simulating RNA-seq datasets with differential transcript expression</article-title><source>Bioinformatics</source><volume>31</volume><fpage>2778</fpage><lpage>2784</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv272</pub-id><pub-id pub-id-type="pmid">25926345</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garieri</surname> <given-names>M</given-names></name><name><surname>Delaneau</surname> <given-names>O</given-names></name><name><surname>Santoni</surname> <given-names>F</given-names></name><name><surname>Fish</surname> <given-names>RJ</given-names></name><name><surname>Mull</surname> <given-names>D</given-names></name><name><surname>Carninci</surname> <given-names>P</given-names></name><name><surname>Dermitzakis</surname> <given-names>ET</given-names></name><name><surname>Antonarakis</surname> <given-names>SE</given-names></name><name><surname>Fort</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The effect of genetic variation on promoter usage and enhancer activity</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>1358</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-01467-7</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giambartolomei</surname> <given-names>C</given-names></name><name><surname>Vukcevic</surname> <given-names>D</given-names></name><name><surname>Schadt</surname> <given-names>EE</given-names></name><name><surname>Franke</surname> <given-names>L</given-names></name><name><surname>Hingorani</surname> <given-names>AD</given-names></name><name><surname>Wallace</surname> <given-names>C</given-names></name><name><surname>Plagnol</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Bayesian test for colocalisation between pairs of genetic association studies using summary statistics</article-title><source>PLOS Genetics</source><volume>10</volume><elocation-id>e1004383</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004383</pub-id><pub-id pub-id-type="pmid">24830394</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruber</surname> <given-names>AJ</given-names></name><name><surname>Schmidt</surname> <given-names>R</given-names></name><name><surname>Gruber</surname> <given-names>AR</given-names></name><name><surname>Martin</surname> <given-names>G</given-names></name><name><surname>Ghosh</surname> <given-names>S</given-names></name><name><surname>Belmadani</surname> <given-names>M</given-names></name><name><surname>Keller</surname> <given-names>W</given-names></name><name><surname>Zavolan</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A comprehensive analysis of 3' end sequencing data sets reveals novel polyadenylation signals and the repressive role of heterogeneous ribonucleoprotein C on cleavage and polyadenylation</article-title><source>Genome Research</source><volume>26</volume><fpage>1145</fpage><lpage>1159</lpage><pub-id pub-id-type="doi">10.1101/gr.202432.115</pub-id><pub-id pub-id-type="pmid">27382025</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>H</given-names></name><name><surname>Fortune</surname> <given-names>MD</given-names></name><name><surname>Burren</surname> <given-names>OS</given-names></name><name><surname>Schofield</surname> <given-names>E</given-names></name><name><surname>Todd</surname> <given-names>JA</given-names></name><name><surname>Wallace</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Integration of disease association and eQTL data using a bayesian colocalisation approach highlights six candidate causal genes in immune-mediated diseases</article-title><source>Human Molecular Genetics</source><volume>24</volume><fpage>3305</fpage><lpage>3313</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddv077</pub-id><pub-id pub-id-type="pmid">25743184</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ha</surname> <given-names>KCH</given-names></name><name><surname>Blencowe</surname> <given-names>BJ</given-names></name><name><surname>Morris</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>QAPA: a new method for the systematic analysis of alternative polyadenylation from RNA-seq data</article-title><source>Genome Biology</source><volume>19</volume><elocation-id>45</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-018-1414-4</pub-id><pub-id pub-id-type="pmid">29592814</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname> <given-names>KD</given-names></name><name><surname>Irizarry</surname> <given-names>RA</given-names></name><name><surname>Wu</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Removing technical variability in RNA-seq data using conditional quantile normalization</article-title><source>Biostatistics</source><volume>13</volume><fpage>204</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1093/biostatistics/kxr054</pub-id><pub-id pub-id-type="pmid">22285995</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iotchkova</surname> <given-names>V</given-names></name><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Morris</surname> <given-names>JA</given-names></name><name><surname>Jain</surname> <given-names>D</given-names></name><name><surname>Barbieri</surname> <given-names>C</given-names></name><name><surname>Walter</surname> <given-names>K</given-names></name><name><surname>Min</surname> <given-names>JL</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Astle</surname> <given-names>W</given-names></name><name><surname>Cocca</surname> <given-names>M</given-names></name><name><surname>Deelen</surname> <given-names>P</given-names></name><name><surname>Elding</surname> <given-names>H</given-names></name><name><surname>Farmaki</surname> <given-names>AE</given-names></name><name><surname>Franklin</surname> <given-names>CS</given-names></name><name><surname>Franberg</surname> <given-names>M</given-names></name><name><surname>Gaunt</surname> <given-names>TR</given-names></name><name><surname>Hofman</surname> <given-names>A</given-names></name><name><surname>Jiang</surname> <given-names>T</given-names></name><name><surname>Kleber</surname> <given-names>ME</given-names></name><name><surname>Lachance</surname> <given-names>G</given-names></name><name><surname>Luan</surname> <given-names>J</given-names></name><name><surname>Malerba</surname> <given-names>G</given-names></name><name><surname>Matchan</surname> <given-names>A</given-names></name><name><surname>Mead</surname> <given-names>D</given-names></name><name><surname>Memari</surname> <given-names>Y</given-names></name><name><surname>Ntalla</surname> <given-names>I</given-names></name><name><surname>Panoutsopoulou</surname> <given-names>K</given-names></name><name><surname>Pazoki</surname> <given-names>R</given-names></name><name><surname>Perry</surname> <given-names>JRB</given-names></name><name><surname>Rivadeneira</surname> <given-names>F</given-names></name><name><surname>Sabater-Lleal</surname> <given-names>M</given-names></name><name><surname>Sennblad</surname> <given-names>B</given-names></name><name><surname>Shin</surname> <given-names>SY</given-names></name><name><surname>Southam</surname> <given-names>L</given-names></name><name><surname>Traglia</surname> <given-names>M</given-names></name><name><surname>van Dijk</surname> <given-names>F</given-names></name><name><surname>van Leeuwen</surname> <given-names>EM</given-names></name><name><surname>Zaza</surname> <given-names>G</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Amin</surname> <given-names>N</given-names></name><name><surname>Butterworth</surname> <given-names>A</given-names></name><name><surname>Chambers</surname> <given-names>JC</given-names></name><name><surname>Dedoussis</surname> <given-names>G</given-names></name><name><surname>Dehghan</surname> <given-names>A</given-names></name><name><surname>Franco</surname> <given-names>OH</given-names></name><name><surname>Franke</surname> <given-names>L</given-names></name><name><surname>Frontini</surname> <given-names>M</given-names></name><name><surname>Gambaro</surname> <given-names>G</given-names></name><name><surname>Gasparini</surname> <given-names>P</given-names></name><name><surname>Hamsten</surname> <given-names>A</given-names></name><name><surname>Issacs</surname> <given-names>A</given-names></name><name><surname>Kooner</surname> <given-names>JS</given-names></name><name><surname>Kooperberg</surname> <given-names>C</given-names></name><name><surname>Langenberg</surname> <given-names>C</given-names></name><name><surname>Marz</surname> <given-names>W</given-names></name><name><surname>Scott</surname> <given-names>RA</given-names></name><name><surname>Swertz</surname> <given-names>MA</given-names></name><name><surname>Toniolo</surname> <given-names>D</given-names></name><name><surname>Uitterlinden</surname> <given-names>AG</given-names></name><name><surname>van Duijn</surname> <given-names>CM</given-names></name><name><surname>Watkins</surname> <given-names>H</given-names></name><name><surname>Zeggini</surname> <given-names>E</given-names></name><name><surname>Maurano</surname> <given-names>MT</given-names></name><name><surname>Timpson</surname> <given-names>NJ</given-names></name><name><surname>Reiner</surname> <given-names>AP</given-names></name><name><surname>Auer</surname> <given-names>PL</given-names></name><name><surname>Soranzo</surname> <given-names>N</given-names></name><collab>UK10K Consortium</collab></person-group><year iso-8601-date="2016">2016</year><article-title>Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps</article-title><source>Nature Genetics</source><volume>48</volume><fpage>1303</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1038/ng.3668</pub-id><pub-id pub-id-type="pmid">27668658</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>E</given-names></name><name><surname>Oliphant</surname> <given-names>T</given-names></name><name><surname>Peterson</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2001">2001</year><data-title>SciPy: open source scientific tools for python</data-title><source>BibSonomy</source></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jun</surname> <given-names>G</given-names></name><name><surname>Flickinger</surname> <given-names>M</given-names></name><name><surname>Hetrick</surname> <given-names>KN</given-names></name><name><surname>Romm</surname> <given-names>JM</given-names></name><name><surname>Doheny</surname> <given-names>KF</given-names></name><name><surname>Abecasis</surname> <given-names>GR</given-names></name><name><surname>Boehnke</surname> <given-names>M</given-names></name><name><surname>Kang</surname> <given-names>HM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Detecting and estimating contamination of human DNA samples in sequencing and array-based genotype data</article-title><source>The American Journal of Human Genetics</source><volume>91</volume><fpage>839</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2012.09.004</pub-id><pub-id pub-id-type="pmid">23103226</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>ET</given-names></name><name><surname>Airoldi</surname> <given-names>EM</given-names></name><name><surname>Burge</surname> <given-names>CB</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Analysis and design of RNA sequencing experiments for identifying isoform regulation</article-title><source>Nature Methods</source><volume>7</volume><fpage>1009</fpage><lpage>1015</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1528</pub-id><pub-id pub-id-type="pmid">21057496</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>ET</given-names></name><name><surname>Silterra</surname> <given-names>J</given-names></name><name><surname>Schwartz</surname> <given-names>S</given-names></name><name><surname>Wong</surname> <given-names>B</given-names></name><name><surname>Thorvaldsdóttir</surname> <given-names>H</given-names></name><name><surname>Robinson</surname> <given-names>JT</given-names></name><name><surname>Mesirov</surname> <given-names>JP</given-names></name><name><surname>Airoldi</surname> <given-names>EM</given-names></name><name><surname>Burge</surname> <given-names>CB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Quantitative visualization of alternative exon expression from RNA-seq data</article-title><source>Bioinformatics</source><volume>31</volume><fpage>2400</fpage><lpage>2402</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv034</pub-id><pub-id pub-id-type="pmid">25617416</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilpinen</surname> <given-names>H</given-names></name><name><surname>Goncalves</surname> <given-names>A</given-names></name><name><surname>Leha</surname> <given-names>A</given-names></name><name><surname>Afzal</surname> <given-names>V</given-names></name><name><surname>Alasoo</surname> <given-names>K</given-names></name><name><surname>Ashford</surname> <given-names>S</given-names></name><name><surname>Bala</surname> <given-names>S</given-names></name><name><surname>Bensaddek</surname> <given-names>D</given-names></name><name><surname>Casale</surname> <given-names>FP</given-names></name><name><surname>Culley</surname> <given-names>OJ</given-names></name><name><surname>Danecek</surname> <given-names>P</given-names></name><name><surname>Faulconbridge</surname> <given-names>A</given-names></name><name><surname>Harrison</surname> <given-names>PW</given-names></name><name><surname>Kathuria</surname> <given-names>A</given-names></name><name><surname>McCarthy</surname> <given-names>D</given-names></name><name><surname>McCarthy</surname> <given-names>SA</given-names></name><name><surname>Meleckyte</surname> <given-names>R</given-names></name><name><surname>Memari</surname> <given-names>Y</given-names></name><name><surname>Moens</surname> <given-names>N</given-names></name><name><surname>Soares</surname> <given-names>F</given-names></name><name><surname>Mann</surname> <given-names>A</given-names></name><name><surname>Streeter</surname> <given-names>I</given-names></name><name><surname>Agu</surname> <given-names>CA</given-names></name><name><surname>Alderton</surname> <given-names>A</given-names></name><name><surname>Nelson</surname> <given-names>R</given-names></name><name><surname>Harper</surname> <given-names>S</given-names></name><name><surname>Patel</surname> <given-names>M</given-names></name><name><surname>White</surname> <given-names>A</given-names></name><name><surname>Patel</surname> <given-names>SR</given-names></name><name><surname>Clarke</surname> <given-names>L</given-names></name><name><surname>Halai</surname> <given-names>R</given-names></name><name><surname>Kirton</surname> <given-names>CM</given-names></name><name><surname>Kolb-Kokocinski</surname> <given-names>A</given-names></name><name><surname>Beales</surname> <given-names>P</given-names></name><name><surname>Birney</surname> <given-names>E</given-names></name><name><surname>Danovi</surname> <given-names>D</given-names></name><name><surname>Lamond</surname> <given-names>AI</given-names></name><name><surname>Ouwehand</surname> <given-names>WH</given-names></name><name><surname>Vallier</surname> <given-names>L</given-names></name><name><surname>Watt</surname> <given-names>FM</given-names></name><name><surname>Durbin</surname> <given-names>R</given-names></name><name><surname>Stegle</surname> <given-names>O</given-names></name><name><surname>Gaffney</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Common genetic variation drives molecular heterogeneity in human iPSCs</article-title><source>Nature</source><volume>546</volume><fpage>370</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1038/nature22403</pub-id><pub-id pub-id-type="pmid">28489815</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim-Hellmuth</surname> <given-names>S</given-names></name><name><surname>Bechheim</surname> <given-names>M</given-names></name><name><surname>Pütz</surname> <given-names>B</given-names></name><name><surname>Mohammadi</surname> <given-names>P</given-names></name><name><surname>Nédélec</surname> <given-names>Y</given-names></name><name><surname>Giangreco</surname> <given-names>N</given-names></name><name><surname>Becker</surname> <given-names>J</given-names></name><name><surname>Kaiser</surname> <given-names>V</given-names></name><name><surname>Fricker</surname> <given-names>N</given-names></name><name><surname>Beier</surname> <given-names>E</given-names></name><name><surname>Boor</surname> <given-names>P</given-names></name><name><surname>Castel</surname> <given-names>SE</given-names></name><name><surname>Nöthen</surname> <given-names>MM</given-names></name><name><surname>Barreiro</surname> <given-names>LB</given-names></name><name><surname>Pickrell</surname> <given-names>JK</given-names></name><name><surname>Müller-Myhsok</surname> <given-names>B</given-names></name><name><surname>Lappalainen</surname> <given-names>T</given-names></name><name><surname>Schumacher</surname> <given-names>J</given-names></name><name><surname>Hornung</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genetic regulatory effects modified by immune activation contribute to autoimmune disease associations</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>266</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-00366-1</pub-id><pub-id pub-id-type="pmid">28814792</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Köster</surname> <given-names>J</given-names></name><name><surname>Rahmann</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Snakemake--a scalable bioinformatics workflow engine</article-title><source>Bioinformatics</source><volume>28</volume><fpage>2520</fpage><lpage>2522</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts480</pub-id><pub-id pub-id-type="pmid">22908215</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumasaka</surname> <given-names>N</given-names></name><name><surname>Knights</surname> <given-names>AJ</given-names></name><name><surname>Gaffney</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>High-resolution genetic mapping of putative causal interactions between regions of open chromatin</article-title><source>Nature Genetics</source><volume>51</volume><fpage>128</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0278-6</pub-id><pub-id pub-id-type="pmid">30478436</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname> <given-names>JC</given-names></name><name><surname>Ibrahim-Verbaas</surname> <given-names>CA</given-names></name><name><surname>Harold</surname> <given-names>D</given-names></name><name><surname>Naj</surname> <given-names>AC</given-names></name><name><surname>Sims</surname> <given-names>R</given-names></name><name><surname>Bellenguez</surname> <given-names>C</given-names></name><name><surname>DeStafano</surname> <given-names>AL</given-names></name><name><surname>Bis</surname> <given-names>JC</given-names></name><name><surname>Beecham</surname> <given-names>GW</given-names></name><name><surname>Grenier-Boley</surname> <given-names>B</given-names></name><name><surname>Russo</surname> <given-names>G</given-names></name><name><surname>Thorton-Wells</surname> <given-names>TA</given-names></name><name><surname>Jones</surname> <given-names>N</given-names></name><name><surname>Smith</surname> <given-names>AV</given-names></name><name><surname>Chouraki</surname> <given-names>V</given-names></name><name><surname>Thomas</surname> <given-names>C</given-names></name><name><surname>Ikram</surname> <given-names>MA</given-names></name><name><surname>Zelenika</surname> <given-names>D</given-names></name><name><surname>Vardarajan</surname> <given-names>BN</given-names></name><name><surname>Kamatani</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>CF</given-names></name><name><surname>Gerrish</surname> <given-names>A</given-names></name><name><surname>Schmidt</surname> <given-names>H</given-names></name><name><surname>Kunkle</surname> <given-names>B</given-names></name><name><surname>Dunstan</surname> <given-names>ML</given-names></name><name><surname>Ruiz</surname> <given-names>A</given-names></name><name><surname>Bihoreau</surname> <given-names>MT</given-names></name><name><surname>Choi</surname> <given-names>SH</given-names></name><name><surname>Reitz</surname> <given-names>C</given-names></name><name><surname>Pasquier</surname> <given-names>F</given-names></name><name><surname>Cruchaga</surname> <given-names>C</given-names></name><name><surname>Craig</surname> <given-names>D</given-names></name><name><surname>Amin</surname> <given-names>N</given-names></name><name><surname>Berr</surname> <given-names>C</given-names></name><name><surname>Lopez</surname> <given-names>OL</given-names></name><name><surname>De Jager</surname> <given-names>PL</given-names></name><name><surname>Deramecourt</surname> <given-names>V</given-names></name><name><surname>Johnston</surname> <given-names>JA</given-names></name><name><surname>Evans</surname> <given-names>D</given-names></name><name><surname>Lovestone</surname> <given-names>S</given-names></name><name><surname>Letenneur</surname> <given-names>L</given-names></name><name><surname>Morón</surname> <given-names>FJ</given-names></name><name><surname>Rubinsztein</surname> <given-names>DC</given-names></name><name><surname>Eiriksdottir</surname> <given-names>G</given-names></name><name><surname>Sleegers</surname> <given-names>K</given-names></name><name><surname>Goate</surname> <given-names>AM</given-names></name><name><surname>Fiévet</surname> <given-names>N</given-names></name><name><surname>Huentelman</surname> <given-names>MW</given-names></name><name><surname>Gill</surname> <given-names>M</given-names></name><name><surname>Brown</surname> <given-names>K</given-names></name><name><surname>Kamboh</surname> <given-names>MI</given-names></name><name><surname>Keller</surname> <given-names>L</given-names></name><name><surname>Barberger-Gateau</surname> <given-names>P</given-names></name><name><surname>McGuiness</surname> <given-names>B</given-names></name><name><surname>Larson</surname> <given-names>EB</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name><name><surname>Myers</surname> <given-names>AJ</given-names></name><name><surname>Dufouil</surname> <given-names>C</given-names></name><name><surname>Todd</surname> <given-names>S</given-names></name><name><surname>Wallon</surname> <given-names>D</given-names></name><name><surname>Love</surname> <given-names>S</given-names></name><name><surname>Rogaeva</surname> <given-names>E</given-names></name><name><surname>Gallacher</surname> <given-names>J</given-names></name><name><surname>St George-Hyslop</surname> <given-names>P</given-names></name><name><surname>Clarimon</surname> <given-names>J</given-names></name><name><surname>Lleo</surname> <given-names>A</given-names></name><name><surname>Bayer</surname> <given-names>A</given-names></name><name><surname>Tsuang</surname> <given-names>DW</given-names></name><name><surname>Yu</surname> <given-names>L</given-names></name><name><surname>Tsolaki</surname> <given-names>M</given-names></name><name><surname>Bossù</surname> <given-names>P</given-names></name><name><surname>Spalletta</surname> <given-names>G</given-names></name><name><surname>Proitsi</surname> <given-names>P</given-names></name><name><surname>Collinge</surname> <given-names>J</given-names></name><name><surname>Sorbi</surname> <given-names>S</given-names></name><name><surname>Sanchez-Garcia</surname> <given-names>F</given-names></name><name><surname>Fox</surname> <given-names>NC</given-names></name><name><surname>Hardy</surname> <given-names>J</given-names></name><name><surname>Deniz Naranjo</surname> <given-names>MC</given-names></name><name><surname>Bosco</surname> <given-names>P</given-names></name><name><surname>Clarke</surname> <given-names>R</given-names></name><name><surname>Brayne</surname> <given-names>C</given-names></name><name><surname>Galimberti</surname> <given-names>D</given-names></name><name><surname>Mancuso</surname> <given-names>M</given-names></name><name><surname>Matthews</surname> <given-names>F</given-names></name><name><surname>Moebus</surname> <given-names>S</given-names></name><name><surname>Mecocci</surname> <given-names>P</given-names></name><name><surname>Del Zompo</surname> <given-names>M</given-names></name><name><surname>Maier</surname> <given-names>W</given-names></name><name><surname>Hampel</surname> <given-names>H</given-names></name><name><surname>Pilotto</surname> <given-names>A</given-names></name><name><surname>Bullido</surname> <given-names>M</given-names></name><name><surname>Panza</surname> <given-names>F</given-names></name><name><surname>Caffarra</surname> <given-names>P</given-names></name><name><surname>Nacmias</surname> <given-names>B</given-names></name><name><surname>Gilbert</surname> <given-names>JR</given-names></name><name><surname>Mayhaus</surname> <given-names>M</given-names></name><name><surname>Lannefelt</surname> <given-names>L</given-names></name><name><surname>Hakonarson</surname> <given-names>H</given-names></name><name><surname>Pichler</surname> <given-names>S</given-names></name><name><surname>Carrasquillo</surname> <given-names>MM</given-names></name><name><surname>Ingelsson</surname> <given-names>M</given-names></name><name><surname>Beekly</surname> <given-names>D</given-names></name><name><surname>Alvarez</surname> <given-names>V</given-names></name><name><surname>Zou</surname> <given-names>F</given-names></name><name><surname>Valladares</surname> <given-names>O</given-names></name><name><surname>Younkin</surname> <given-names>SG</given-names></name><name><surname>Coto</surname> <given-names>E</given-names></name><name><surname>Hamilton-Nelson</surname> <given-names>KL</given-names></name><name><surname>Gu</surname> <given-names>W</given-names></name><name><surname>Razquin</surname> <given-names>C</given-names></name><name><surname>Pastor</surname> <given-names>P</given-names></name><name><surname>Mateo</surname> <given-names>I</given-names></name><name><surname>Owen</surname> <given-names>MJ</given-names></name><name><surname>Faber</surname> <given-names>KM</given-names></name><name><surname>Jonsson</surname> <given-names>PV</given-names></name><name><surname>Combarros</surname> <given-names>O</given-names></name><name><surname>O'Donovan</surname> <given-names>MC</given-names></name><name><surname>Cantwell</surname> <given-names>LB</given-names></name><name><surname>Soininen</surname> <given-names>H</given-names></name><name><surname>Blacker</surname> <given-names>D</given-names></name><name><surname>Mead</surname> <given-names>S</given-names></name><name><surname>Mosley</surname> <given-names>TH</given-names></name><name><surname>Bennett</surname> <given-names>DA</given-names></name><name><surname>Harris</surname> <given-names>TB</given-names></name><name><surname>Fratiglioni</surname> <given-names>L</given-names></name><name><surname>Holmes</surname> <given-names>C</given-names></name><name><surname>de Bruijn</surname> <given-names>RF</given-names></name><name><surname>Passmore</surname> <given-names>P</given-names></name><name><surname>Montine</surname> <given-names>TJ</given-names></name><name><surname>Bettens</surname> <given-names>K</given-names></name><name><surname>Rotter</surname> <given-names>JI</given-names></name><name><surname>Brice</surname> <given-names>A</given-names></name><name><surname>Morgan</surname> <given-names>K</given-names></name><name><surname>Foroud</surname> <given-names>TM</given-names></name><name><surname>Kukull</surname> <given-names>WA</given-names></name><name><surname>Hannequin</surname> <given-names>D</given-names></name><name><surname>Powell</surname> <given-names>JF</given-names></name><name><surname>Nalls</surname> <given-names>MA</given-names></name><name><surname>Ritchie</surname> <given-names>K</given-names></name><name><surname>Lunetta</surname> <given-names>KL</given-names></name><name><surname>Kauwe</surname> <given-names>JS</given-names></name><name><surname>Boerwinkle</surname> <given-names>E</given-names></name><name><surname>Riemenschneider</surname> <given-names>M</given-names></name><name><surname>Boada</surname> <given-names>M</given-names></name><name><surname>Hiltuenen</surname> <given-names>M</given-names></name><name><surname>Martin</surname> <given-names>ER</given-names></name><name><surname>Schmidt</surname> <given-names>R</given-names></name><name><surname>Rujescu</surname> <given-names>D</given-names></name><name><surname>Wang</surname> <given-names>LS</given-names></name><name><surname>Dartigues</surname> <given-names>JF</given-names></name><name><surname>Mayeux</surname> <given-names>R</given-names></name><name><surname>Tzourio</surname> <given-names>C</given-names></name><name><surname>Hofman</surname> <given-names>A</given-names></name><name><surname>Nöthen</surname> <given-names>MM</given-names></name><name><surname>Graff</surname> <given-names>C</given-names></name><name><surname>Psaty</surname> <given-names>BM</given-names></name><name><surname>Jones</surname> <given-names>L</given-names></name><name><surname>Haines</surname> <given-names>JL</given-names></name><name><surname>Holmans</surname> <given-names>PA</given-names></name><name><surname>Lathrop</surname> <given-names>M</given-names></name><name><surname>Pericak-Vance</surname> <given-names>MA</given-names></name><name><surname>Launer</surname> <given-names>LJ</given-names></name><name><surname>Farrer</surname> <given-names>LA</given-names></name><name><surname>van Duijn</surname> <given-names>CM</given-names></name><name><surname>Van Broeckhoven</surname> <given-names>C</given-names></name><name><surname>Moskvina</surname> <given-names>V</given-names></name><name><surname>Seshadri</surname> <given-names>S</given-names></name><name><surname>Williams</surname> <given-names>J</given-names></name><name><surname>Schellenberg</surname> <given-names>GD</given-names></name><name><surname>Amouyel</surname> <given-names>P</given-names></name><collab>European Alzheimer's Disease Initiative (EADI)</collab><collab>Genetic and Environmental Risk in Alzheimer's Disease</collab><collab>Alzheimer's Disease Genetic Consortium</collab><collab>Cohorts for Heart and Aging Research in Genomic Epidemiology</collab></person-group><year iso-8601-date="2013">2013</year><article-title>Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for alzheimer's disease</article-title><source>Nature Genetics</source><volume>45</volume><fpage>1452</fpage><lpage>1458</lpage><pub-id pub-id-type="doi">10.1038/ng.2802</pub-id><pub-id pub-id-type="pmid">24162737</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lappalainen</surname> <given-names>T</given-names></name><name><surname>Sammeth</surname> <given-names>M</given-names></name><name><surname>Friedländer</surname> <given-names>MR</given-names></name><name><surname>'t Hoen</surname> <given-names>PA</given-names></name><name><surname>Monlong</surname> <given-names>J</given-names></name><name><surname>Rivas</surname> <given-names>MA</given-names></name><name><surname>Gonzàlez-Porta</surname> <given-names>M</given-names></name><name><surname>Kurbatova</surname> <given-names>N</given-names></name><name><surname>Griebel</surname> <given-names>T</given-names></name><name><surname>Ferreira</surname> <given-names>PG</given-names></name><name><surname>Barann</surname> <given-names>M</given-names></name><name><surname>Wieland</surname> <given-names>T</given-names></name><name><surname>Greger</surname> <given-names>L</given-names></name><name><surname>van Iterson</surname> <given-names>M</given-names></name><name><surname>Almlöf</surname> <given-names>J</given-names></name><name><surname>Ribeca</surname> <given-names>P</given-names></name><name><surname>Pulyakhina</surname> <given-names>I</given-names></name><name><surname>Esser</surname> <given-names>D</given-names></name><name><surname>Giger</surname> <given-names>T</given-names></name><name><surname>Tikhonov</surname> <given-names>A</given-names></name><name><surname>Sultan</surname> <given-names>M</given-names></name><name><surname>Bertier</surname> <given-names>G</given-names></name><name><surname>MacArthur</surname> <given-names>DG</given-names></name><name><surname>Lek</surname> <given-names>M</given-names></name><name><surname>Lizano</surname> <given-names>E</given-names></name><name><surname>Buermans</surname> <given-names>HP</given-names></name><name><surname>Padioleau</surname> <given-names>I</given-names></name><name><surname>Schwarzmayr</surname> <given-names>T</given-names></name><name><surname>Karlberg</surname> <given-names>O</given-names></name><name><surname>Ongen</surname> <given-names>H</given-names></name><name><surname>Kilpinen</surname> <given-names>H</given-names></name><name><surname>Beltran</surname> <given-names>S</given-names></name><name><surname>Gut</surname> <given-names>M</given-names></name><name><surname>Kahlem</surname> <given-names>K</given-names></name><name><surname>Amstislavskiy</surname> <given-names>V</given-names></name><name><surname>Stegle</surname> <given-names>O</given-names></name><name><surname>Pirinen</surname> <given-names>M</given-names></name><name><surname>Montgomery</surname> <given-names>SB</given-names></name><name><surname>Donnelly</surname> <given-names>P</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><name><surname>Flicek</surname> <given-names>P</given-names></name><name><surname>Strom</surname> <given-names>TM</given-names></name><name><surname>Lehrach</surname> <given-names>H</given-names></name><name><surname>Schreiber</surname> <given-names>S</given-names></name><name><surname>Sudbrak</surname> <given-names>R</given-names></name><name><surname>Carracedo</surname> <given-names>A</given-names></name><name><surname>Antonarakis</surname> <given-names>SE</given-names></name><name><surname>Häsler</surname> <given-names>R</given-names></name><name><surname>Syvänen</surname> <given-names>AC</given-names></name><name><surname>van Ommen</surname> <given-names>GJ</given-names></name><name><surname>Brazma</surname> <given-names>A</given-names></name><name><surname>Meitinger</surname> <given-names>T</given-names></name><name><surname>Rosenstiel</surname> <given-names>P</given-names></name><name><surname>Guigó</surname> <given-names>R</given-names></name><name><surname>Gut</surname> <given-names>IG</given-names></name><name><surname>Estivill</surname> <given-names>X</given-names></name><name><surname>Dermitzakis</surname> <given-names>ET</given-names></name><collab>Geuvadis Consortium</collab></person-group><year iso-8601-date="2013">2013</year><article-title>Transcriptome and genome sequencing uncovers functional variation in humans</article-title><source>Nature</source><volume>501</volume><fpage>506</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1038/nature12531</pub-id><pub-id pub-id-type="pmid">24037378</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname> <given-names>M</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Pagès</surname> <given-names>H</given-names></name><name><surname>Aboyoun</surname> <given-names>P</given-names></name><name><surname>Carlson</surname> <given-names>M</given-names></name><name><surname>Gentleman</surname> <given-names>R</given-names></name><name><surname>Morgan</surname> <given-names>MT</given-names></name><name><surname>Carey</surname> <given-names>VJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Software for computing and annotating genomic ranges</article-title><source>PLOS Computational Biology</source><volume>9</volume><elocation-id>e1003118</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003118</pub-id><pub-id pub-id-type="pmid">23950696</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>SH</given-names></name><name><surname>Singh</surname> <given-names>I</given-names></name><name><surname>Tisdale</surname> <given-names>S</given-names></name><name><surname>Abdel-Wahab</surname> <given-names>O</given-names></name><name><surname>Leslie</surname> <given-names>CS</given-names></name><name><surname>Mayr</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Widespread intronic polyadenylation inactivates tumour suppressor genes in leukaemia</article-title><source>Nature</source><volume>561</volume><fpage>127</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0465-8</pub-id><pub-id pub-id-type="pmid">30150773</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>YI</given-names></name><name><surname>van de Geijn</surname> <given-names>B</given-names></name><name><surname>Raj</surname> <given-names>A</given-names></name><name><surname>Knowles</surname> <given-names>DA</given-names></name><name><surname>Petti</surname> <given-names>AA</given-names></name><name><surname>Golan</surname> <given-names>D</given-names></name><name><surname>Gilad</surname> <given-names>Y</given-names></name><name><surname>Pritchard</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>RNA splicing is a primary link between genetic variation and disease</article-title><source>Science</source><volume>352</volume><fpage>600</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1126/science.aad9417</pub-id><pub-id pub-id-type="pmid">27126046</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>YI</given-names></name><name><surname>Knowles</surname> <given-names>DA</given-names></name><name><surname>Humphrey</surname> <given-names>J</given-names></name><name><surname>Barbeira</surname> <given-names>AN</given-names></name><name><surname>Dickinson</surname> <given-names>SP</given-names></name><name><surname>Im</surname> <given-names>HK</given-names></name><name><surname>Pritchard</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Annotation-free quantification of RNA splicing using leafcutter</article-title><source>Nature Genetics</source><volume>50</volume><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1038/s41588-017-0004-9</pub-id><pub-id pub-id-type="pmid">29229983</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>Y</given-names></name><name><surname>Smyth</surname> <given-names>GK</given-names></name><name><surname>Shi</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><volume>30</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><pub-id pub-id-type="pmid">24227677</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>JZ</given-names></name><name><surname>van Sommeren</surname> <given-names>S</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Ng</surname> <given-names>SC</given-names></name><name><surname>Alberts</surname> <given-names>R</given-names></name><name><surname>Takahashi</surname> <given-names>A</given-names></name><name><surname>Ripke</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>JC</given-names></name><name><surname>Jostins</surname> <given-names>L</given-names></name><name><surname>Shah</surname> <given-names>T</given-names></name><name><surname>Abedian</surname> <given-names>S</given-names></name><name><surname>Cheon</surname> <given-names>JH</given-names></name><name><surname>Cho</surname> <given-names>J</given-names></name><name><surname>Dayani</surname> <given-names>NE</given-names></name><name><surname>Franke</surname> <given-names>L</given-names></name><name><surname>Fuyuno</surname> <given-names>Y</given-names></name><name><surname>Hart</surname> <given-names>A</given-names></name><name><surname>Juyal</surname> <given-names>RC</given-names></name><name><surname>Juyal</surname> <given-names>G</given-names></name><name><surname>Kim</surname> <given-names>WH</given-names></name><name><surname>Morris</surname> <given-names>AP</given-names></name><name><surname>Poustchi</surname> <given-names>H</given-names></name><name><surname>Newman</surname> <given-names>WG</given-names></name><name><surname>Midha</surname> <given-names>V</given-names></name><name><surname>Orchard</surname> <given-names>TR</given-names></name><name><surname>Vahedi</surname> <given-names>H</given-names></name><name><surname>Sood</surname> <given-names>A</given-names></name><name><surname>Sung</surname> <given-names>JY</given-names></name><name><surname>Malekzadeh</surname> <given-names>R</given-names></name><name><surname>Westra</surname> <given-names>HJ</given-names></name><name><surname>Yamazaki</surname> <given-names>K</given-names></name><name><surname>Yang</surname> <given-names>SK</given-names></name><name><surname>Barrett</surname> <given-names>JC</given-names></name><name><surname>Alizadeh</surname> <given-names>BZ</given-names></name><name><surname>Parkes</surname> <given-names>M</given-names></name><name><surname>Bk</surname> <given-names>T</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>Kubo</surname> <given-names>M</given-names></name><name><surname>Anderson</surname> <given-names>CA</given-names></name><name><surname>Weersma</surname> <given-names>RK</given-names></name><collab>International Multiple Sclerosis Genetics Consortium</collab><collab>International IBD Genetics Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations</article-title><source>Nature Genetics</source><volume>47</volume><fpage>979</fpage><lpage>986</lpage><pub-id pub-id-type="doi">10.1038/ng.3359</pub-id><pub-id pub-id-type="pmid">26192919</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Hogenesch</surname> <given-names>JB</given-names></name><name><surname>Irizarry</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Modeling of RNA-seq fragment sequence bias reduces systematic errors in transcript abundance estimation</article-title><source>Nature Biotechnology</source><volume>34</volume><fpage>1287</fpage><lpage>1291</lpage><pub-id pub-id-type="doi">10.1038/nbt.3682</pub-id><pub-id pub-id-type="pmid">27669167</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname> <given-names>M</given-names></name><name><surname>Simpson</surname> <given-names>JF</given-names></name><name><surname>Parikh</surname> <given-names>I</given-names></name><name><surname>Wilfred</surname> <given-names>BR</given-names></name><name><surname>Fardo</surname> <given-names>DW</given-names></name><name><surname>Nelson</surname> <given-names>PT</given-names></name><name><surname>Estus</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing</article-title><source>Journal of Neuroscience</source><volume>33</volume><fpage>13320</fpage><lpage>13325</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1224-13.2013</pub-id><pub-id pub-id-type="pmid">23946390</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname> <given-names>AP</given-names></name><name><surname>Voight</surname> <given-names>BF</given-names></name><name><surname>Teslovich</surname> <given-names>TM</given-names></name><name><surname>Ferreira</surname> <given-names>T</given-names></name><name><surname>Segrè</surname> <given-names>AV</given-names></name><name><surname>Steinthorsdottir</surname> <given-names>V</given-names></name><name><surname>Strawbridge</surname> <given-names>RJ</given-names></name><name><surname>Khan</surname> <given-names>H</given-names></name><name><surname>Grallert</surname> <given-names>H</given-names></name><name><surname>Mahajan</surname> <given-names>A</given-names></name><name><surname>Prokopenko</surname> <given-names>I</given-names></name><name><surname>Kang</surname> <given-names>HM</given-names></name><name><surname>Dina</surname> <given-names>C</given-names></name><name><surname>Esko</surname> <given-names>T</given-names></name><name><surname>Fraser</surname> <given-names>RM</given-names></name><name><surname>Kanoni</surname> <given-names>S</given-names></name><name><surname>Kumar</surname> <given-names>A</given-names></name><name><surname>Lagou</surname> <given-names>V</given-names></name><name><surname>Langenberg</surname> <given-names>C</given-names></name><name><surname>Luan</surname> <given-names>J</given-names></name><name><surname>Lindgren</surname> <given-names>CM</given-names></name><name><surname>Müller-Nurasyid</surname> <given-names>M</given-names></name><name><surname>Pechlivanis</surname> <given-names>S</given-names></name><name><surname>Rayner</surname> <given-names>NW</given-names></name><name><surname>Scott</surname> <given-names>LJ</given-names></name><name><surname>Wiltshire</surname> <given-names>S</given-names></name><name><surname>Yengo</surname> <given-names>L</given-names></name><name><surname>Kinnunen</surname> <given-names>L</given-names></name><name><surname>Rossin</surname> <given-names>EJ</given-names></name><name><surname>Raychaudhuri</surname> <given-names>S</given-names></name><name><surname>Johnson</surname> <given-names>AD</given-names></name><name><surname>Dimas</surname> <given-names>AS</given-names></name><name><surname>Loos</surname> <given-names>RJ</given-names></name><name><surname>Vedantam</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Florez</surname> <given-names>JC</given-names></name><name><surname>Fox</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>CT</given-names></name><name><surname>Rybin</surname> <given-names>D</given-names></name><name><surname>Couper</surname> <given-names>DJ</given-names></name><name><surname>Kao</surname> <given-names>WH</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Cornelis</surname> <given-names>MC</given-names></name><name><surname>Kraft</surname> <given-names>P</given-names></name><name><surname>Sun</surname> <given-names>Q</given-names></name><name><surname>van Dam</surname> <given-names>RM</given-names></name><name><surname>Stringham</surname> <given-names>HM</given-names></name><name><surname>Chines</surname> <given-names>PS</given-names></name><name><surname>Fischer</surname> <given-names>K</given-names></name><name><surname>Fontanillas</surname> <given-names>P</given-names></name><name><surname>Holmen</surname> <given-names>OL</given-names></name><name><surname>Hunt</surname> <given-names>SE</given-names></name><name><surname>Jackson</surname> <given-names>AU</given-names></name><name><surname>Kong</surname> <given-names>A</given-names></name><name><surname>Lawrence</surname> <given-names>R</given-names></name><name><surname>Meyer</surname> <given-names>J</given-names></name><name><surname>Perry</surname> <given-names>JR</given-names></name><name><surname>Platou</surname> <given-names>CG</given-names></name><name><surname>Potter</surname> <given-names>S</given-names></name><name><surname>Rehnberg</surname> <given-names>E</given-names></name><name><surname>Robertson</surname> <given-names>N</given-names></name><name><surname>Sivapalaratnam</surname> <given-names>S</given-names></name><name><surname>Stančáková</surname> <given-names>A</given-names></name><name><surname>Stirrups</surname> <given-names>K</given-names></name><name><surname>Thorleifsson</surname> <given-names>G</given-names></name><name><surname>Tikkanen</surname> <given-names>E</given-names></name><name><surname>Wood</surname> <given-names>AR</given-names></name><name><surname>Almgren</surname> <given-names>P</given-names></name><name><surname>Atalay</surname> <given-names>M</given-names></name><name><surname>Benediktsson</surname> <given-names>R</given-names></name><name><surname>Bonnycastle</surname> <given-names>LL</given-names></name><name><surname>Burtt</surname> <given-names>N</given-names></name><name><surname>Carey</surname> <given-names>J</given-names></name><name><surname>Charpentier</surname> <given-names>G</given-names></name><name><surname>Crenshaw</surname> <given-names>AT</given-names></name><name><surname>Doney</surname> <given-names>AS</given-names></name><name><surname>Dorkhan</surname> <given-names>M</given-names></name><name><surname>Edkins</surname> <given-names>S</given-names></name><name><surname>Emilsson</surname> <given-names>V</given-names></name><name><surname>Eury</surname> <given-names>E</given-names></name><name><surname>Forsen</surname> <given-names>T</given-names></name><name><surname>Gertow</surname> <given-names>K</given-names></name><name><surname>Gigante</surname> <given-names>B</given-names></name><name><surname>Grant</surname> <given-names>GB</given-names></name><name><surname>Groves</surname> <given-names>CJ</given-names></name><name><surname>Guiducci</surname> <given-names>C</given-names></name><name><surname>Herder</surname> <given-names>C</given-names></name><name><surname>Hreidarsson</surname> <given-names>AB</given-names></name><name><surname>Hui</surname> <given-names>J</given-names></name><name><surname>James</surname> <given-names>A</given-names></name><name><surname>Jonsson</surname> <given-names>A</given-names></name><name><surname>Rathmann</surname> <given-names>W</given-names></name><name><surname>Klopp</surname> <given-names>N</given-names></name><name><surname>Kravic</surname> <given-names>J</given-names></name><name><surname>Krjutškov</surname> <given-names>K</given-names></name><name><surname>Langford</surname> <given-names>C</given-names></name><name><surname>Leander</surname> <given-names>K</given-names></name><name><surname>Lindholm</surname> <given-names>E</given-names></name><name><surname>Lobbens</surname> <given-names>S</given-names></name><name><surname>Männistö</surname> <given-names>S</given-names></name><name><surname>Mirza</surname> <given-names>G</given-names></name><name><surname>Mühleisen</surname> <given-names>TW</given-names></name><name><surname>Musk</surname> <given-names>B</given-names></name><name><surname>Parkin</surname> <given-names>M</given-names></name><name><surname>Rallidis</surname> <given-names>L</given-names></name><name><surname>Saramies</surname> <given-names>J</given-names></name><name><surname>Sennblad</surname> <given-names>B</given-names></name><name><surname>Shah</surname> <given-names>S</given-names></name><name><surname>Sigurðsson</surname> <given-names>G</given-names></name><name><surname>Silveira</surname> <given-names>A</given-names></name><name><surname>Steinbach</surname> <given-names>G</given-names></name><name><surname>Thorand</surname> <given-names>B</given-names></name><name><surname>Trakalo</surname> <given-names>J</given-names></name><name><surname>Veglia</surname> <given-names>F</given-names></name><name><surname>Wennauer</surname> <given-names>R</given-names></name><name><surname>Winckler</surname> <given-names>W</given-names></name><name><surname>Zabaneh</surname> <given-names>D</given-names></name><name><surname>Campbell</surname> <given-names>H</given-names></name><name><surname>van Duijn</surname> <given-names>C</given-names></name><name><surname>Uitterlinden</surname> <given-names>AG</given-names></name><name><surname>Hofman</surname> <given-names>A</given-names></name><name><surname>Sijbrands</surname> <given-names>E</given-names></name><name><surname>Abecasis</surname> <given-names>GR</given-names></name><name><surname>Owen</surname> <given-names>KR</given-names></name><name><surname>Zeggini</surname> <given-names>E</given-names></name><name><surname>Trip</surname> <given-names>MD</given-names></name><name><surname>Forouhi</surname> <given-names>NG</given-names></name><name><surname>Syvänen</surname> <given-names>AC</given-names></name><name><surname>Eriksson</surname> <given-names>JG</given-names></name><name><surname>Peltonen</surname> <given-names>L</given-names></name><name><surname>Nöthen</surname> <given-names>MM</given-names></name><name><surname>Balkau</surname> <given-names>B</given-names></name><name><surname>Palmer</surname> <given-names>CN</given-names></name><name><surname>Lyssenko</surname> <given-names>V</given-names></name><name><surname>Tuomi</surname> <given-names>T</given-names></name><name><surname>Isomaa</surname> <given-names>B</given-names></name><name><surname>Hunter</surname> <given-names>DJ</given-names></name><name><surname>Qi</surname> <given-names>L</given-names></name><name><surname>Shuldiner</surname> <given-names>AR</given-names></name><name><surname>Roden</surname> <given-names>M</given-names></name><name><surname>Barroso</surname> <given-names>I</given-names></name><name><surname>Wilsgaard</surname> <given-names>T</given-names></name><name><surname>Beilby</surname> <given-names>J</given-names></name><name><surname>Hovingh</surname> <given-names>K</given-names></name><name><surname>Price</surname> <given-names>JF</given-names></name><name><surname>Wilson</surname> <given-names>JF</given-names></name><name><surname>Rauramaa</surname> <given-names>R</given-names></name><name><surname>Lakka</surname> <given-names>TA</given-names></name><name><surname>Lind</surname> <given-names>L</given-names></name><name><surname>Dedoussis</surname> <given-names>G</given-names></name><name><surname>Njølstad</surname> <given-names>I</given-names></name><name><surname>Pedersen</surname> <given-names>NL</given-names></name><name><surname>Khaw</surname> <given-names>KT</given-names></name><name><surname>Wareham</surname> <given-names>NJ</given-names></name><name><surname>Keinanen-Kiukaanniemi</surname> <given-names>SM</given-names></name><name><surname>Saaristo</surname> <given-names>TE</given-names></name><name><surname>Korpi-Hyövälti</surname> <given-names>E</given-names></name><name><surname>Saltevo</surname> <given-names>J</given-names></name><name><surname>Laakso</surname> <given-names>M</given-names></name><name><surname>Kuusisto</surname> <given-names>J</given-names></name><name><surname>Metspalu</surname> <given-names>A</given-names></name><name><surname>Collins</surname> <given-names>FS</given-names></name><name><surname>Mohlke</surname> <given-names>KL</given-names></name><name><surname>Bergman</surname> <given-names>RN</given-names></name><name><surname>Tuomilehto</surname> <given-names>J</given-names></name><name><surname>Boehm</surname> <given-names>BO</given-names></name><name><surname>Gieger</surname> <given-names>C</given-names></name><name><surname>Hveem</surname> <given-names>K</given-names></name><name><surname>Cauchi</surname> <given-names>S</given-names></name><name><surname>Froguel</surname> <given-names>P</given-names></name><name><surname>Baldassarre</surname> <given-names>D</given-names></name><name><surname>Tremoli</surname> <given-names>E</given-names></name><name><surname>Humphries</surname> <given-names>SE</given-names></name><name><surname>Saleheen</surname> <given-names>D</given-names></name><name><surname>Danesh</surname> <given-names>J</given-names></name><name><surname>Ingelsson</surname> <given-names>E</given-names></name><name><surname>Ripatti</surname> <given-names>S</given-names></name><name><surname>Salomaa</surname> <given-names>V</given-names></name><name><surname>Erbel</surname> <given-names>R</given-names></name><name><surname>Jöckel</surname> <given-names>KH</given-names></name><name><surname>Moebus</surname> <given-names>S</given-names></name><name><surname>Peters</surname> <given-names>A</given-names></name><name><surname>Illig</surname> <given-names>T</given-names></name><name><surname>de Faire</surname> <given-names>U</given-names></name><name><surname>Hamsten</surname> <given-names>A</given-names></name><name><surname>Morris</surname> <given-names>AD</given-names></name><name><surname>Donnelly</surname> <given-names>PJ</given-names></name><name><surname>Frayling</surname> <given-names>TM</given-names></name><name><surname>Hattersley</surname> <given-names>AT</given-names></name><name><surname>Boerwinkle</surname> <given-names>E</given-names></name><name><surname>Melander</surname> <given-names>O</given-names></name><name><surname>Kathiresan</surname> <given-names>S</given-names></name><name><surname>Nilsson</surname> <given-names>PM</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><name><surname>Thorsteinsdottir</surname> <given-names>U</given-names></name><name><surname>Groop</surname> <given-names>LC</given-names></name><name><surname>Stefansson</surname> <given-names>K</given-names></name><name><surname>Hu</surname> <given-names>F</given-names></name><name><surname>Pankow</surname> <given-names>JS</given-names></name><name><surname>Dupuis</surname> <given-names>J</given-names></name><name><surname>Meigs</surname> <given-names>JB</given-names></name><name><surname>Altshuler</surname> <given-names>D</given-names></name><name><surname>Boehnke</surname> <given-names>M</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><collab>Wellcome Trust Case Control Consortium</collab><collab>Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators</collab><collab>Genetic Investigation of ANthropometric Traits (GIANT) Consortium</collab><collab>Asian Genetic Epidemiology Network–Type 2 Diabetes (AGEN-T2D) Consortium</collab><collab>South Asian Type 2 Diabetes (SAT2D) Consortium</collab><collab>DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium</collab></person-group><year iso-8601-date="2012">2012</year><article-title>Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes</article-title><source>Nature Genetics</source><volume>44</volume><fpage>981</fpage><lpage>990</lpage><pub-id pub-id-type="doi">10.1038/ng.2383</pub-id><pub-id pub-id-type="pmid">22885922</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nédélec</surname> <given-names>Y</given-names></name><name><surname>Sanz</surname> <given-names>J</given-names></name><name><surname>Baharian</surname> <given-names>G</given-names></name><name><surname>Szpiech</surname> <given-names>ZA</given-names></name><name><surname>Pacis</surname> <given-names>A</given-names></name><name><surname>Dumaine</surname> <given-names>A</given-names></name><name><surname>Grenier</surname> <given-names>JC</given-names></name><name><surname>Freiman</surname> <given-names>A</given-names></name><name><surname>Sams</surname> <given-names>AJ</given-names></name><name><surname>Hebert</surname> <given-names>S</given-names></name><name><surname>Pagé Sabourin</surname> <given-names>A</given-names></name><name><surname>Luca</surname> <given-names>F</given-names></name><name><surname>Blekhman</surname> <given-names>R</given-names></name><name><surname>Hernandez</surname> <given-names>RD</given-names></name><name><surname>Pique-Regi</surname> <given-names>R</given-names></name><name><surname>Tung</surname> <given-names>J</given-names></name><name><surname>Yotova</surname> <given-names>V</given-names></name><name><surname>Barreiro</surname> <given-names>LB</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genetic ancestry and natural selection drive population differences in immune responses to pathogens</article-title><source>Cell</source><volume>167</volume><fpage>657</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.09.025</pub-id><pub-id pub-id-type="pmid">27768889</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname> <given-names>CP</given-names></name><name><surname>Goel</surname> <given-names>A</given-names></name><name><surname>Butterworth</surname> <given-names>AS</given-names></name><name><surname>Kanoni</surname> <given-names>S</given-names></name><name><surname>Webb</surname> <given-names>TR</given-names></name><name><surname>Marouli</surname> <given-names>E</given-names></name><name><surname>Zeng</surname> <given-names>L</given-names></name><name><surname>Ntalla</surname> <given-names>I</given-names></name><name><surname>Lai</surname> <given-names>FY</given-names></name><name><surname>Hopewell</surname> <given-names>JC</given-names></name><name><surname>Giannakopoulou</surname> <given-names>O</given-names></name><name><surname>Jiang</surname> <given-names>T</given-names></name><name><surname>Hamby</surname> <given-names>SE</given-names></name><name><surname>Di Angelantonio</surname> <given-names>E</given-names></name><name><surname>Assimes</surname> <given-names>TL</given-names></name><name><surname>Bottinger</surname> <given-names>EP</given-names></name><name><surname>Chambers</surname> <given-names>JC</given-names></name><name><surname>Clarke</surname> <given-names>R</given-names></name><name><surname>Palmer</surname> <given-names>CNA</given-names></name><name><surname>Cubbon</surname> <given-names>RM</given-names></name><name><surname>Ellinor</surname> <given-names>P</given-names></name><name><surname>Ermel</surname> <given-names>R</given-names></name><name><surname>Evangelou</surname> <given-names>E</given-names></name><name><surname>Franks</surname> <given-names>PW</given-names></name><name><surname>Grace</surname> <given-names>C</given-names></name><name><surname>Gu</surname> <given-names>D</given-names></name><name><surname>Hingorani</surname> <given-names>AD</given-names></name><name><surname>Howson</surname> <given-names>JMM</given-names></name><name><surname>Ingelsson</surname> <given-names>E</given-names></name><name><surname>Kastrati</surname> <given-names>A</given-names></name><name><surname>Kessler</surname> <given-names>T</given-names></name><name><surname>Kyriakou</surname> <given-names>T</given-names></name><name><surname>Lehtimäki</surname> <given-names>T</given-names></name><name><surname>Lu</surname> <given-names>X</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>März</surname> <given-names>W</given-names></name><name><surname>McPherson</surname> <given-names>R</given-names></name><name><surname>Metspalu</surname> <given-names>A</given-names></name><name><surname>Pujades-Rodriguez</surname> <given-names>M</given-names></name><name><surname>Ruusalepp</surname> <given-names>A</given-names></name><name><surname>Schadt</surname> <given-names>EE</given-names></name><name><surname>Schmidt</surname> <given-names>AF</given-names></name><name><surname>Sweeting</surname> <given-names>MJ</given-names></name><name><surname>Zalloua</surname> <given-names>PA</given-names></name><name><surname>AlGhalayini</surname> <given-names>K</given-names></name><name><surname>Keavney</surname> <given-names>BD</given-names></name><name><surname>Kooner</surname> <given-names>JS</given-names></name><name><surname>Loos</surname> <given-names>RJF</given-names></name><name><surname>Patel</surname> <given-names>RS</given-names></name><name><surname>Rutter</surname> <given-names>MK</given-names></name><name><surname>Tomaszewski</surname> <given-names>M</given-names></name><name><surname>Tzoulaki</surname> <given-names>I</given-names></name><name><surname>Zeggini</surname> <given-names>E</given-names></name><name><surname>Erdmann</surname> <given-names>J</given-names></name><name><surname>Dedoussis</surname> <given-names>G</given-names></name><name><surname>Björkegren</surname> <given-names>JLM</given-names></name><name><surname>Schunkert</surname> <given-names>H</given-names></name><name><surname>Farrall</surname> <given-names>M</given-names></name><name><surname>Danesh</surname> <given-names>J</given-names></name><name><surname>Samani</surname> <given-names>NJ</given-names></name><name><surname>Watkins</surname> <given-names>H</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><collab>EPIC-CVD Consortium</collab><collab>CARDIoGRAMplusC4D</collab><collab>UK Biobank CardioMetabolic Consortium CHD working group</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Association analyses based on false discovery rate implicate new loci for coronary artery disease</article-title><source>Nature Genetics</source><volume>49</volume><fpage>1385</fpage><lpage>1391</lpage><pub-id pub-id-type="doi">10.1038/ng.3913</pub-id><pub-id pub-id-type="pmid">28714975</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikpay</surname> <given-names>M</given-names></name><name><surname>Goel</surname> <given-names>A</given-names></name><name><surname>Won</surname> <given-names>HH</given-names></name><name><surname>Hall</surname> <given-names>LM</given-names></name><name><surname>Willenborg</surname> <given-names>C</given-names></name><name><surname>Kanoni</surname> <given-names>S</given-names></name><name><surname>Saleheen</surname> <given-names>D</given-names></name><name><surname>Kyriakou</surname> <given-names>T</given-names></name><name><surname>Nelson</surname> <given-names>CP</given-names></name><name><surname>Hopewell</surname> <given-names>JC</given-names></name><name><surname>Webb</surname> <given-names>TR</given-names></name><name><surname>Zeng</surname> <given-names>L</given-names></name><name><surname>Dehghan</surname> <given-names>A</given-names></name><name><surname>Alver</surname> <given-names>M</given-names></name><name><surname>Armasu</surname> <given-names>SM</given-names></name><name><surname>Auro</surname> <given-names>K</given-names></name><name><surname>Bjonnes</surname> <given-names>A</given-names></name><name><surname>Chasman</surname> <given-names>DI</given-names></name><name><surname>Chen</surname> <given-names>S</given-names></name><name><surname>Ford</surname> <given-names>I</given-names></name><name><surname>Franceschini</surname> <given-names>N</given-names></name><name><surname>Gieger</surname> <given-names>C</given-names></name><name><surname>Grace</surname> <given-names>C</given-names></name><name><surname>Gustafsson</surname> <given-names>S</given-names></name><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Hwang</surname> <given-names>SJ</given-names></name><name><surname>Kim</surname> <given-names>YK</given-names></name><name><surname>Kleber</surname> <given-names>ME</given-names></name><name><surname>Lau</surname> <given-names>KW</given-names></name><name><surname>Lu</surname> <given-names>X</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Lyytikäinen</surname> <given-names>LP</given-names></name><name><surname>Mihailov</surname> <given-names>E</given-names></name><name><surname>Morrison</surname> <given-names>AC</given-names></name><name><surname>Pervjakova</surname> <given-names>N</given-names></name><name><surname>Qu</surname> <given-names>L</given-names></name><name><surname>Rose</surname> <given-names>LM</given-names></name><name><surname>Salfati</surname> <given-names>E</given-names></name><name><surname>Saxena</surname> <given-names>R</given-names></name><name><surname>Scholz</surname> <given-names>M</given-names></name><name><surname>Smith</surname> <given-names>AV</given-names></name><name><surname>Tikkanen</surname> <given-names>E</given-names></name><name><surname>Uitterlinden</surname> <given-names>A</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Zhao</surname> <given-names>W</given-names></name><name><surname>de Andrade</surname> <given-names>M</given-names></name><name><surname>de Vries</surname> <given-names>PS</given-names></name><name><surname>van Zuydam</surname> <given-names>NR</given-names></name><name><surname>Anand</surname> <given-names>SS</given-names></name><name><surname>Bertram</surname> <given-names>L</given-names></name><name><surname>Beutner</surname> <given-names>F</given-names></name><name><surname>Dedoussis</surname> <given-names>G</given-names></name><name><surname>Frossard</surname> <given-names>P</given-names></name><name><surname>Gauguier</surname> <given-names>D</given-names></name><name><surname>Goodall</surname> <given-names>AH</given-names></name><name><surname>Gottesman</surname> <given-names>O</given-names></name><name><surname>Haber</surname> <given-names>M</given-names></name><name><surname>Han</surname> <given-names>BG</given-names></name><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Jalilzadeh</surname> <given-names>S</given-names></name><name><surname>Kessler</surname> <given-names>T</given-names></name><name><surname>König</surname> <given-names>IR</given-names></name><name><surname>Lannfelt</surname> <given-names>L</given-names></name><name><surname>Lieb</surname> <given-names>W</given-names></name><name><surname>Lind</surname> <given-names>L</given-names></name><name><surname>Lindgren</surname> <given-names>CM</given-names></name><name><surname>Lokki</surname> <given-names>ML</given-names></name><name><surname>Magnusson</surname> <given-names>PK</given-names></name><name><surname>Mallick</surname> <given-names>NH</given-names></name><name><surname>Mehra</surname> <given-names>N</given-names></name><name><surname>Meitinger</surname> <given-names>T</given-names></name><name><surname>Memon</surname> <given-names>FU</given-names></name><name><surname>Morris</surname> <given-names>AP</given-names></name><name><surname>Nieminen</surname> <given-names>MS</given-names></name><name><surname>Pedersen</surname> <given-names>NL</given-names></name><name><surname>Peters</surname> <given-names>A</given-names></name><name><surname>Rallidis</surname> <given-names>LS</given-names></name><name><surname>Rasheed</surname> <given-names>A</given-names></name><name><surname>Samuel</surname> <given-names>M</given-names></name><name><surname>Shah</surname> <given-names>SH</given-names></name><name><surname>Sinisalo</surname> <given-names>J</given-names></name><name><surname>Stirrups</surname> <given-names>KE</given-names></name><name><surname>Trompet</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Zaman</surname> <given-names>KS</given-names></name><name><surname>Ardissino</surname> <given-names>D</given-names></name><name><surname>Boerwinkle</surname> <given-names>E</given-names></name><name><surname>Borecki</surname> <given-names>IB</given-names></name><name><surname>Bottinger</surname> <given-names>EP</given-names></name><name><surname>Buring</surname> <given-names>JE</given-names></name><name><surname>Chambers</surname> <given-names>JC</given-names></name><name><surname>Collins</surname> <given-names>R</given-names></name><name><surname>Cupples</surname> <given-names>LA</given-names></name><name><surname>Danesh</surname> <given-names>J</given-names></name><name><surname>Demuth</surname> <given-names>I</given-names></name><name><surname>Elosua</surname> <given-names>R</given-names></name><name><surname>Epstein</surname> <given-names>SE</given-names></name><name><surname>Esko</surname> <given-names>T</given-names></name><name><surname>Feitosa</surname> <given-names>MF</given-names></name><name><surname>Franco</surname> <given-names>OH</given-names></name><name><surname>Franzosi</surname> <given-names>MG</given-names></name><name><surname>Granger</surname> <given-names>CB</given-names></name><name><surname>Gu</surname> <given-names>D</given-names></name><name><surname>Gudnason</surname> <given-names>V</given-names></name><name><surname>Hall</surname> <given-names>AS</given-names></name><name><surname>Hamsten</surname> <given-names>A</given-names></name><name><surname>Harris</surname> <given-names>TB</given-names></name><name><surname>Hazen</surname> <given-names>SL</given-names></name><name><surname>Hengstenberg</surname> <given-names>C</given-names></name><name><surname>Hofman</surname> <given-names>A</given-names></name><name><surname>Ingelsson</surname> <given-names>E</given-names></name><name><surname>Iribarren</surname> <given-names>C</given-names></name><name><surname>Jukema</surname> <given-names>JW</given-names></name><name><surname>Karhunen</surname> <given-names>PJ</given-names></name><name><surname>Kim</surname> <given-names>BJ</given-names></name><name><surname>Kooner</surname> <given-names>JS</given-names></name><name><surname>Kullo</surname> <given-names>IJ</given-names></name><name><surname>Lehtimäki</surname> <given-names>T</given-names></name><name><surname>Loos</surname> <given-names>RJF</given-names></name><name><surname>Melander</surname> <given-names>O</given-names></name><name><surname>Metspalu</surname> <given-names>A</given-names></name><name><surname>März</surname> <given-names>W</given-names></name><name><surname>Palmer</surname> <given-names>CN</given-names></name><name><surname>Perola</surname> <given-names>M</given-names></name><name><surname>Quertermous</surname> <given-names>T</given-names></name><name><surname>Rader</surname> <given-names>DJ</given-names></name><name><surname>Ridker</surname> <given-names>PM</given-names></name><name><surname>Ripatti</surname> <given-names>S</given-names></name><name><surname>Roberts</surname> <given-names>R</given-names></name><name><surname>Salomaa</surname> <given-names>V</given-names></name><name><surname>Sanghera</surname> <given-names>DK</given-names></name><name><surname>Schwartz</surname> <given-names>SM</given-names></name><name><surname>Seedorf</surname> <given-names>U</given-names></name><name><surname>Stewart</surname> <given-names>AF</given-names></name><name><surname>Stott</surname> <given-names>DJ</given-names></name><name><surname>Thiery</surname> <given-names>J</given-names></name><name><surname>Zalloua</surname> <given-names>PA</given-names></name><name><surname>O'Donnell</surname> <given-names>CJ</given-names></name><name><surname>Reilly</surname> <given-names>MP</given-names></name><name><surname>Assimes</surname> <given-names>TL</given-names></name><name><surname>Thompson</surname> <given-names>JR</given-names></name><name><surname>Erdmann</surname> <given-names>J</given-names></name><name><surname>Clarke</surname> <given-names>R</given-names></name><name><surname>Watkins</surname> <given-names>H</given-names></name><name><surname>Kathiresan</surname> <given-names>S</given-names></name><name><surname>McPherson</surname> <given-names>R</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><name><surname>Schunkert</surname> <given-names>H</given-names></name><name><surname>Samani</surname> <given-names>NJ</given-names></name><name><surname>Farrall</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease</article-title><source>Nature Genetics</source><volume>47</volume><fpage>1121</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1038/ng.3396</pub-id><pub-id pub-id-type="pmid">26343387</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odhams</surname> <given-names>CA</given-names></name><name><surname>Cunninghame Graham</surname> <given-names>DS</given-names></name><name><surname>Vyse</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Profiling RNA-Seq at multiple resolutions markedly increases the number of causal eQTLs in autoimmune disease</article-title><source>PLOS Genetics</source><volume>13</volume><elocation-id>e1007071</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007071</pub-id><pub-id pub-id-type="pmid">29059182</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname> <given-names>Y</given-names></name><name><surname>Wu</surname> <given-names>D</given-names></name><name><surname>Trynka</surname> <given-names>G</given-names></name><name><surname>Raj</surname> <given-names>T</given-names></name><name><surname>Terao</surname> <given-names>C</given-names></name><name><surname>Ikari</surname> <given-names>K</given-names></name><name><surname>Kochi</surname> <given-names>Y</given-names></name><name><surname>Ohmura</surname> <given-names>K</given-names></name><name><surname>Suzuki</surname> <given-names>A</given-names></name><name><surname>Yoshida</surname> <given-names>S</given-names></name><name><surname>Graham</surname> <given-names>RR</given-names></name><name><surname>Manoharan</surname> <given-names>A</given-names></name><name><surname>Ortmann</surname> <given-names>W</given-names></name><name><surname>Bhangale</surname> <given-names>T</given-names></name><name><surname>Denny</surname> <given-names>JC</given-names></name><name><surname>Carroll</surname> <given-names>RJ</given-names></name><name><surname>Eyler</surname> <given-names>AE</given-names></name><name><surname>Greenberg</surname> <given-names>JD</given-names></name><name><surname>Kremer</surname> <given-names>JM</given-names></name><name><surname>Pappas</surname> <given-names>DA</given-names></name><name><surname>Jiang</surname> <given-names>L</given-names></name><name><surname>Yin</surname> <given-names>J</given-names></name><name><surname>Ye</surname> <given-names>L</given-names></name><name><surname>Su</surname> <given-names>DF</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Xie</surname> <given-names>G</given-names></name><name><surname>Keystone</surname> <given-names>E</given-names></name><name><surname>Westra</surname> <given-names>HJ</given-names></name><name><surname>Esko</surname> <given-names>T</given-names></name><name><surname>Metspalu</surname> <given-names>A</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Gupta</surname> <given-names>N</given-names></name><name><surname>Mirel</surname> <given-names>D</given-names></name><name><surname>Stahl</surname> <given-names>EA</given-names></name><name><surname>Diogo</surname> <given-names>D</given-names></name><name><surname>Cui</surname> <given-names>J</given-names></name><name><surname>Liao</surname> <given-names>K</given-names></name><name><surname>Guo</surname> <given-names>MH</given-names></name><name><surname>Myouzen</surname> <given-names>K</given-names></name><name><surname>Kawaguchi</surname> <given-names>T</given-names></name><name><surname>Coenen</surname> <given-names>MJ</given-names></name><name><surname>van Riel</surname> <given-names>PL</given-names></name><name><surname>van de Laar</surname> <given-names>MA</given-names></name><name><surname>Guchelaar</surname> <given-names>HJ</given-names></name><name><surname>Huizinga</surname> <given-names>TW</given-names></name><name><surname>Dieudé</surname> <given-names>P</given-names></name><name><surname>Mariette</surname> <given-names>X</given-names></name><name><surname>Bridges</surname> <given-names>SL</given-names></name><name><surname>Zhernakova</surname> <given-names>A</given-names></name><name><surname>Toes</surname> <given-names>RE</given-names></name><name><surname>Tak</surname> <given-names>PP</given-names></name><name><surname>Miceli-Richard</surname> <given-names>C</given-names></name><name><surname>Bang</surname> <given-names>SY</given-names></name><name><surname>Lee</surname> <given-names>HS</given-names></name><name><surname>Martin</surname> <given-names>J</given-names></name><name><surname>Gonzalez-Gay</surname> <given-names>MA</given-names></name><name><surname>Rodriguez-Rodriguez</surname> <given-names>L</given-names></name><name><surname>Rantapää-Dahlqvist</surname> <given-names>S</given-names></name><name><surname>Arlestig</surname> <given-names>L</given-names></name><name><surname>Choi</surname> <given-names>HK</given-names></name><name><surname>Kamatani</surname> <given-names>Y</given-names></name><name><surname>Galan</surname> <given-names>P</given-names></name><name><surname>Lathrop</surname> <given-names>M</given-names></name><name><surname>Eyre</surname> <given-names>S</given-names></name><name><surname>Bowes</surname> <given-names>J</given-names></name><name><surname>Barton</surname> <given-names>A</given-names></name><name><surname>de Vries</surname> <given-names>N</given-names></name><name><surname>Moreland</surname> <given-names>LW</given-names></name><name><surname>Criswell</surname> <given-names>LA</given-names></name><name><surname>Karlson</surname> <given-names>EW</given-names></name><name><surname>Taniguchi</surname> <given-names>A</given-names></name><name><surname>Yamada</surname> <given-names>R</given-names></name><name><surname>Kubo</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>JS</given-names></name><name><surname>Bae</surname> <given-names>SC</given-names></name><name><surname>Worthington</surname> <given-names>J</given-names></name><name><surname>Padyukov</surname> <given-names>L</given-names></name><name><surname>Klareskog</surname> <given-names>L</given-names></name><name><surname>Gregersen</surname> <given-names>PK</given-names></name><name><surname>Raychaudhuri</surname> <given-names>S</given-names></name><name><surname>Stranger</surname> <given-names>BE</given-names></name><name><surname>De Jager</surname> <given-names>PL</given-names></name><name><surname>Franke</surname> <given-names>L</given-names></name><name><surname>Visscher</surname> <given-names>PM</given-names></name><name><surname>Brown</surname> <given-names>MA</given-names></name><name><surname>Yamanaka</surname> <given-names>H</given-names></name><name><surname>Mimori</surname> <given-names>T</given-names></name><name><surname>Takahashi</surname> <given-names>A</given-names></name><name><surname>Xu</surname> <given-names>H</given-names></name><name><surname>Behrens</surname> <given-names>TW</given-names></name><name><surname>Siminovitch</surname> <given-names>KA</given-names></name><name><surname>Momohara</surname> <given-names>S</given-names></name><name><surname>Matsuda</surname> <given-names>F</given-names></name><name><surname>Yamamoto</surname> <given-names>K</given-names></name><name><surname>Plenge</surname> <given-names>RM</given-names></name><collab>RACI consortium</collab><collab>GARNET consortium</collab></person-group><year iso-8601-date="2014">2014</year><article-title>Genetics of rheumatoid arthritis contributes to biology and drug discovery</article-title><source>Nature</source><volume>506</volume><fpage>376</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1038/nature12873</pub-id><pub-id pub-id-type="pmid">24390342</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onengut-Gumuscu</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>WM</given-names></name><name><surname>Burren</surname> <given-names>O</given-names></name><name><surname>Cooper</surname> <given-names>NJ</given-names></name><name><surname>Quinlan</surname> <given-names>AR</given-names></name><name><surname>Mychaleckyj</surname> <given-names>JC</given-names></name><name><surname>Farber</surname> <given-names>E</given-names></name><name><surname>Bonnie</surname> <given-names>JK</given-names></name><name><surname>Szpak</surname> <given-names>M</given-names></name><name><surname>Schofield</surname> <given-names>E</given-names></name><name><surname>Achuthan</surname> <given-names>P</given-names></name><name><surname>Guo</surname> <given-names>H</given-names></name><name><surname>Fortune</surname> <given-names>MD</given-names></name><name><surname>Stevens</surname> <given-names>H</given-names></name><name><surname>Walker</surname> <given-names>NM</given-names></name><name><surname>Ward</surname> <given-names>LD</given-names></name><name><surname>Kundaje</surname> <given-names>A</given-names></name><name><surname>Kellis</surname> <given-names>M</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>Barrett</surname> <given-names>JC</given-names></name><name><surname>Cooper</surname> <given-names>JD</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><name><surname>Todd</surname> <given-names>JA</given-names></name><name><surname>Wallace</surname> <given-names>C</given-names></name><name><surname>Concannon</surname> <given-names>P</given-names></name><name><surname>Rich</surname> <given-names>SS</given-names></name><collab>Type 1 Diabetes Genetics Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers</article-title><source>Nature Genetics</source><volume>47</volume><fpage>381</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1038/ng.3245</pub-id><pub-id pub-id-type="pmid">25751624</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ongen</surname> <given-names>H</given-names></name><name><surname>Dermitzakis</surname> <given-names>ET</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Alternative splicing QTLs in european and african populations</article-title><source>The American Journal of Human Genetics</source><volume>97</volume><fpage>567</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2015.09.004</pub-id><pub-id pub-id-type="pmid">26430802</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname> <given-names>S</given-names></name><name><surname>Gupta</surname> <given-names>R</given-names></name><name><surname>Kim</surname> <given-names>H</given-names></name><name><surname>Wickramasinghe</surname> <given-names>P</given-names></name><name><surname>Baubet</surname> <given-names>V</given-names></name><name><surname>Showe</surname> <given-names>LC</given-names></name><name><surname>Dahmane</surname> <given-names>N</given-names></name><name><surname>Davuluri</surname> <given-names>RV</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Alternative transcription exceeds alternative splicing in generating the transcriptome diversity of cerebellar development</article-title><source>Genome Research</source><volume>21</volume><fpage>1260</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1101/gr.120535.111</pub-id><pub-id pub-id-type="pmid">21712398</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patro</surname> <given-names>R</given-names></name><name><surname>Duggal</surname> <given-names>G</given-names></name><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Irizarry</surname> <given-names>RA</given-names></name><name><surname>Kingsford</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Salmon provides fast and bias-aware quantification of transcript expression</article-title><source>Nature Methods</source><volume>14</volume><fpage>417</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4197</pub-id><pub-id pub-id-type="pmid">28263959</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pertea</surname> <given-names>M</given-names></name><name><surname>Pertea</surname> <given-names>GM</given-names></name><name><surname>Antonescu</surname> <given-names>CM</given-names></name><name><surname>Chang</surname> <given-names>TC</given-names></name><name><surname>Mendell</surname> <given-names>JT</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>StringTie enables improved reconstruction of a transcriptome from RNA-seq reads</article-title><source>Nature Biotechnology</source><volume>33</volume><fpage>290</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1038/nbt.3122</pub-id><pub-id pub-id-type="pmid">25690850</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickrell</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Joint analysis of functional genomic data and genome-wide association studies of 18 human traits</article-title><source>The American Journal of Human Genetics</source><volume>94</volume><fpage>559</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2014.03.004</pub-id><pub-id pub-id-type="pmid">24702953</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pliner</surname> <given-names>HA</given-names></name><name><surname>Packer</surname> <given-names>JS</given-names></name><name><surname>McFaline-Figueroa</surname> <given-names>JL</given-names></name><name><surname>Cusanovich</surname> <given-names>DA</given-names></name><name><surname>Daza</surname> <given-names>RM</given-names></name><name><surname>Aghamirzaie</surname> <given-names>D</given-names></name><name><surname>Srivatsan</surname> <given-names>S</given-names></name><name><surname>Qiu</surname> <given-names>X</given-names></name><name><surname>Jackson</surname> <given-names>D</given-names></name><name><surname>Minkina</surname> <given-names>A</given-names></name><name><surname>Adey</surname> <given-names>AC</given-names></name><name><surname>Steemers</surname> <given-names>FJ</given-names></name><name><surname>Shendure</surname> <given-names>J</given-names></name><name><surname>Trapnell</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cicero predicts cis-Regulatory DNA interactions from Single-Cell chromatin accessibility data</article-title><source>Molecular Cell</source><volume>71</volume><fpage>858</fpage><lpage>871</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.06.044</pub-id><pub-id pub-id-type="pmid">30078726</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes</surname> <given-names>A</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Alternative start and termination sites of transcription drive most transcript isoform differences across human tissues</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>582</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx1165</pub-id><pub-id pub-id-type="pmid">29202200</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname> <given-names>AL</given-names></name><name><surname>Watza</surname> <given-names>D</given-names></name><name><surname>Findley</surname> <given-names>A</given-names></name><name><surname>Alazizi</surname> <given-names>A</given-names></name><name><surname>Wen</surname> <given-names>X</given-names></name><name><surname>Pai</surname> <given-names>AA</given-names></name><name><surname>Pique-Regi</surname> <given-names>R</given-names></name><name><surname>Luca</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Environmental perturbations lead to extensive directional shifts in RNA processing</article-title><source>PLOS Genetics</source><volume>13</volume><elocation-id>e1006995</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006995</pub-id><pub-id pub-id-type="pmid">29023442</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname> <given-names>A</given-names></name><name><surname>Trapnell</surname> <given-names>C</given-names></name><name><surname>Donaghey</surname> <given-names>J</given-names></name><name><surname>Rinn</surname> <given-names>JL</given-names></name><name><surname>Pachter</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Improving RNA-Seq expression estimates by correcting for fragment bias</article-title><source>Genome Biology</source><volume>12</volume><elocation-id>R22</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2011-12-3-r22</pub-id><pub-id pub-id-type="pmid">21410973</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab></person-group><year iso-8601-date="2014">2014</year><article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title><source>Nature</source><volume>511</volume><fpage>421</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1038/nature13595</pub-id><pub-id pub-id-type="pmid">25056061</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soneson</surname> <given-names>C</given-names></name><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Robinson</surname> <given-names>MD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences</article-title><source>F1000Research</source><volume>4</volume><fpage>1521</fpage><pub-id pub-id-type="doi">10.12688/f1000research.7563.1</pub-id><pub-id pub-id-type="pmid">26925227</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Soneson</surname> <given-names>C</given-names></name><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Patro</surname> <given-names>R</given-names></name><name><surname>Hussain</surname> <given-names>S</given-names></name><name><surname>Malhotra</surname> <given-names>D</given-names></name><name><surname>Robinson</surname> <given-names>MD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A junction coverage compatibility score to quantify the reliability of transcript abundance estimates and annotation catalogs</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/378539</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Sterne-Weiler</surname> <given-names>T</given-names></name><name><surname>Weatheritt</surname> <given-names>RJ</given-names></name><name><surname>Best</surname> <given-names>A</given-names></name><name><surname>Kch</surname> <given-names>H</given-names></name><name><surname>Blencowe</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Whippet: an efficient method for the detection and quantification of alternative splicing reveals extensive transcriptomic complexity</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/158519</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname> <given-names>M</given-names></name><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Davis</surname> <given-names>CA</given-names></name><name><surname>Djebali</surname> <given-names>S</given-names></name><name><surname>Dobin</surname> <given-names>A</given-names></name><name><surname>Graveley</surname> <given-names>BR</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Mason</surname> <given-names>CE</given-names></name><name><surname>Olson</surname> <given-names>S</given-names></name><name><surname>Pervouchine</surname> <given-names>D</given-names></name><name><surname>Sloan</surname> <given-names>CA</given-names></name><name><surname>Wei</surname> <given-names>X</given-names></name><name><surname>Zhan</surname> <given-names>L</given-names></name><name><surname>Irizarry</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A benchmark for RNA-seq quantification pipelines</article-title><source>Genome Biology</source><volume>17</volume><elocation-id>74</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-016-0940-1</pub-id><pub-id pub-id-type="pmid">27107712</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trynka</surname> <given-names>G</given-names></name><name><surname>Hunt</surname> <given-names>KA</given-names></name><name><surname>Bockett</surname> <given-names>NA</given-names></name><name><surname>Romanos</surname> <given-names>J</given-names></name><name><surname>Mistry</surname> <given-names>V</given-names></name><name><surname>Szperl</surname> <given-names>A</given-names></name><name><surname>Bakker</surname> <given-names>SF</given-names></name><name><surname>Bardella</surname> <given-names>MT</given-names></name><name><surname>Bhaw-Rosun</surname> <given-names>L</given-names></name><name><surname>Castillejo</surname> <given-names>G</given-names></name><name><surname>de la Concha</surname> <given-names>EG</given-names></name><name><surname>de Almeida</surname> <given-names>RC</given-names></name><name><surname>Dias</surname> <given-names>KR</given-names></name><name><surname>van Diemen</surname> <given-names>CC</given-names></name><name><surname>Dubois</surname> <given-names>PC</given-names></name><name><surname>Duerr</surname> <given-names>RH</given-names></name><name><surname>Edkins</surname> <given-names>S</given-names></name><name><surname>Franke</surname> <given-names>L</given-names></name><name><surname>Fransen</surname> <given-names>K</given-names></name><name><surname>Gutierrez</surname> <given-names>J</given-names></name><name><surname>Heap</surname> <given-names>GA</given-names></name><name><surname>Hrdlickova</surname> <given-names>B</given-names></name><name><surname>Hunt</surname> <given-names>S</given-names></name><name><surname>Plaza Izurieta</surname> <given-names>L</given-names></name><name><surname>Izzo</surname> <given-names>V</given-names></name><name><surname>Joosten</surname> <given-names>LA</given-names></name><name><surname>Langford</surname> <given-names>C</given-names></name><name><surname>Mazzilli</surname> <given-names>MC</given-names></name><name><surname>Mein</surname> <given-names>CA</given-names></name><name><surname>Midah</surname> <given-names>V</given-names></name><name><surname>Mitrovic</surname> <given-names>M</given-names></name><name><surname>Mora</surname> <given-names>B</given-names></name><name><surname>Morelli</surname> <given-names>M</given-names></name><name><surname>Nutland</surname> <given-names>S</given-names></name><name><surname>Núñez</surname> <given-names>C</given-names></name><name><surname>Onengut-Gumuscu</surname> <given-names>S</given-names></name><name><surname>Pearce</surname> <given-names>K</given-names></name><name><surname>Platteel</surname> <given-names>M</given-names></name><name><surname>Polanco</surname> <given-names>I</given-names></name><name><surname>Potter</surname> <given-names>S</given-names></name><name><surname>Ribes-Koninckx</surname> <given-names>C</given-names></name><name><surname>Ricaño-Ponce</surname> <given-names>I</given-names></name><name><surname>Rich</surname> <given-names>SS</given-names></name><name><surname>Rybak</surname> <given-names>A</given-names></name><name><surname>Santiago</surname> <given-names>JL</given-names></name><name><surname>Senapati</surname> <given-names>S</given-names></name><name><surname>Sood</surname> <given-names>A</given-names></name><name><surname>Szajewska</surname> <given-names>H</given-names></name><name><surname>Troncone</surname> <given-names>R</given-names></name><name><surname>Varadé</surname> <given-names>J</given-names></name><name><surname>Wallace</surname> <given-names>C</given-names></name><name><surname>Wolters</surname> <given-names>VM</given-names></name><name><surname>Zhernakova</surname> <given-names>A</given-names></name><name><surname>Thelma</surname> <given-names>BK</given-names></name><name><surname>Cukrowska</surname> <given-names>B</given-names></name><name><surname>Urcelay</surname> <given-names>E</given-names></name><name><surname>Bilbao</surname> <given-names>JR</given-names></name><name><surname>Mearin</surname> <given-names>ML</given-names></name><name><surname>Barisani</surname> <given-names>D</given-names></name><name><surname>Barrett</surname> <given-names>JC</given-names></name><name><surname>Plagnol</surname> <given-names>V</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><name><surname>Wijmenga</surname> <given-names>C</given-names></name><name><surname>van Heel</surname> <given-names>DA</given-names></name><collab>Spanish Consortium on the Genetics of Coeliac Disease (CEGEC)</collab><collab>PreventCD Study Group</collab><collab>Wellcome Trust Case Control Consortium (WTCCC)</collab></person-group><year iso-8601-date="2011">2011</year><article-title>Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease</article-title><source>Nature Genetics</source><volume>43</volume><fpage>1193</fpage><lpage>1201</lpage><pub-id pub-id-type="doi">10.1038/ng.998</pub-id><pub-id pub-id-type="pmid">22057235</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Nostrand</surname> <given-names>EL</given-names></name><name><surname>Pratt</surname> <given-names>GA</given-names></name><name><surname>Shishkin</surname> <given-names>AA</given-names></name><name><surname>Gelboin-Burkhart</surname> <given-names>C</given-names></name><name><surname>Fang</surname> <given-names>MY</given-names></name><name><surname>Sundararaman</surname> <given-names>B</given-names></name><name><surname>Blue</surname> <given-names>SM</given-names></name><name><surname>Nguyen</surname> <given-names>TB</given-names></name><name><surname>Surka</surname> <given-names>C</given-names></name><name><surname>Elkins</surname> <given-names>K</given-names></name><name><surname>Stanton</surname> <given-names>R</given-names></name><name><surname>Rigo</surname> <given-names>F</given-names></name><name><surname>Guttman</surname> <given-names>M</given-names></name><name><surname>Yeo</surname> <given-names>GW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP)</article-title><source>Nature Methods</source><volume>13</volume><fpage>508</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3810</pub-id><pub-id pub-id-type="pmid">27018577</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Van Nostrand</surname> <given-names>EL</given-names></name><name><surname>Freese</surname> <given-names>P</given-names></name><name><surname>Pratt</surname> <given-names>GA</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Wei</surname> <given-names>X</given-names></name><name><surname>Blue</surname> <given-names>SM</given-names></name><name><surname>Dominguez</surname> <given-names>D</given-names></name><name><surname>Cody</surname> <given-names>NAL</given-names></name><name><surname>Olson</surname> <given-names>S</given-names></name><name><surname>Sundararaman</surname> <given-names>B</given-names></name><name><surname>Xiao</surname> <given-names>R</given-names></name><name><surname>Zhan</surname> <given-names>L</given-names></name><name><surname>Bazile</surname> <given-names>C</given-names></name><name><surname>Bouvrette</surname> <given-names>LPB</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Duff</surname> <given-names>MO</given-names></name><name><surname>Garcia</surname> <given-names>K</given-names></name><name><surname>Gelboin-Burkhart</surname> <given-names>C</given-names></name><name><surname>Hochman</surname> <given-names>A</given-names></name><name><surname>Lambert</surname> <given-names>NJ</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Nguyen</surname> <given-names>TB</given-names></name><name><surname>Palden</surname> <given-names>T</given-names></name><name><surname>Rabano</surname> <given-names>I</given-names></name><name><surname>Sathe</surname> <given-names>S</given-names></name><name><surname>Stanton</surname> <given-names>R</given-names></name><name><surname>Louie</surname> <given-names>AL</given-names></name><name><surname>Aigner</surname> <given-names>S</given-names></name><name><surname>Bergalet</surname> <given-names>J</given-names></name><name><surname>Zhou</surname> <given-names>B</given-names></name><name><surname>Su</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>R</given-names></name><name><surname>Yee</surname> <given-names>BA</given-names></name><name><surname>X-d</surname> <given-names>F</given-names></name><name><surname>Lecuyer</surname> <given-names>E</given-names></name><name><surname>Burge</surname> <given-names>CB</given-names></name><name><surname>Graveley</surname> <given-names>B</given-names></name><name><surname>Yeo</surname> <given-names>GW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A Large-Scale binding and functional map of human RNA binding proteins</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/179648</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaquero-Garcia</surname> <given-names>J</given-names></name><name><surname>Barrera</surname> <given-names>A</given-names></name><name><surname>Gazzara</surname> <given-names>MR</given-names></name><name><surname>González-Vallinas</surname> <given-names>J</given-names></name><name><surname>Lahens</surname> <given-names>NF</given-names></name><name><surname>Hogenesch</surname> <given-names>JB</given-names></name><name><surname>Lynch</surname> <given-names>KW</given-names></name><name><surname>Barash</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A new view of transcriptome complexity and regulation through the lens of local splicing variations</article-title><source>eLife</source><volume>5</volume><elocation-id>e11752</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.11752</pub-id><pub-id pub-id-type="pmid">26829591</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname> <given-names>GP</given-names></name><name><surname>Kin</surname> <given-names>K</given-names></name><name><surname>Lynch</surname> <given-names>VJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Measurement of mRNA abundance using RNA-seq data: rpkm measure is inconsistent among samples</article-title><source>Theory in Biosciences</source><volume>131</volume><fpage>281</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1007/s12064-012-0162-3</pub-id><pub-id pub-id-type="pmid">22872506</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Q</given-names></name><name><surname>Rio</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>JUM is a computational method for comprehensive annotation-free analysis of alternative pre-mRNA splicing patterns</article-title><source>PNAS</source><volume>115</volume><fpage>E8181</fpage><lpage>E8190</lpage><pub-id pub-id-type="doi">10.1073/pnas.1806018115</pub-id><pub-id pub-id-type="pmid">30104386</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname> <given-names>CJ</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Villani</surname> <given-names>AC</given-names></name><name><surname>Gate</surname> <given-names>RE</given-names></name><name><surname>Subramaniam</surname> <given-names>M</given-names></name><name><surname>Bhangale</surname> <given-names>T</given-names></name><name><surname>Lee</surname> <given-names>MN</given-names></name><name><surname>Raj</surname> <given-names>T</given-names></name><name><surname>Raychowdhury</surname> <given-names>R</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Rogel</surname> <given-names>N</given-names></name><name><surname>Simmons</surname> <given-names>S</given-names></name><name><surname>Imboywa</surname> <given-names>SH</given-names></name><name><surname>Chipendo</surname> <given-names>PI</given-names></name><name><surname>McCabe</surname> <given-names>C</given-names></name><name><surname>Lee</surname> <given-names>MH</given-names></name><name><surname>Frohlich</surname> <given-names>IY</given-names></name><name><surname>Stranger</surname> <given-names>BE</given-names></name><name><surname>De Jager</surname> <given-names>PL</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name><name><surname>Behrens</surname> <given-names>T</given-names></name><name><surname>Hacohen</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genetic analysis of isoform usage in the human anti-viral response reveals influenza-specific regulation of <italic>ERAP2</italic> transcripts under balancing selection</article-title><source>Genome Research</source><volume>28</volume><pub-id pub-id-type="doi">10.1101/gr.240390.118</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zerbino</surname> <given-names>DR</given-names></name><name><surname>Achuthan</surname> <given-names>P</given-names></name><name><surname>Akanni</surname> <given-names>W</given-names></name><name><surname>Amode</surname> <given-names>MR</given-names></name><name><surname>Barrell</surname> <given-names>D</given-names></name><name><surname>Bhai</surname> <given-names>J</given-names></name><name><surname>Billis</surname> <given-names>K</given-names></name><name><surname>Cummins</surname> <given-names>C</given-names></name><name><surname>Gall</surname> <given-names>A</given-names></name><name><surname>Girón</surname> <given-names>CG</given-names></name><name><surname>Gil</surname> <given-names>L</given-names></name><name><surname>Gordon</surname> <given-names>L</given-names></name><name><surname>Haggerty</surname> <given-names>L</given-names></name><name><surname>Haskell</surname> <given-names>E</given-names></name><name><surname>Hourlier</surname> <given-names>T</given-names></name><name><surname>Izuogu</surname> <given-names>OG</given-names></name><name><surname>Janacek</surname> <given-names>SH</given-names></name><name><surname>Juettemann</surname> <given-names>T</given-names></name><name><surname>To</surname> <given-names>JK</given-names></name><name><surname>Laird</surname> <given-names>MR</given-names></name><name><surname>Lavidas</surname> <given-names>I</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Loveland</surname> <given-names>JE</given-names></name><name><surname>Maurel</surname> <given-names>T</given-names></name><name><surname>McLaren</surname> <given-names>W</given-names></name><name><surname>Moore</surname> <given-names>B</given-names></name><name><surname>Mudge</surname> <given-names>J</given-names></name><name><surname>Murphy</surname> <given-names>DN</given-names></name><name><surname>Newman</surname> <given-names>V</given-names></name><name><surname>Nuhn</surname> <given-names>M</given-names></name><name><surname>Ogeh</surname> <given-names>D</given-names></name><name><surname>Ong</surname> <given-names>CK</given-names></name><name><surname>Parker</surname> <given-names>A</given-names></name><name><surname>Patricio</surname> <given-names>M</given-names></name><name><surname>Riat</surname> <given-names>HS</given-names></name><name><surname>Schuilenburg</surname> <given-names>H</given-names></name><name><surname>Sheppard</surname> <given-names>D</given-names></name><name><surname>Sparrow</surname> <given-names>H</given-names></name><name><surname>Taylor</surname> <given-names>K</given-names></name><name><surname>Thormann</surname> <given-names>A</given-names></name><name><surname>Vullo</surname> <given-names>A</given-names></name><name><surname>Walts</surname> <given-names>B</given-names></name><name><surname>Zadissa</surname> <given-names>A</given-names></name><name><surname>Frankish</surname> <given-names>A</given-names></name><name><surname>Hunt</surname> <given-names>SE</given-names></name><name><surname>Kostadima</surname> <given-names>M</given-names></name><name><surname>Langridge</surname> <given-names>N</given-names></name><name><surname>Martin</surname> <given-names>FJ</given-names></name><name><surname>Muffato</surname> <given-names>M</given-names></name><name><surname>Perry</surname> <given-names>E</given-names></name><name><surname>Ruffier</surname> <given-names>M</given-names></name><name><surname>Staines</surname> <given-names>DM</given-names></name><name><surname>Trevanion</surname> <given-names>SJ</given-names></name><name><surname>Aken</surname> <given-names>BL</given-names></name><name><surname>Cunningham</surname> <given-names>F</given-names></name><name><surname>Yates</surname> <given-names>A</given-names></name><name><surname>Flicek</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ensembl 2018</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>D754</fpage><lpage>D761</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx1098</pub-id><pub-id pub-id-type="pmid">29155950</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Sun</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Kocher</surname> <given-names>JP</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CrossMap: a versatile tool for coordinate conversion between genome assemblies</article-title><source>Bioinformatics</source><volume>30</volume><fpage>1006</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt730</pub-id><pub-id pub-id-type="pmid">24351709</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>X</given-names></name><name><surname>Levine</surname> <given-names>D</given-names></name><name><surname>Shen</surname> <given-names>J</given-names></name><name><surname>Gogarten</surname> <given-names>SM</given-names></name><name><surname>Laurie</surname> <given-names>C</given-names></name><name><surname>Weir</surname> <given-names>BS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A high-performance computing toolset for relatedness and principal component analysis of SNP data</article-title><source>Bioinformatics</source><volume>28</volume><fpage>3326</fpage><lpage>3328</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts606</pub-id><pub-id pub-id-type="pmid">23060615</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhernakova</surname> <given-names>DV</given-names></name><name><surname>de Klerk</surname> <given-names>E</given-names></name><name><surname>Westra</surname> <given-names>HJ</given-names></name><name><surname>Mastrokolias</surname> <given-names>A</given-names></name><name><surname>Amini</surname> <given-names>S</given-names></name><name><surname>Ariyurek</surname> <given-names>Y</given-names></name><name><surname>Jansen</surname> <given-names>R</given-names></name><name><surname>Penninx</surname> <given-names>BW</given-names></name><name><surname>Hottenga</surname> <given-names>JJ</given-names></name><name><surname>Willemsen</surname> <given-names>G</given-names></name><name><surname>de Geus</surname> <given-names>EJ</given-names></name><name><surname>Boomsma</surname> <given-names>DI</given-names></name><name><surname>Veldink</surname> <given-names>JH</given-names></name><name><surname>van den Berg</surname> <given-names>LH</given-names></name><name><surname>Wijmenga</surname> <given-names>C</given-names></name><name><surname>den Dunnen</surname> <given-names>JT</given-names></name><name><surname>van Ommen</surname> <given-names>GJ</given-names></name><name><surname>'t Hoen</surname> <given-names>PA</given-names></name><name><surname>Franke</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>DeepSAGE reveals genetic variants associated with alternative polyadenylation and expression of coding and non-coding transcripts</article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1003594</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003594</pub-id><pub-id pub-id-type="pmid">23818875</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.41673.039</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Parker</surname><given-names>Stephen</given-names></name><role>Reviewing Editor</role><aff><institution>University of Michigan</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Genetic effects on promoter usage are highly context-specific and contribute to complex traits&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Stephen Parker as the Reviewing Editor and Mark McCarthy as the Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Roger Pique-Regi (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>Most transcript usage QTL (tuQTL) studies do not differentiate between events leading to differential isoform usage, such as alternative promoter, alternative 3ʹ end, or alternative splicing that are a likely consequence of different molecular mechanisms. Alasoo and colleagues describe the development of such a tool – txrevise, which processes (Ensembl) transcript annotations to build an annotation of independent promoters, internal exons and 3' ends for use with an external tool such as Salmon for transcript quantification. They additionally map genetic associations for total gene expression, full length transcript usage and exon-exon junction using established methods and compare the approaches and results to those from txrevise. The authors show that promoter usage QTLs are generally more context specific and colocalize with genetic signals for complex traits. The approach is sound, and the methods/observations will be helpful to the field. The paper is well-written and we think will be appealing to a broad audience. However, there are several points that should be addressed, which we outline below.</p><p>Essential revisions:</p><p>1) There were two QTL scans done, where the initial scan happened over a smaller window. Was there any instance where the larger +/- 500 kb scan resulted in a stronger signal compared to the initial +/- 100 kb scan? If so, how were these treated?</p><p>2) More details about assignment of groups 1 and 2 during the txrevise process would be helpful. Surely there are examples that are not as simple as the one depicted in Figure 1—figure supplement 3. How are those more complicated cases treated? Another way of phrasing this: how do you decide when to choose more exons vs. fewer transcripts? Clarification of this approach will be helpful.</p><p>3) The word &quot;group&quot; may have different meanings in different sections of the txrevise methods. For example, in the last paragraph of the subsection “Quantifying transcriptional events with txrevise”, &quot;group&quot; describes the two different approaches to creating common scaffolds. At the end of the same section of the Materials and methods, it's not clear here what &quot;group&quot; means. Does it mean as above (the two different scaffold approaches) or one of the three different categories (promoter, internal, 3ʹ UTR)? Clarity here will be helpful for other labs that want to use this approach.</p><p>4) Not clear how multiple testing correction happens with txrevise – are you using the --grp-best flag across all the separate bits (promoter, internal, 3ʹ UTR) of a gene model, or only within the three different partitions? And what about across the two groups that are created? When mapping multiple QTLs, it is not clear if the authors map them all simultaneously or if they use a conditional on the lead QTL strategy. The authors should clarify this.</p><p>5) In Figure 2B, authors performed a replication analysis of QTLs. This appears to be only based on the LD between the lead QTL variants for different comparisons. However, the direction of effect size is ignored. This should also be included in all the replication analyses.</p><p>6) Given that promoter shifts are an important component of context specific tuQTL and are also enriched for complex traits, the authors could use their ATAC-seq data to further illustrate the mechanism and perhaps validate. Are changes on promoter usage dependent on the promoters being open? Do these types of tuQTL also have a QTL on ATAC-seq on the promoters? Even if the outcome is negative, which might indicate a more complex relationship between promoter usage and chromatin accessibility, this would further strengthen the manuscript.</p><p>7) The coupling part was uniformly perceived as weaker compared to the rest of the work and could be removed as it is a bit orthogonal to the main focus, especially considering it is not tied to any main figure.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.41673.040</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) There were two QTL scans done, where the initial scan happened over a smaller window. Was there any instance where the larger +/- 500 kb scan resulted in a stronger signal compared to the initial +/- 100 kb scan? If so, how were these treated?</p></disp-quote><p>We have now modified the section “Association testing” in Materials and methods to clarify that only the lead variants identified in the initial +/- 100 kb scan were used for all downstream analyses. Since genes often have multiple independent eQTLs, we think it is likely that a larger scan in a +/- 500kb window will sometimes identify stronger signals. However, we did not quantify this, because the summary statistics from the larger window were only used for colocalisation analysis based on the lead variants identified in the smaller +/- 100kb. We did this to ensure that all of the variants in the +/- 200kb region around the lead QTL variant were included in the colocalisation analysis, because truncated summary statistics can lead to overestimation of the posterior probability of colocalisation.</p><disp-quote content-type="editor-comment"><p>2) More details about assignment of groups 1 and 2 during the txrevise process would be helpful. Surely there are examples that are not as simple as the one depicted in Figure 1—figure supplement 3. How are those more complicated cases treated? Another way of phrasing this: how do you decide when to choose more exons vs. fewer transcripts? Clarification of this approach will be helpful.</p></disp-quote><p>We agree that, in general, it is not easy to automatically decide whether to prioritise more shared exons between transcripts or larger number of transcripts; indeed, txrevise does not solve this particular problem. We have now modified the legend for Figure 1—figure supplement 3 to clarify that for each gene, txrevise always identifies two groups of transcripts and then performs all of the analyses across the two groups.</p><disp-quote content-type="editor-comment"><p>3) The word &quot;group&quot; may have different meanings in different sections of the txrevise methods. For example, in the last paragraph of the subsection “Quantifying transcriptional events with txrevise”, &quot;group&quot; describes the two different approaches to creating common scaffolds. At the end of the same section of the Materials and methods, it's not clear here what &quot;group&quot; means. Does it mean as above (the two different scaffold approaches) or one of the three different categories (promoter, internal, 3' UTR)? Clarity here will be helpful for other labs that want to use this approach.</p></disp-quote><p>We thank the reviewer for pointing out these inconsistencies. We have now edited the text in the Materials and methods section (subsection “Quantifying transcriptional events with txrevise”) and in the caption for Figure 1—figure supplement 3. In particular, the term “group” now always refers to the subset of transcripts used to identify the scaffold for event constructions. For the three different categories (promoter, internal exons, 3ʹ ends) we now consistently use the term “types of transcriptional events”.</p><disp-quote content-type="editor-comment"><p>4) Not clear how multiple testing correction happens with txrevise – are you using the --grp-best flag across all the separate bits (promoter, internal, 3' UTR) of a gene model, or only within the three different partitions? And what about across the two groups that are created? When mapping multiple QTLs, it is not clear if the authors map them all simultaneously or if they use a conditional on the lead QTL strategy.</p></disp-quote><p>We have now modified the “Association testing” subsection in the Materials and methods to clarify that the permutations were performed across the two subsets of transcripts used for event construction, thus reporting at most three tuQTLs per gene, i.e. one for each event type (promoters, internal exons, 3ʹ ends). After identifying permutation p-values with QTLtools, we also use Benjamini-Hochberg correction to account for the number of independent features that we have tested. Thus, even though we test 3x more features with txrevise, we account for that by using the Benjamini-Hochberg correction. We have also clarified that we mapped multiple QTLs only in the txrevise and Leafcutter analyses, because with those approaches we tested multiple event types (promoters, internal exons, 3ʹ ends) or multiple intron clusters per gene. We did not use conditional analysis.</p><disp-quote content-type="editor-comment"><p>5) In Figure 2B, authors performed a replication analysis of QTLs. This appears to be only based on the LD between the lead QTL variants for different comparisons. However, the direction of effect size is ignored. This should also be included in all the replication analyses.</p></disp-quote><p>The replication analysis is only presented to highlight the fact that different quantification approaches detect complementary sets of genetic associations. Including the effect size direction in our analysis can only reduce the number of QTLs that replicate between methods and not increase it. Therefore, this would not change the conclusions of our analysis.</p><p>Nonetheless, we agree that including effect direction in the replication analysis would be beneficial in principle. However, defining the direction of effect in such a way that is consistent between different quantification methods is challenging. For eQTLs, a reasonable definition would be the effect size of the alternative allele on the total read count originating from the gene. However, this becomes much more challenging for full-length transcript usage QTLs, because any variant that is associated with the increased usage of one transcript is by definition also associated with decreased usage of some other transcripts of the gene (since all transcripts have to sum up to 1). Thus, it is not clear which transcript should be used to define the direction of the effect. Similarly, it is challenging to compare the direction of effect sizes between Leafcutter tuQTLs and full-length tuQTLs, because it is not clear how to map Leafcutter splicing events to specific Ensembl transcripts, especially if Leafcutter analysis includes novel splice junctions not present in Ensembl. We now explicitly acknowledge this limitation of our analysis in the Materials and methods section (subsection “QTL replication between quantification methods”).</p><disp-quote content-type="editor-comment"><p>6) Given that promoter shifts are an important component of context specific tuQTL and are also enriched for complex traits, the authors could use their ATAC-seq data to further illustrate the mechanism and perhaps validate. Are changes on promoter usage dependent on the promoters being open? Do these types of tuQTL also have a QTL on ATAC-seq on the promoters? Even if the outcome is negative, which might indicate a more complex relationship between promoter usage and chromatin accessibility, this would further strengthen the manuscript.</p></disp-quote><p>We thank the reviewers for this excellent suggestion. We have now performed additional analysis assessing the overlap between promoter usage QTLs that we detect in our current study and chromatin accessibility QTLs that we have reported previously (Alasoo et al., 2018). These analyses revealed that 6% of the promoter usage QTLs are linked to putative coordinated changes in promoter accessibility (r<sup>2</sup> &gt; 0.9 between the lead variants) (subsection “Genomic properties of transcript usage QTLs”, third paragraph). To illustrate how this can yield mechanistic insight into promoter usage QTLs, we now also discuss one such example in more detail, as shown in Figure 2—figure supplement 7. We further describe this analysis in the Discussion, noting that although the overlap that we detected is small, this is likely influenced by low power in our chromatin accessibility dataset that contained only 41 individuals (Discussion, second paragraph).</p><disp-quote content-type="editor-comment"><p>7) The coupling part was uniformly perceived as weaker compared to the rest of the work and could be removed as it is a bit orthogonal to the main focus, especially considering it is not tied to any main figure.</p></disp-quote><p>We thank the reviewers for the suggestion. We initially added this section to justify the need for event-level analysis. However, we agree that it is orthogonal to the main focus of the paper and we have now removed this section as well as Supplementary Figure 8 from the manuscript. We have also removed the related section from the Discussion.</p></body></sub-article></article>